MXPA99002153A - Personal care compositions - Google Patents
Personal care compositionsInfo
- Publication number
- MXPA99002153A MXPA99002153A MXPA/A/1999/002153A MX9902153A MXPA99002153A MX PA99002153 A MXPA99002153 A MX PA99002153A MX 9902153 A MX9902153 A MX 9902153A MX PA99002153 A MXPA99002153 A MX PA99002153A
- Authority
- MX
- Mexico
- Prior art keywords
- units
- monomer
- copolymer
- carbon atoms
- weight
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 373
- 229920001577 copolymer Polymers 0.000 claims abstract description 327
- 239000000178 monomer Substances 0.000 claims abstract description 263
- 230000002209 hydrophobic Effects 0.000 claims abstract description 141
- 239000002904 solvent Substances 0.000 claims abstract description 137
- 150000001412 amines Chemical class 0.000 claims abstract description 71
- 125000000524 functional group Chemical group 0.000 claims abstract description 36
- 230000000536 complexating Effects 0.000 claims abstract description 14
- 230000002378 acidificating Effects 0.000 claims abstract description 10
- 125000004432 carbon atoms Chemical group C* 0.000 claims description 157
- -1 polyethylene Polymers 0.000 claims description 129
- 210000004209 Hair Anatomy 0.000 claims description 101
- 229920000642 polymer Polymers 0.000 claims description 71
- 238000006116 polymerization reaction Methods 0.000 claims description 46
- 210000003491 Skin Anatomy 0.000 claims description 42
- 239000002253 acid Substances 0.000 claims description 41
- 239000000969 carrier Substances 0.000 claims description 41
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 37
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 claims description 36
- 125000000217 alkyl group Chemical group 0.000 claims description 34
- 239000000463 material Substances 0.000 claims description 34
- CERQOIWHTDAKMF-UHFFFAOYSA-N methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 31
- 239000011780 sodium chloride Substances 0.000 claims description 28
- 150000003839 salts Chemical class 0.000 claims description 27
- 229940086555 cyclomethicone Drugs 0.000 claims description 25
- 230000003750 conditioning Effects 0.000 claims description 24
- WDQMWEYDKDCEHT-UHFFFAOYSA-N 2-ethylhexyl 2-methylprop-2-enoate Chemical compound CCCCC(CC)COC(=O)C(C)=C WDQMWEYDKDCEHT-UHFFFAOYSA-N 0.000 claims description 23
- 239000012298 atmosphere Substances 0.000 claims description 23
- UQEAIHBTYFGYIE-UHFFFAOYSA-N Hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 claims description 22
- 239000000443 aerosol Substances 0.000 claims description 21
- 125000003545 alkoxy group Chemical group 0.000 claims description 21
- 150000002148 esters Chemical class 0.000 claims description 20
- 238000007334 copolymerization reaction Methods 0.000 claims description 19
- 229920001296 polysiloxane Polymers 0.000 claims description 19
- 239000002453 shampoo Substances 0.000 claims description 18
- 239000004094 surface-active agent Substances 0.000 claims description 18
- 238000009835 boiling Methods 0.000 claims description 17
- 239000000499 gel Substances 0.000 claims description 16
- 150000002430 hydrocarbons Chemical class 0.000 claims description 16
- 229910052799 carbon Inorganic materials 0.000 claims description 15
- 125000004122 cyclic group Chemical group 0.000 claims description 15
- 125000001931 aliphatic group Chemical group 0.000 claims description 14
- 239000006260 foam Substances 0.000 claims description 14
- RRHGJUQNOFWUDK-UHFFFAOYSA-N isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 claims description 14
- 150000001298 alcohols Chemical class 0.000 claims description 13
- 229910052739 hydrogen Inorganic materials 0.000 claims description 13
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 13
- 239000003999 initiator Substances 0.000 claims description 13
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 13
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-Methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 239000001257 hydrogen Substances 0.000 claims description 12
- 125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 claims description 12
- 229920002367 Polyisobutene Polymers 0.000 claims description 11
- 125000004181 carboxyalkyl group Chemical group 0.000 claims description 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- 150000007524 organic acids Chemical class 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 11
- 125000003118 aryl group Chemical group 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- 239000007921 spray Substances 0.000 claims description 10
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 9
- 239000006210 lotion Substances 0.000 claims description 9
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 8
- 230000001166 anti-perspirant Effects 0.000 claims description 8
- 239000003213 antiperspirant Substances 0.000 claims description 8
- 150000003512 tertiary amines Chemical class 0.000 claims description 8
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 claims description 7
- 230000003255 anti-acne Effects 0.000 claims description 7
- 230000000845 anti-microbial Effects 0.000 claims description 7
- 239000006071 cream Substances 0.000 claims description 7
- 150000002431 hydrogen Chemical group 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 7
- 230000001256 tonic Effects 0.000 claims description 7
- 235000015961 tonic Nutrition 0.000 claims description 7
- DFVOXRAAHOJJBN-UHFFFAOYSA-N 6-methylhept-1-ene Chemical compound CC(C)CCCC=C DFVOXRAAHOJJBN-UHFFFAOYSA-N 0.000 claims description 6
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims description 6
- 230000000202 analgesic Effects 0.000 claims description 6
- 239000002781 deodorant agent Substances 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 235000005985 organic acids Nutrition 0.000 claims description 6
- 239000000344 soap Substances 0.000 claims description 6
- SJMYWORNLPSJQO-UHFFFAOYSA-N tert-butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(C)(C)C SJMYWORNLPSJQO-UHFFFAOYSA-N 0.000 claims description 6
- OZCMOJQQLBXBKI-UHFFFAOYSA-N 1-ethenoxy-2-methylpropane Chemical compound CC(C)COC=C OZCMOJQQLBXBKI-UHFFFAOYSA-N 0.000 claims description 5
- DXIJHCSGLOHNES-UHFFFAOYSA-N 3,3-dimethylbut-1-enylbenzene Chemical compound CC(C)(C)C=CC1=CC=CC=C1 DXIJHCSGLOHNES-UHFFFAOYSA-N 0.000 claims description 5
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinylpyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 5
- 125000003282 alkyl amino group Chemical group 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 239000003093 cationic surfactant Substances 0.000 claims description 5
- 230000001815 facial Effects 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 229920000768 polyamine Chemical group 0.000 claims description 5
- PPBRXRYQALVLMV-UHFFFAOYSA-N styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 5
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 claims description 4
- JGRXEBOFWPLEAV-UHFFFAOYSA-N 2-ethylbutyl prop-2-enoate Chemical compound CCC(CC)COC(=O)C=C JGRXEBOFWPLEAV-UHFFFAOYSA-N 0.000 claims description 4
- SEDMFAYCVMLBFB-UHFFFAOYSA-N 2-methylpentyl prop-2-enoate Chemical compound CCCC(C)COC(=O)C=C SEDMFAYCVMLBFB-UHFFFAOYSA-N 0.000 claims description 4
- ZVYGIPWYVVJFRW-UHFFFAOYSA-N 3-methylbutyl prop-2-enoate Chemical compound CC(C)CCOC(=O)C=C ZVYGIPWYVVJFRW-UHFFFAOYSA-N 0.000 claims description 4
- 239000004909 Moisturizer Substances 0.000 claims description 4
- 229940088644 N,N-dimethylacrylamide Drugs 0.000 claims description 4
- YLGYACDQVQQZSW-UHFFFAOYSA-N N,N-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 claims description 4
- 229960000716 TONICS Drugs 0.000 claims description 4
- 230000003444 anaesthetic Effects 0.000 claims description 4
- 239000003908 antipruritic agent Substances 0.000 claims description 4
- 125000004429 atoms Chemical group 0.000 claims description 4
- GUOJYIXWHMJFDM-UHFFFAOYSA-N decan-2-yl prop-2-enoate Chemical compound CCCCCCCCC(C)OC(=O)C=C GUOJYIXWHMJFDM-UHFFFAOYSA-N 0.000 claims description 4
- GTBGXKPAKVYEKJ-UHFFFAOYSA-N decyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCOC(=O)C(C)=C GTBGXKPAKVYEKJ-UHFFFAOYSA-N 0.000 claims description 4
- PBOSTUDLECTMNL-UHFFFAOYSA-N dodecyl prop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C=C PBOSTUDLECTMNL-UHFFFAOYSA-N 0.000 claims description 4
- LNMQRPPRQDGUDR-UHFFFAOYSA-N hexyl prop-2-enoate Chemical compound CCCCCCOC(=O)C=C LNMQRPPRQDGUDR-UHFFFAOYSA-N 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 230000001333 moisturizer Effects 0.000 claims description 4
- MDYPDLBFDATSCF-UHFFFAOYSA-N nonyl prop-2-enoate Chemical compound CCCCCCCCCOC(=O)C=C MDYPDLBFDATSCF-UHFFFAOYSA-N 0.000 claims description 4
- HMZGPNHSPWNGEP-UHFFFAOYSA-N octadecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C(C)=C HMZGPNHSPWNGEP-UHFFFAOYSA-N 0.000 claims description 4
- NZIDBRBFGPQCRY-UHFFFAOYSA-N octyl 2-methylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C(C)=C NZIDBRBFGPQCRY-UHFFFAOYSA-N 0.000 claims description 4
- 239000002674 ointment Substances 0.000 claims description 4
- GYDSPAVLTMAXHT-UHFFFAOYSA-N pentyl 2-methylprop-2-enoate Chemical compound CCCCCOC(=O)C(C)=C GYDSPAVLTMAXHT-UHFFFAOYSA-N 0.000 claims description 4
- 229920002589 poly(vinylethylene) polymer Polymers 0.000 claims description 4
- 229920000058 polyacrylate Polymers 0.000 claims description 4
- 150000003141 primary amines Chemical class 0.000 claims description 4
- PNXMTCDJUBJHQJ-UHFFFAOYSA-N propyl prop-2-enoate Chemical compound CCCOC(=O)C=C PNXMTCDJUBJHQJ-UHFFFAOYSA-N 0.000 claims description 4
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 claims description 3
- KLCNJIQZXOQYTE-UHFFFAOYSA-N 4,4-dimethylpent-1-ene Chemical compound CC(C)(C)CC=C KLCNJIQZXOQYTE-UHFFFAOYSA-N 0.000 claims description 3
- FQPSGWSUVKBHSU-UHFFFAOYSA-N Methacrylamide Chemical class CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 claims description 3
- 206010040829 Skin discolouration Diseases 0.000 claims description 3
- 150000003926 acrylamides Chemical class 0.000 claims description 3
- 150000008051 alkyl sulfates Chemical class 0.000 claims description 3
- 125000000746 allylic group Chemical group 0.000 claims description 3
- 150000001450 anions Chemical class 0.000 claims description 3
- 230000001139 anti-pruritic Effects 0.000 claims description 3
- QNRMTGGDHLBXQZ-UHFFFAOYSA-N buta-1,2-diene Chemical compound CC=C=C QNRMTGGDHLBXQZ-UHFFFAOYSA-N 0.000 claims description 3
- KAKZBPTYRLMSJV-UHFFFAOYSA-N butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- SCFQUKBBGYTJNC-UHFFFAOYSA-N heptyl prop-2-enoate Chemical compound CCCCCCCOC(=O)C=C SCFQUKBBGYTJNC-UHFFFAOYSA-N 0.000 claims description 3
- 150000003949 imides Chemical class 0.000 claims description 3
- 230000000977 initiatory Effects 0.000 claims description 3
- VQTUBCCKSQIDNK-UHFFFAOYSA-N isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 claims description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-M methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 3
- 150000003335 secondary amines Chemical class 0.000 claims description 3
- NVZWEEGUWXZOKI-UHFFFAOYSA-N 1-ethenyl-2-methylbenzene Chemical compound CC1=CC=CC=C1C=C NVZWEEGUWXZOKI-UHFFFAOYSA-N 0.000 claims description 2
- JZHGRUMIRATHIU-UHFFFAOYSA-N 1-ethenyl-3-methylbenzene Chemical compound CC1=CC=CC(C=C)=C1 JZHGRUMIRATHIU-UHFFFAOYSA-N 0.000 claims description 2
- JLBJTVDPSNHSKJ-UHFFFAOYSA-N 1-ethenyl-4-methylbenzene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 claims description 2
- 125000006017 1-propenyl group Chemical group 0.000 claims description 2
- LUECERFWADIZPD-UHFFFAOYSA-N 1-tert-butyl-2-ethenylbenzene Chemical compound CC(C)(C)C1=CC=CC=C1C=C LUECERFWADIZPD-UHFFFAOYSA-N 0.000 claims description 2
- CFVWNXQPGQOHRJ-UHFFFAOYSA-N 2-methylpropyl prop-2-enoate Chemical compound CC(C)COC(=O)C=C CFVWNXQPGQOHRJ-UHFFFAOYSA-N 0.000 claims description 2
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims description 2
- 229920001748 Polybutylene Polymers 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical group N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 2
- 230000000903 blocking Effects 0.000 claims description 2
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 claims description 2
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 claims description 2
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims description 2
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxyl anion Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 2
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl radical Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 claims description 2
- 229940065472 octyl acrylate Drugs 0.000 claims description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- ANISOHQJBAQUQP-UHFFFAOYSA-N octyl prop-2-enoate Chemical compound CCCCCCCCOC(=O)C=C ANISOHQJBAQUQP-UHFFFAOYSA-N 0.000 claims description 2
- 229920000196 poly(lauryl methacrylate) Polymers 0.000 claims description 2
- 229920000129 polyhexylmethacrylate Polymers 0.000 claims description 2
- 229920000197 polyisopropyl acrylate Polymers 0.000 claims description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 claims description 2
- KEROTHRUZYBWCY-UHFFFAOYSA-N tridecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCOC(=O)C(C)=C KEROTHRUZYBWCY-UHFFFAOYSA-N 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- XFHJDMUEHUHAJW-UHFFFAOYSA-N N-tert-butylprop-2-enamide Chemical compound CC(C)(C)NC(=O)C=C XFHJDMUEHUHAJW-UHFFFAOYSA-N 0.000 claims 2
- 239000004698 Polyethylene (PE) Substances 0.000 claims 2
- 150000007513 acids Chemical class 0.000 claims 2
- 150000008064 anhydrides Chemical class 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000002573 ethenylidene group Chemical group [*]=C=C([H])[H] 0.000 claims 2
- 150000002734 metacrylic acid derivatives Chemical class 0.000 claims 2
- 229920000573 polyethylene Polymers 0.000 claims 2
- ZKYCLDTVJCJYIB-UHFFFAOYSA-N 2-methylidenedecanamide Chemical compound CCCCCCCCC(=C)C(N)=O ZKYCLDTVJCJYIB-UHFFFAOYSA-N 0.000 claims 1
- 241000127225 Enceliopsis nudicaulis Species 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 150000002978 peroxides Chemical class 0.000 claims 1
- 229920000212 poly(isobutyl acrylate) Polymers 0.000 claims 1
- YZCKVEUIGOORGS-IGMARMGPSA-N protium Chemical compound [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 claims 1
- 230000003381 solubilizing Effects 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 58
- 239000000047 product Substances 0.000 description 53
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 37
- WVDDGKGOMKODPV-UHFFFAOYSA-N benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 33
- 239000000243 solution Substances 0.000 description 33
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 26
- 230000014759 maintenance of location Effects 0.000 description 25
- 239000012071 phase Substances 0.000 description 25
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 24
- 238000010348 incorporation Methods 0.000 description 19
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 18
- 239000000839 emulsion Substances 0.000 description 18
- 239000000126 substance Substances 0.000 description 18
- 230000000699 topical Effects 0.000 description 18
- 239000004205 dimethyl polysiloxane Substances 0.000 description 17
- 239000002304 perfume Substances 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 15
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 13
- 239000003995 emulsifying agent Substances 0.000 description 13
- 239000004615 ingredient Substances 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 229910052757 nitrogen Inorganic materials 0.000 description 12
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 11
- 235000019445 benzyl alcohol Nutrition 0.000 description 11
- 239000007810 chemical reaction solvent Substances 0.000 description 11
- 239000002537 cosmetic Substances 0.000 description 11
- 229920001888 polyacrylic acid Polymers 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 229940008099 dimethicone Drugs 0.000 description 10
- 229940073561 hexamethyldisiloxane Drugs 0.000 description 10
- 230000002194 synthesizing Effects 0.000 description 10
- BXWNKGSJHAJOGX-UHFFFAOYSA-N Cetyl alcohol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 9
- 229960000541 cetyl alcohol Drugs 0.000 description 9
- 239000000084 colloidal system Substances 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 8
- NNPPMTNAJDCUHE-UHFFFAOYSA-N Isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 8
- BEGLCMHJXHIJLR-UHFFFAOYSA-N Methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 8
- GLDOVTGHNKAZLK-UHFFFAOYSA-N Stearyl alcohol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 239000001282 iso-butane Substances 0.000 description 8
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 7
- 125000000129 anionic group Chemical group 0.000 description 7
- 229910052786 argon Inorganic materials 0.000 description 7
- 125000002091 cationic group Chemical group 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 7
- 235000021317 phosphate Nutrition 0.000 description 7
- 238000010926 purge Methods 0.000 description 7
- 150000003254 radicals Chemical class 0.000 description 7
- 239000002562 thickening agent Substances 0.000 description 7
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 6
- SFBHPFQSSDCYSL-UHFFFAOYSA-N N,N-dimethyltetradecan-1-amine Chemical compound CCCCCCCCCCCCCCN(C)C SFBHPFQSSDCYSL-UHFFFAOYSA-N 0.000 description 6
- 229940101267 Panthenol Drugs 0.000 description 6
- 229940032044 QUATERNIUM-18 Drugs 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000003945 anionic surfactant Substances 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000008266 hair spray Substances 0.000 description 6
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 235000020957 pantothenol Nutrition 0.000 description 6
- 239000011619 pantothenol Substances 0.000 description 6
- 239000003380 propellant Substances 0.000 description 6
- REYJJPSVUYRZGE-UHFFFAOYSA-N stearylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- CWSZBVAUYPTXTG-UHFFFAOYSA-N 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OCCO)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 CWSZBVAUYPTXTG-UHFFFAOYSA-N 0.000 description 5
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 5
- SNPLKNRPJHDVJA-UHFFFAOYSA-N DL-Panthenol Chemical compound OCC(C)(C)C(O)C(=O)NCCCO SNPLKNRPJHDVJA-UHFFFAOYSA-N 0.000 description 5
- 229920001451 Polypropylene glycol Polymers 0.000 description 5
- 229940057981 STEARALKONIUM CHLORIDE Drugs 0.000 description 5
- 229940105131 STEARAMINE Drugs 0.000 description 5
- SFVFIFLLYFPGHH-UHFFFAOYSA-M Stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 5
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 5
- 229910052782 aluminium Inorganic materials 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 229940079593 drugs Drugs 0.000 description 5
- 239000003974 emollient agent Substances 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 238000005755 formation reaction Methods 0.000 description 5
- 229920000578 graft polymer Polymers 0.000 description 5
- 229920000591 gum Polymers 0.000 description 5
- 229920001519 homopolymer Polymers 0.000 description 5
- 229940021182 non-steroidal anti-inflammatory drugs Drugs 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 5
- 229960003500 triclosan Drugs 0.000 description 5
- 239000000230 xanthan gum Substances 0.000 description 5
- 229920001285 xanthan gum Polymers 0.000 description 5
- 235000010493 xanthan gum Nutrition 0.000 description 5
- 229940082509 xanthan gum Drugs 0.000 description 5
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 4
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 4
- WSDISUOETYTPRL-UHFFFAOYSA-N DMDM hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 4
- NHLUVTZJQOJKCC-UHFFFAOYSA-N N,N-dimethylhexadecan-1-amine Chemical compound CCCCCCCCCCCCCCCCN(C)C NHLUVTZJQOJKCC-UHFFFAOYSA-N 0.000 description 4
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K Trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical class [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 4
- 239000003431 cross linking reagent Substances 0.000 description 4
- 229940088977 dimethyl palmitamine Drugs 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 150000002735 metacrylic acids Chemical class 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- 239000001509 sodium citrate Substances 0.000 description 4
- 239000000516 sunscreening agent Substances 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 239000011778 trisodium citrate Substances 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N 1-[(1S,2R,3R,4S,5R,6R)-3-carbamimidamido-6-{[(2R,3R,4R,5S)-3-{[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy}-2,4,5-trihydroxycyclohexyl]guanidine Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 3
- QEDJMOONZLUIMC-UHFFFAOYSA-N 1-tert-butyl-4-ethenylbenzene Chemical compound CC(C)(C)C1=CC=C(C=C)C=C1 QEDJMOONZLUIMC-UHFFFAOYSA-N 0.000 description 3
- WXZMFSXDPGVJKK-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 3
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 3
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Glycol distearate Chemical class CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 3
- NAPSCFZYZVSQHF-UHFFFAOYSA-N N,N-dimethyloctadecan-1-amine Chemical compound CCCCCCCCCCCCCCCCCCN(C)C NAPSCFZYZVSQHF-UHFFFAOYSA-N 0.000 description 3
- BTSZTGGZJQFALU-UHFFFAOYSA-N Piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 3
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 150000001253 acrylic acids Chemical class 0.000 description 3
- 125000005250 alkyl acrylate group Chemical group 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N butylene glycol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 125000004093 cyano group Chemical group *C#N 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 125000004663 dialkyl amino group Chemical group 0.000 description 3
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecan-1-amine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N edta Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000003020 moisturizing Effects 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- KCAMXZBMXVIIQN-UHFFFAOYSA-N octan-3-yl 2-methylprop-2-enoate Chemical compound CCCCCC(CC)OC(=O)C(C)=C KCAMXZBMXVIIQN-UHFFFAOYSA-N 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229950001046 piroctone Drugs 0.000 description 3
- 229920001281 polyalkylene Polymers 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 230000000475 sunscreen Effects 0.000 description 3
- QYKIQEUNHZKYBP-UHFFFAOYSA-N vinyl ether Chemical class C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 3
- 239000002888 zwitterionic surfactant Substances 0.000 description 3
- LJRDOKAZOAKLDU-UDXJMMFXSA-N (2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric ac Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO LJRDOKAZOAKLDU-UDXJMMFXSA-N 0.000 description 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 2
- IQXJCCZJOIKIAD-UHFFFAOYSA-N 1-(2-methoxyethoxy)hexadecane Chemical compound CCCCCCCCCCCCCCCCOCCOC IQXJCCZJOIKIAD-UHFFFAOYSA-N 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N 1-Decanol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 description 2
- LSMSSYSRCUNIFX-UHFFFAOYSA-N 1-methyl-4-prop-1-enylbenzene Chemical compound CC=CC1=CC=C(C)C=C1 LSMSSYSRCUNIFX-UHFFFAOYSA-N 0.000 description 2
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-Ethylhexanol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-Methyl-2,4-pentanediol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- UHZZMRAGKVHANO-UHFFFAOYSA-M 2-chloroethyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 description 2
- RUMACXVDVNRZJZ-UHFFFAOYSA-N 2-methylpropyl 2-methylprop-2-enoate Chemical compound CC(C)COC(=O)C(C)=C RUMACXVDVNRZJZ-UHFFFAOYSA-N 0.000 description 2
- XGSXUSCKTLWSLU-UHFFFAOYSA-N 3-[dimethyl(trimethylsilyloxy)silyl]propan-1-ol Chemical compound C[Si](C)(C)O[Si](C)(C)CCCO XGSXUSCKTLWSLU-UHFFFAOYSA-N 0.000 description 2
- GSSWFBLVISCYBP-UHFFFAOYSA-N 3-chloropropyl-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)CCCCl GSSWFBLVISCYBP-UHFFFAOYSA-N 0.000 description 2
- MTNDZQHUAFNZQY-UHFFFAOYSA-O 4,5-dihydro-1H-imidazol-1-ium Chemical group C1CN=C[NH2+]1 MTNDZQHUAFNZQY-UHFFFAOYSA-O 0.000 description 2
- JIUFYGIESXPUPL-UHFFFAOYSA-N 5-methylhex-1-ene Chemical compound CC(C)CCC=C JIUFYGIESXPUPL-UHFFFAOYSA-N 0.000 description 2
- 229940063953 AMMONIUM LAURYL SULFATE Drugs 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 244000144927 Aloe barbadensis Species 0.000 description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- BTBJBAZGXNKLQC-UHFFFAOYSA-N Ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 2
- 229940098691 COCO MONOETHANOLAMIDE Drugs 0.000 description 2
- 229960001631 Carbomer Drugs 0.000 description 2
- 229940075509 Carbomer 1342 Drugs 0.000 description 2
- KDLRVYVGXIQJDK-AWPVFWJPSA-N Clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 2
- 240000005497 Cyamopsis tetragonoloba Species 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-α-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N Decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- USIUVYZYUHIAEV-UHFFFAOYSA-N Diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N Eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N Kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 229940078555 MYRISTYL PROPIONATE Drugs 0.000 description 2
- MHIGBKBJSQVXNH-IWVLMIASSA-N Metacycline Chemical compound C=C([C@H]1[C@@H]2O)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O MHIGBKBJSQVXNH-IWVLMIASSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N Methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 2
- FMJSMJQBSVNSBF-UHFFFAOYSA-N Octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl methoxycinnamate Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N Oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- XDRYMKDFEDOLFX-UHFFFAOYSA-N Pentamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCOC1=CC=C(C(N)=N)C=C1 XDRYMKDFEDOLFX-UHFFFAOYSA-N 0.000 description 2
- 229960004448 Pentamidine Drugs 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N Resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N Simethicone Chemical class C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- OFVLGDICTFRJMM-WESIUVDSSA-N Tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 2
- 229960002180 Tetracycline Drugs 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- BGHCVCJVXZWKCC-UHFFFAOYSA-N Tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 2
- NLVFBUXFDBBNBW-PBSUHMDJSA-N Tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 2
- SHGAZHPCJJPHSC-NWVFGJFESA-N Tretinoin Chemical compound OC(=O)/C=C(\C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NWVFGJFESA-N 0.000 description 2
- 229960001727 Tretinoin Drugs 0.000 description 2
- 229920001567 Vinyl ester Polymers 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229940046282 Zinc Drugs 0.000 description 2
- 229940091251 Zinc Supplements Drugs 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000005210 alkyl ammonium group Chemical group 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- OPVLOHUACNWTQT-UHFFFAOYSA-N azane;2-dodecoxyethyl hydrogen sulfate Chemical compound N.CCCCCCCCCCCCOCCOS(O)(=O)=O OPVLOHUACNWTQT-UHFFFAOYSA-N 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N benzohydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 239000002981 blocking agent Substances 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229940074979 cetyl palmitate Drugs 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229960002227 clindamycin Drugs 0.000 description 2
- ZPUCINDJVBIVPJ-BARDWOONSA-N cocaine Natural products O([C@@H]1C[C@H]2CC[C@H](N2C)[C@@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-BARDWOONSA-N 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 238000010924 continuous production Methods 0.000 description 2
- AMNQQNTZDFYVGH-UHFFFAOYSA-N dimethyl-phenyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)C1=CC=CC=C1 AMNQQNTZDFYVGH-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 239000008079 hexane Substances 0.000 description 2
- 229940051250 hexylene glycol Drugs 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229960001680 ibuprofen Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 229960003494 metacycline Drugs 0.000 description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
- 229960002509 miconazole Drugs 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- QDHHCQZDFGDHMP-UHFFFAOYSA-N monochloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N n-butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N n-pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 2
- 229960000601 octocrylene Drugs 0.000 description 2
- 229960001173 oxybenzone Drugs 0.000 description 2
- PXDJXZJSCPSGGI-UHFFFAOYSA-N palmityl palmitate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NJRWNWYFPOFDFN-UHFFFAOYSA-L phosphonate(2-) Chemical compound [O-][P]([O-])=O NJRWNWYFPOFDFN-UHFFFAOYSA-L 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000037335 skin penetration Effects 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- DIORMHZUUKOISG-UHFFFAOYSA-M sulfoformate Chemical compound OC(=O)S([O-])(=O)=O DIORMHZUUKOISG-UHFFFAOYSA-M 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- PLZVEHJLHYMBBY-UHFFFAOYSA-N tetradecan-1-amine Chemical compound CCCCCCCCCCCCCCN PLZVEHJLHYMBBY-UHFFFAOYSA-N 0.000 description 2
- YRZGMTHQPGNLEK-UHFFFAOYSA-N tetradecyl propanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CC YRZGMTHQPGNLEK-UHFFFAOYSA-N 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- XTXRWKRVRITETP-UHFFFAOYSA-N vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N (1S,3R,4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,25R,27R,29R,32R,33R,35S,37S,38R)-3-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14, Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- KWQJKAHZHOILKK-UHFFFAOYSA-N (2,3,4,5,6-pentachlorophenyl) prop-2-enoate Chemical compound ClC1=C(Cl)C(Cl)=C(OC(=O)C=C)C(Cl)=C1Cl KWQJKAHZHOILKK-UHFFFAOYSA-N 0.000 description 1
- CIDUJQMULVCIBT-MQDUPKMGSA-N (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4-amino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](NC)[C@@](C)(O)CO1)O)NCC)[C@H]1OC(CN)=CC[C@H]1N CIDUJQMULVCIBT-MQDUPKMGSA-N 0.000 description 1
- AGFWIZQEWFGATK-UNZHCMSXSA-N (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4-amino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;sulfuric acid Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](NC)[C@@](C)(O)CO1)O)NCC)[C@H]1OC(CN)=CC[C@H]1N.O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](NC)[C@@](C)(O)CO1)O)NCC)[C@H]1OC(CN)=CC[C@H]1N AGFWIZQEWFGATK-UNZHCMSXSA-N 0.000 description 1
- AUODDLQVRAJAJM-XJQDNNTCSA-N (2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride Chemical compound Cl.CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 AUODDLQVRAJAJM-XJQDNNTCSA-N 0.000 description 1
- OIQXFRANQVWXJF-QBFSEMIESA-N (2Z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 1
- LCXCLBUJRIUARF-UHFFFAOYSA-N (3,5-dimethyl-1-adamantyl) prop-2-enoate Chemical compound C1C(C2)CC3(C)CC1(C)CC2(OC(=O)C=C)C3 LCXCLBUJRIUARF-UHFFFAOYSA-N 0.000 description 1
- WSEBKJRVPMLGFV-UHFFFAOYSA-M (3-chloro-2-hydroxypropyl)-(2-hydroxyethyl)-dimethylazanium;chloride Chemical compound [Cl-].OCC[N+](C)(C)CC(O)CCl WSEBKJRVPMLGFV-UHFFFAOYSA-M 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- VCOPTHOUUNAYKQ-WBTCAYNUSA-N (3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;(3S)-3,6-diamino-N-[[(2S,5S,8 Chemical compound N1C(=O)\C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC(=O)[C@@H]1[C@@H]1NC(N)=NCC1.N1C(=O)\C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC(=O)[C@@H]1[C@@H]1NC(N)=NCC1 VCOPTHOUUNAYKQ-WBTCAYNUSA-N 0.000 description 1
- PTNZGHXUZDHMIQ-CVHRZJFOSA-N (4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O PTNZGHXUZDHMIQ-CVHRZJFOSA-N 0.000 description 1
- SVDOODSCHVSYEK-IFLJXUKPSA-N (4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydron;chloride Chemical compound Cl.C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O SVDOODSCHVSYEK-IFLJXUKPSA-N 0.000 description 1
- YCIHPQHVWDULOY-FMZCEJRJSA-N (4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O YCIHPQHVWDULOY-FMZCEJRJSA-N 0.000 description 1
- DHPRQBPJLMKORJ-XRNKAMNCSA-N (4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O DHPRQBPJLMKORJ-XRNKAMNCSA-N 0.000 description 1
- QYAPHLRPFNSDNH-LYNLVHCPSA-N (4S,4aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC(Cl)=C2[C@](O)(C)C3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O QYAPHLRPFNSDNH-LYNLVHCPSA-N 0.000 description 1
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- NPNPZTNLOVBDOC-UHFFFAOYSA-N 1,1-Difluoroethane Chemical compound CC(F)F NPNPZTNLOVBDOC-UHFFFAOYSA-N 0.000 description 1
- AOHJOMMDDJHIJH-UHFFFAOYSA-N 1,2-Diaminopropane Chemical compound CC(N)CN AOHJOMMDDJHIJH-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N 1,2-ethanediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- MGNZXYYWBUKAII-UHFFFAOYSA-N 1,3-Cyclohexadiene Chemical compound C1CC=CC=C1 MGNZXYYWBUKAII-UHFFFAOYSA-N 0.000 description 1
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 description 1
- 239000005968 1-Decanol Substances 0.000 description 1
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 1
- OAAZUWWNSYWWHG-UHFFFAOYSA-N 1-phenoxypropan-1-ol Chemical compound CCC(O)OC1=CC=CC=C1 OAAZUWWNSYWWHG-UHFFFAOYSA-N 0.000 description 1
- SMSKIVCCLIQXFD-UHFFFAOYSA-N 1-tert-butyl-3-ethenylbenzene Chemical compound CC(C)(C)C1=CC=CC(C=C)=C1 SMSKIVCCLIQXFD-UHFFFAOYSA-N 0.000 description 1
- XOCOMEGNVMCRMP-UHFFFAOYSA-N 2,2,4,4,6,6,8,8-octaethyl-1,3,5,7,2,4,6,8-tetraoxatetrasilocane Chemical compound CC[Si]1(CC)O[Si](CC)(CC)O[Si](CC)(CC)O[Si](CC)(CC)O1 XOCOMEGNVMCRMP-UHFFFAOYSA-N 0.000 description 1
- OASIVQPAROZYHE-UHFFFAOYSA-N 2,3-dihydroxypropyl octadecaneperoxoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OOCC(O)CO OASIVQPAROZYHE-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- ZGQVRVGEIATNCZ-UHFFFAOYSA-N 2-(1-hexadecyl-4,5-dihydroimidazol-2-yl)ethanamine Chemical compound CCCCCCCCCCCCCCCCN1CCN=C1CCN ZGQVRVGEIATNCZ-UHFFFAOYSA-N 0.000 description 1
- NYPPCCZHHLGDBU-UHFFFAOYSA-N 2-(3-methoxypropyl)-2,4,4,6,6,8,8-heptamethyl-1,3,5,7,2,4,6,8-tetraoxatetrasilocane Chemical compound COCCC[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 NYPPCCZHHLGDBU-UHFFFAOYSA-N 0.000 description 1
- LFXGVNNHUHYULN-UHFFFAOYSA-N 2-(methoxymethyl)-2,4,4,6,6,8-hexamethyl-8-propyl-1,3,5,7,2,4,6,8-tetraoxatetrasilocane Chemical compound CCC[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(COC)O1 LFXGVNNHUHYULN-UHFFFAOYSA-N 0.000 description 1
- CNPVJWYWYZMPDS-UHFFFAOYSA-N 2-Methyldecane Chemical compound CCCCCCCCC(C)C CNPVJWYWYZMPDS-UHFFFAOYSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-Vinylpyridine Chemical class C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 1
- TYCOFFBAZNSQOJ-UHFFFAOYSA-N 2-[4-(3-fluorophenyl)phenyl]propanoic acid Chemical compound C1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC(F)=C1 TYCOFFBAZNSQOJ-UHFFFAOYSA-N 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N 2-[6-[[amino-[[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexyl]-1-[amino-(4-chloroanilino)methylidene]guanidine;hydron;dichloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- ZQBJRVYLUFBBEQ-UHFFFAOYSA-N 2-[diamino(3-formamidopropyl)azaniumyl]acetate Chemical compound [O-]C(=O)C[N+](N)(N)CCCNC=O ZQBJRVYLUFBBEQ-UHFFFAOYSA-N 0.000 description 1
- URLOOCHBFSMCKH-UHFFFAOYSA-N 2-[hexadecanoyl(methyl)amino]acetic acid;sodium Chemical compound [Na].CCCCCCCCCCCCCCCC(=O)N(C)CC(O)=O URLOOCHBFSMCKH-UHFFFAOYSA-N 0.000 description 1
- PIUJWWBOMGMSAY-UHFFFAOYSA-N 2-ethenoxybutane Chemical compound CCC(C)OC=C PIUJWWBOMGMSAY-UHFFFAOYSA-N 0.000 description 1
- MLMGJTAJUDSUKA-UHFFFAOYSA-N 2-ethenyl-1H-imidazole Chemical compound C=CC1=NC=CN1 MLMGJTAJUDSUKA-UHFFFAOYSA-N 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N 2-hydroxyethyl 2-methylacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- NEQXUPRFDXNNTA-UHFFFAOYSA-N 2-hydroxyethylazanium;2-hydroxypropanoate Chemical compound [NH3+]CCO.CC(O)C([O-])=O NEQXUPRFDXNNTA-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N 2-methyl-2-propenoic acid methyl ester Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N 2-phenyl-3H-benzimidazole-5-sulfonic acid Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- ILYSAKHOYBPSPC-UHFFFAOYSA-N 2-phenylbenzoic acid Chemical class OC(=O)C1=CC=CC=C1C1=CC=CC=C1 ILYSAKHOYBPSPC-UHFFFAOYSA-N 0.000 description 1
- AGBXYHCHUYARJY-UHFFFAOYSA-M 2-phenylethenesulfonate Chemical compound [O-]S(=O)(=O)C=CC1=CC=CC=C1 AGBXYHCHUYARJY-UHFFFAOYSA-M 0.000 description 1
- LAMUXTNQCICZQX-UHFFFAOYSA-N 3-chloropropan-1-ol Chemical compound OCCCCl LAMUXTNQCICZQX-UHFFFAOYSA-N 0.000 description 1
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 description 1
- CEBRPXLXYCFYGU-UHFFFAOYSA-N 3-methylbut-1-enylbenzene Chemical compound CC(C)C=CC1=CC=CC=C1 CEBRPXLXYCFYGU-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-Aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- HEOCBCNFKCOKBX-SDNWHVSQSA-N 4-Methylbenzylidene camphor Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)C2(C)CCC\1C2(C)C HEOCBCNFKCOKBX-SDNWHVSQSA-N 0.000 description 1
- JDVPQXZIJDEHAN-UHFFFAOYSA-M 4-amino-4-oxobutanoate Chemical class NC(=O)CCC([O-])=O JDVPQXZIJDEHAN-UHFFFAOYSA-M 0.000 description 1
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 1
- BDQHDFBEAFMWII-UHFFFAOYSA-N 6-hydroxyhexanal;hydrochloride Chemical compound Cl.OCCCCCC=O BDQHDFBEAFMWII-UHFFFAOYSA-N 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L 7681-57-4 Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229960004308 ACETYLCYSTEINE Drugs 0.000 description 1
- 229940035676 ANALGESICS Drugs 0.000 description 1
- 229940031012 ANTI-ACNE PREPARATIONS Drugs 0.000 description 1
- 229940022659 Acetaminophen Drugs 0.000 description 1
- 206010000496 Acne Diseases 0.000 description 1
- ZZHLYYDVIOPZBE-UHFFFAOYSA-N Alimemazine Chemical compound C1=CC=C2N(CC(CN(C)C)C)C3=CC=CC=C3SC2=C1 ZZHLYYDVIOPZBE-UHFFFAOYSA-N 0.000 description 1
- 229960000458 Allantoin Drugs 0.000 description 1
- XXROGKLTLUQVRX-UHFFFAOYSA-N Allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 1
- OSDWBNJEKMUWAV-UHFFFAOYSA-N Allyl chloride Chemical compound ClCC=C OSDWBNJEKMUWAV-UHFFFAOYSA-N 0.000 description 1
- FPHLBGOJWPEVME-UHFFFAOYSA-N Alminoprofen Chemical compound OC(=O)C(C)C1=CC=C(NCC(C)=C)C=C1 FPHLBGOJWPEVME-UHFFFAOYSA-N 0.000 description 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N Amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 1
- 229960001656 Amikacin Sulfate Drugs 0.000 description 1
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 1
- BDJRBEYXGGNYIS-UHFFFAOYSA-N Azelaic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-VAWYXSNFSA-N Azobisisobutyronitrile Chemical compound N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- JFIOVJDNOJYLKP-UHFFFAOYSA-N Bithionol Chemical compound OC1=C(Cl)C=C(Cl)C=C1SC1=CC(Cl)=CC(Cl)=C1O JFIOVJDNOJYLKP-UHFFFAOYSA-N 0.000 description 1
- LEBVLXFERQHONN-UHFFFAOYSA-N Bupivacaine Chemical class CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
- GGQJXCQBBONZFX-IWVLMIASSA-N CHEMBL1237124 Chemical compound C=C([C@H]1[C@@H]2O)C3=C(Cl)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O GGQJXCQBBONZFX-IWVLMIASSA-N 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Calypsol Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-UHFFFAOYSA-N Camphor Chemical compound C1CC2(C)C(=O)CC1C2(C)C DSSYKIVIOFKYAU-UHFFFAOYSA-N 0.000 description 1
- 229960000846 Camphor Drugs 0.000 description 1
- JNIIDKODPGHQSS-DHDCSXOGSA-N Capreomycin Chemical compound N1C(=O)\C(=C\NC(N)=O)NC(=O)C(CNC(=O)CC(N)CCCN)NC(=O)C(CO)NC(=O)C(N)CNC(=O)C1C1NC(N)=NCC1 JNIIDKODPGHQSS-DHDCSXOGSA-N 0.000 description 1
- 108010065839 Capreomycin Proteins 0.000 description 1
- 229960002968 Capreomycin Sulfate Drugs 0.000 description 1
- YKPUWZUDDOIDPM-SOFGYWHQSA-N Capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229940105329 Carboxymethylcellulose Drugs 0.000 description 1
- IVUMCTKHWDRRMH-UHFFFAOYSA-N Carprofen Chemical compound C1=CC(Cl)=C[C]2C3=CC=C(C(C(O)=O)C)C=C3N=C21 IVUMCTKHWDRRMH-UHFFFAOYSA-N 0.000 description 1
- 229940056318 Ceteth-20 Drugs 0.000 description 1
- 229960003260 Chlorhexidine Drugs 0.000 description 1
- 229960004504 Chlorhexidine Hydrochloride Drugs 0.000 description 1
- 229960002023 Chloroprocaine Drugs 0.000 description 1
- VDANGULDQQJODZ-UHFFFAOYSA-N Chloroprocaine Chemical class CCN(CC)CCOC(=O)C1=CC=C(N)C=C1Cl VDANGULDQQJODZ-UHFFFAOYSA-N 0.000 description 1
- OSDLLIBGSJNGJE-UHFFFAOYSA-N Chloroxylenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 description 1
- 229960004475 Chlortetracycline Drugs 0.000 description 1
- 239000004099 Chlortetracycline Substances 0.000 description 1
- 229960003185 Chlortetracycline Hydrochloride Drugs 0.000 description 1
- PUFQVTATUTYEAL-UHFFFAOYSA-N Cinchocaine Chemical class C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCCN(CC)CC)=C21 PUFQVTATUTYEAL-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N Ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
- OLFMBPYPRDPNQA-UHFFFAOYSA-N ClC1=C(C(C(C=C1)(C)O)Cl)C Chemical compound ClC1=C(C(C(C=C1)(C)O)Cl)C OLFMBPYPRDPNQA-UHFFFAOYSA-N 0.000 description 1
- 229960001200 Clindamycin Hydrochloride Drugs 0.000 description 1
- 229940108066 Coal Tar Drugs 0.000 description 1
- 210000004087 Cornea Anatomy 0.000 description 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N Crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N Cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229940031766 DIETHANOLAMINE CETYL PHOSPHATE Drugs 0.000 description 1
- 229960004082 DOXYCYCLINE HYDROCHLORIDE Drugs 0.000 description 1
- AFFLGGQVNFXPEV-UHFFFAOYSA-N Decene Chemical compound CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 1
- 229940009976 Deoxycholate Drugs 0.000 description 1
- NZZIMKJIVMHWJC-UHFFFAOYSA-N Dibenzoylmethane Chemical compound C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 1
- 229940120099 Dibucaine Drugs 0.000 description 1
- DOIRQSBPFJWKBE-UHFFFAOYSA-N Dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N Dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
- 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
- VEVJYJYFAXTUGJ-UHFFFAOYSA-N Dicyclopentenyl acrylate Chemical compound C1C2C3C(OC(=O)C=C)C=CC3C1C=C2 VEVJYJYFAXTUGJ-UHFFFAOYSA-N 0.000 description 1
- RXKJFZQQPQGTFL-UHFFFAOYSA-N Dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 1
- 229940120503 Dihydroxyacetone Drugs 0.000 description 1
- 229960001275 Dimeticone Drugs 0.000 description 1
- 229940101029 Dipotassium Glycyrrhizinate Drugs 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 229960003722 Doxycycline Drugs 0.000 description 1
- 229960000385 Dyclonine Drugs 0.000 description 1
- BZEWSEKUUPWQDQ-UHFFFAOYSA-N Dyclonine Chemical compound C1=CC(OCCCC)=CC=C1C(=O)CCN1CCCCC1 BZEWSEKUUPWQDQ-UHFFFAOYSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 229960003203 Erythromycin Estolate Drugs 0.000 description 1
- 229960000285 Ethambutol Drugs 0.000 description 1
- AEUTYOVWOVBAKS-UWVGGRQHSA-N Ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 1
- 229960001618 Ethambutol Hydrochloride Drugs 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- VTUSIVBDOCDNHS-UHFFFAOYSA-N Etidocaine Chemical class CCCN(CC)C(CC)C(=O)NC1=C(C)C=CC=C1C VTUSIVBDOCDNHS-UHFFFAOYSA-N 0.000 description 1
- 229960003976 Etidocaine Drugs 0.000 description 1
- 229940044949 Eucalyptus oil Drugs 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 229960002217 Eugenol Drugs 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Exidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- ZPAKPRAICRBAOD-UHFFFAOYSA-N Fenbufen Chemical compound C1=CC(C(=O)CCC(=O)O)=CC=C1C1=CC=CC=C1 ZPAKPRAICRBAOD-UHFFFAOYSA-N 0.000 description 1
- RDJGLLICXDHJDY-UHFFFAOYSA-N Fenoprofen Chemical compound OC(=O)C(C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-UHFFFAOYSA-N 0.000 description 1
- 229960001419 Fenoprofen Drugs 0.000 description 1
- 229950001284 Fluprofen Drugs 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N Flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- MNQZXJOMYWMBOU-UHFFFAOYSA-N Glyceraldehyde Chemical compound OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 description 1
- 240000007842 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 1
- 229940093915 Gynecological Organic acids Drugs 0.000 description 1
- 229940031574 HYDROXYMETHYL CELLULOSE Drugs 0.000 description 1
- ROAIXOJGRFKICW-UHFFFAOYSA-N Haiprex Chemical compound C1N(C2)CN3CN1CN2C3.OC(=O)CNC(=O)C1=CC=CC=C1 ROAIXOJGRFKICW-UHFFFAOYSA-N 0.000 description 1
- 210000004919 Hair shaft Anatomy 0.000 description 1
- 206010019049 Hair texture abnormal Diseases 0.000 description 1
- VKYKSIONXSXAKP-UHFFFAOYSA-N Hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
- UXNFIJPHRQEWRQ-UHFFFAOYSA-N Hexamethylenetetramine mandelate salt Chemical compound C1N(C2)CN3CN1CN2C3.OC(=O)C(O)C1=CC=CC=C1 UXNFIJPHRQEWRQ-UHFFFAOYSA-N 0.000 description 1
- DKLKMKYDWHYZTD-UHFFFAOYSA-N Hexylcaine Chemical compound C=1C=CC=CC=1C(=O)OC(C)CNC1CCCCC1 DKLKMKYDWHYZTD-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N Homosalate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- 229960004881 Homosalate Drugs 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Incidol Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N Indene Chemical compound C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
- RJMIEHBSYVWVIN-UHFFFAOYSA-N Indoprofen Chemical compound C1=CC(C(C(O)=O)C)=CC=C1N1C(=O)C2=CC=CC=C2C1 RJMIEHBSYVWVIN-UHFFFAOYSA-N 0.000 description 1
- WYVVKGNFXHOCQV-UHFFFAOYSA-N Iodopropynyl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 1
- 229940045996 Isethionic Acid Drugs 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N Isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N Isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N Itaconic acid Chemical compound OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 102100012021 KLHL41 Human genes 0.000 description 1
- 101710042579 KLHL41 Proteins 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N Kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960002064 Kanamycin Sulfate Drugs 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N Ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- 229940048866 LAURAMINE OXIDE Drugs 0.000 description 1
- 229940031674 LAURETH-7 Drugs 0.000 description 1
- 229960004873 LEVOMENTHOL Drugs 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N Lauryldimethylamine oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N Maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 229940041616 Menthol Drugs 0.000 description 1
- 229940042016 Methacycline Drugs 0.000 description 1
- 229940051860 Methacycline hydrochloride Drugs 0.000 description 1
- 229960004011 Methenamine Drugs 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N Methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 229960000282 Metronidazole Drugs 0.000 description 1
- 229960002395 Metronidazole Hydrochloride Drugs 0.000 description 1
- 229940042472 Mineral Oil Drugs 0.000 description 1
- 229960004023 Minocycline Drugs 0.000 description 1
- DYKFCLLONBREIL-KVUCHLLUSA-N Minocycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O DYKFCLLONBREIL-KVUCHLLUSA-N 0.000 description 1
- 229960002421 Minocycline Hydrochloride Drugs 0.000 description 1
- OJGQFYYLKNCIJD-UHFFFAOYSA-N Miroprofen Chemical compound C1=CC(C(C(O)=O)C)=CC=C1C1=CN(C=CC=C2)C2=N1 OJGQFYYLKNCIJD-UHFFFAOYSA-N 0.000 description 1
- 229950006616 Miroprofen Drugs 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- LSHROXHEILXKHM-UHFFFAOYSA-N N'-[2-[2-[2-(2-aminoethylamino)ethylamino]ethylamino]ethyl]ethane-1,2-diamine Chemical compound NCCNCCNCCNCCNCCN LSHROXHEILXKHM-UHFFFAOYSA-N 0.000 description 1
- 229940049292 N-(3-(dimethylamino)propyl)octadecanamide Drugs 0.000 description 1
- WWVIUVHFPSALDO-UHFFFAOYSA-N N-[3-(dimethylamino)propyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C WWVIUVHFPSALDO-UHFFFAOYSA-N 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- JLSGYVNIIASPIZ-UHFFFAOYSA-N N-methylmethanamine;propyl 2-methylprop-2-enoate Chemical compound CNC.CCCOC(=O)C(C)=C JLSGYVNIIASPIZ-UHFFFAOYSA-N 0.000 description 1
- DYUGTPXLDJQBRB-UHFFFAOYSA-N N-myristoylglycine Chemical compound CCCCCCCCCCCCCC(=O)NCC(O)=O DYUGTPXLDJQBRB-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N Naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- PGBHMTALBVVCIT-VCIWKGPPSA-N Neomycin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 1
- 229940053050 Neomycin Sulfate Drugs 0.000 description 1
- 229960000808 Netilmicin Drugs 0.000 description 1
- 229960004832 Netilmicin Sulfate Drugs 0.000 description 1
- SJYNFBVQFBRSIB-UHFFFAOYSA-N Norbornadiene Chemical compound C1=CC2C=CC1C2 SJYNFBVQFBRSIB-UHFFFAOYSA-N 0.000 description 1
- 229960001180 Norfloxacin Drugs 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N Norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 229960003921 Octisalate Drugs 0.000 description 1
- MITFXPHMIHQXPI-UHFFFAOYSA-N Oraflex Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 1
- OFPXSFXSNFPTHF-UHFFFAOYSA-N Oxaprozin Chemical compound O1C(CCC(=O)O)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 OFPXSFXSNFPTHF-UHFFFAOYSA-N 0.000 description 1
- 229960000625 Oxytetracycline Drugs 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N Oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 229960004368 Oxytetracycline Hydrochloride Drugs 0.000 description 1
- 229940100460 PEG-100 Stearate Drugs 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- 229940055726 Pantothenic Acid Drugs 0.000 description 1
- 229960005065 Paromomycin Sulfate Drugs 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N Phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 229960005323 Phenoxyethanol Drugs 0.000 description 1
- IIMIOEBMYPRQGU-UHFFFAOYSA-L Picoplatin Chemical compound N.[Cl-].[Cl-].[Pt+2].CC1=CC=CC=N1 IIMIOEBMYPRQGU-UHFFFAOYSA-L 0.000 description 1
- PIDSZXPFGCURGN-UHFFFAOYSA-N Pirprofen Chemical compound ClC1=CC(C(C(O)=O)C)=CC=C1N1CC=CC1 PIDSZXPFGCURGN-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229920000289 Polyquaternium Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229940068977 Polysorbate 20 Drugs 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 229940068968 Polysorbate 80 Drugs 0.000 description 1
- DQKXQSGTHWVTAD-UHFFFAOYSA-N Pramocaine Chemical compound C1=CC(OCCCC)=CC=C1OCCCN1CCOCC1 DQKXQSGTHWVTAD-UHFFFAOYSA-N 0.000 description 1
- TVQZAMVBTVNYLA-UHFFFAOYSA-N Pranoprofen Chemical compound C1=CC=C2CC3=CC(C(C(O)=O)C)=CC=C3OC2=N1 TVQZAMVBTVNYLA-UHFFFAOYSA-N 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N Procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229940107700 Pyruvic Acid Drugs 0.000 description 1
- 229940100459 STEARETH-20 Drugs 0.000 description 1
- 229940058287 Salicylic acid derivative anticestodals Drugs 0.000 description 1
- 210000004761 Scalp Anatomy 0.000 description 1
- JNMWHTHYDQTDQZ-UHFFFAOYSA-N Selsun Blue Chemical compound S=[Se]=S JNMWHTHYDQTDQZ-UHFFFAOYSA-N 0.000 description 1
- 229940045998 Sodium Isethionate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M Sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- JNYAEWCLZODPBN-CTQIIAAMSA-N Sorbitan Chemical class OCC(O)C1OCC(O)[C@@H]1O JNYAEWCLZODPBN-CTQIIAAMSA-N 0.000 description 1
- FBPFZTCFMRRESA-NQAPHZHOSA-N Sorbitol Chemical compound OCC(O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-NQAPHZHOSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229960005322 Streptomycin Drugs 0.000 description 1
- 229960002385 Streptomycin Sulfate Drugs 0.000 description 1
- 229960004492 Suprofen Drugs 0.000 description 1
- MDKGKXOCJGEUJW-UHFFFAOYSA-N Suprofen Chemical compound C1=CC(C(C(O)=O)C)=CC=C1C(=O)C1=CC=CS1 MDKGKXOCJGEUJW-UHFFFAOYSA-N 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Natural products NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 229960002372 Tetracaine Drugs 0.000 description 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N Tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 1
- GUHPRPJDBZHYCJ-UHFFFAOYSA-N Tiaprofenic acid Chemical compound S1C(C(C(O)=O)C)=CC=C1C(=O)C1=CC=CC=C1 GUHPRPJDBZHYCJ-UHFFFAOYSA-N 0.000 description 1
- 229960000707 Tobramycin Drugs 0.000 description 1
- 229960004477 Tobramycin Sulfate Drugs 0.000 description 1
- FUSNMLFNXJSCDI-UHFFFAOYSA-N Tolnaftate Chemical compound C=1C=C2C=CC=CC2=CC=1OC(=S)N(C)C1=CC=CC(C)=C1 FUSNMLFNXJSCDI-UHFFFAOYSA-N 0.000 description 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 1
- CYRMSUTZVYGINF-UHFFFAOYSA-N Trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
- 229940035740 Trimeprazine Drugs 0.000 description 1
- 230000037338 UVA radiation Effects 0.000 description 1
- 229940029983 VITAMINS Drugs 0.000 description 1
- 229940046009 Vitamin E Drugs 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Xylocaine Chemical class CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 229940118827 Zinc phenolsulfonate Drugs 0.000 description 1
- OTPSWLRZXRHDNX-UHFFFAOYSA-L Zinc pyrithione Chemical compound S1C2=CC=CC=N2=O[Zn]21O=N1=CC=CC=C1S2 OTPSWLRZXRHDNX-UHFFFAOYSA-L 0.000 description 1
- MCMNRKCIXSYSNV-UHFFFAOYSA-N ZrO2 Chemical class O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 1
- UJNOLBSYLSYIBM-NOOOWODRSA-N [(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexyl] (2S)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@H](C)O UJNOLBSYLSYIBM-NOOOWODRSA-N 0.000 description 1
- SCMSRHIBVBIECI-UHFFFAOYSA-N [2-hydroxy-4-(2-hydroxyethoxy)phenyl]-phenylmethanone Chemical compound OC1=CC(OCCO)=CC=C1C(=O)C1=CC=CC=C1 SCMSRHIBVBIECI-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- DHFCLYNGVLPKPK-UHFFFAOYSA-N acetamide;2-aminoethanol Chemical compound CC(N)=O.NCCO DHFCLYNGVLPKPK-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000240 adjuvant Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229960003790 alimemazine Drugs 0.000 description 1
- 150000007824 aliphatic compounds Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 125000005466 alkylenyl group Chemical group 0.000 description 1
- 230000000172 allergic Effects 0.000 description 1
- 229960004663 alminoprofen Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- PQHIYIRGUOAYPG-UHFFFAOYSA-N aluminum;chloro 2-hydroxypropaneperoxoate Chemical compound [Al].CC(O)C(=O)OOCl PQHIYIRGUOAYPG-UHFFFAOYSA-N 0.000 description 1
- DVBBEGGVSYJLME-UHFFFAOYSA-N aluminum;hydrochloride Chemical compound [Al].Cl DVBBEGGVSYJLME-UHFFFAOYSA-N 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- YAKZEVHORUHNLS-UHFFFAOYSA-K aluminum;sodium;2-hydroxypropanoate;chloride;hydroxide;hydrate Chemical compound O.[OH-].[Na+].[Al+3].[Cl-].CC(O)C([O-])=O YAKZEVHORUHNLS-UHFFFAOYSA-K 0.000 description 1
- 229960004821 amikacin Drugs 0.000 description 1
- FXKSEJFHKVNEFI-GCZBSULCSA-N amikacin disulfate Chemical compound [H+].[H+].[H+].[H+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O FXKSEJFHKVNEFI-GCZBSULCSA-N 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001760 anti-analgesic Effects 0.000 description 1
- 230000000844 anti-bacterial Effects 0.000 description 1
- 230000000843 anti-fungal Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000111 anti-oxidant Effects 0.000 description 1
- 230000000842 anti-protozoal Effects 0.000 description 1
- 230000001153 anti-wrinkle Effects 0.000 description 1
- 229940111133 antiinflammatory and antirheumatic drugs Oxicams Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003904 antiprotozoal agent Substances 0.000 description 1
- 229940027983 antiseptics and disinfectants Quaternary ammonium compounds Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 229960002255 azelaic acid Drugs 0.000 description 1
- 229960005430 benoxaprofen Drugs 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 229960003150 bupivacaine Drugs 0.000 description 1
- MPMBRWOOISTHJV-UHFFFAOYSA-N but-1-enylbenzene Chemical compound CCC=CC1=CC=CC=C1 MPMBRWOOISTHJV-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- SOGAXMICEFXMKE-UHFFFAOYSA-N butyl 2-methylprop-2-enoate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 229930007890 camphor Natural products 0.000 description 1
- 229960004602 capreomycin Drugs 0.000 description 1
- 229930003833 capsaicin Natural products 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229960003184 carprofen Drugs 0.000 description 1
- 229940073669 ceteareth 20 Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-M cholate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-M 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- 229960001747 cinchocaine Drugs 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 239000011280 coal tar Substances 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 238000001246 colloidal dispersion Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-M deoxycholate Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-M 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 229940042935 dichlorodifluoromethane Drugs 0.000 description 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- STJDVFLIFYPTDX-UHFFFAOYSA-N dimethyl-(2-phenylethyl)-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)CCC1=CC=CC=C1 STJDVFLIFYPTDX-UHFFFAOYSA-N 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical class Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 1
- PGZPBNJYTNQMAX-UHFFFAOYSA-N dimethylazanium;methyl sulfate Chemical compound C[NH2+]C.COS([O-])(=O)=O PGZPBNJYTNQMAX-UHFFFAOYSA-N 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L disodium;2-[2-[carboxylatomethyl(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetate Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- OKBPCTLSPGDQBO-UHFFFAOYSA-L disodium;dichloride Chemical class [Na+].[Na+].[Cl-].[Cl-] OKBPCTLSPGDQBO-UHFFFAOYSA-L 0.000 description 1
- JVQOASIPRRGMOS-UHFFFAOYSA-M dodecyl(trimethyl)azanium;hydroxide Chemical compound [OH-].CCCCCCCCCCCC[N+](C)(C)C JVQOASIPRRGMOS-UHFFFAOYSA-M 0.000 description 1
- JBIWCJUYHHGXTC-AKNGSSGZSA-N doxycycline Chemical compound O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O JBIWCJUYHHGXTC-AKNGSSGZSA-N 0.000 description 1
- 230000001804 emulsifying Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- AWMFUEJKWXESNL-JZBHMOKNSA-N erythromycin estolate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O.O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)OC(=O)CC)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AWMFUEJKWXESNL-JZBHMOKNSA-N 0.000 description 1
- 229950001028 erythromycin propionate Drugs 0.000 description 1
- 229960004142 erythromycin stearate Drugs 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- YCUBDDIKWLELPD-UHFFFAOYSA-N ethenyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OC=C YCUBDDIKWLELPD-UHFFFAOYSA-N 0.000 description 1
- WBZPMFHFKXZDRZ-UHFFFAOYSA-N ethenyl 6,6-dimethylheptanoate Chemical compound CC(C)(C)CCCCC(=O)OC=C WBZPMFHFKXZDRZ-UHFFFAOYSA-N 0.000 description 1
- UIWXSTHGICQLQT-UHFFFAOYSA-N ethenyl propanoate Chemical compound CCC(=O)OC=C UIWXSTHGICQLQT-UHFFFAOYSA-N 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N ethylene glycol monomethyl ether Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229960001395 fenbufen Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- NEENSEWRFBUEBZ-UHFFFAOYSA-N formic acid;octadecan-1-amine Chemical compound OC=O.CCCCCCCCCCCCCCCCCCN NEENSEWRFBUEBZ-UHFFFAOYSA-N 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N fumaric acid Chemical compound OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229940083124 ganglion-blocking antiadrenergic Secondary and tertiary amines Drugs 0.000 description 1
- 239000010647 garlic oil Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M glycolate Chemical class OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- AHAREKHAZNPPMI-UHFFFAOYSA-N hexa-1,3-diene Chemical compound CCC=CC=C AHAREKHAZNPPMI-UHFFFAOYSA-N 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- GKKMCECQQIKAHA-UHFFFAOYSA-N hexadecyl dihydrogen phosphate;2-(2-hydroxyethylamino)ethanol Chemical compound OCCNCCO.CCCCCCCCCCCCCCCCOP(O)(O)=O GKKMCECQQIKAHA-UHFFFAOYSA-N 0.000 description 1
- GLAGVQPHOPCJMJ-UHFFFAOYSA-M hexadecyl-dimethyl-(1-phenylpropyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C(CC)C1=CC=CC=C1 GLAGVQPHOPCJMJ-UHFFFAOYSA-M 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- TZMQHOJDDMFGQX-UHFFFAOYSA-N hexane-1,1,1-triol Chemical compound CCCCCC(O)(O)O TZMQHOJDDMFGQX-UHFFFAOYSA-N 0.000 description 1
- 229960005388 hexylcaine Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000000887 hydrating Effects 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- RNYJXPUAFDFIQJ-UHFFFAOYSA-N hydron;octadecan-1-amine;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[NH3+] RNYJXPUAFDFIQJ-UHFFFAOYSA-N 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- VAMFXQBUQXONLZ-UHFFFAOYSA-N icos-1-ene Chemical compound CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 description 1
- 150000002462 imidazolines Chemical group 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 229960004187 indoprofen Drugs 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940079866 intestinal antibiotics Drugs 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 229910000460 iron oxide Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 1
- 230000001530 keratinolytic Effects 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 230000002045 lasting Effects 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 125000005439 maleimidyl group Chemical class C1(C=CC(N1*)=O)=O 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229960000826 meclocycline Drugs 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- INWLQCZOYSRPNW-UHFFFAOYSA-N mepivacaine Chemical compound CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C INWLQCZOYSRPNW-UHFFFAOYSA-N 0.000 description 1
- 229960002409 mepivacaine Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 229960003900 methenamine hippurate Drugs 0.000 description 1
- 229960002786 methenamine mandelate Drugs 0.000 description 1
- AOLJCKIDPDZWBS-UHFFFAOYSA-N methyl 3-(dimethylamino)-2-methylprop-2-enoate Chemical compound COC(=O)C(C)=CN(C)C AOLJCKIDPDZWBS-UHFFFAOYSA-N 0.000 description 1
- MXEKGCYXPNIRFV-UHFFFAOYSA-N methyl 4-(2-methylprop-2-enoyloxy)benzoate Chemical compound COC(=O)C1=CC=C(OC(=O)C(C)=C)C=C1 MXEKGCYXPNIRFV-UHFFFAOYSA-N 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- FPTPAIQTXYFGJC-UHFFFAOYSA-N metronidazole hydrochloride Chemical compound Cl.CC1=NC=C([N+]([O-])=O)N1CCO FPTPAIQTXYFGJC-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- GLMUAFMGXXHGLU-VQAITOIOSA-N minocycline hydrochloride Chemical compound [H+].[Cl-].C([C@H]1C2)C3=C(N(C)C)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O GLMUAFMGXXHGLU-VQAITOIOSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 150000002780 morpholines Chemical class 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 150000002829 nitrogen Chemical group 0.000 description 1
- 125000005574 norbornylene group Chemical group 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- LYRFLYHAGKPMFH-UHFFFAOYSA-N octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(N)=O LYRFLYHAGKPMFH-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229960002739 oxaprozin Drugs 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N pantothenic acid Natural products OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 229960001914 paromomycin Drugs 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- HVAMZGADVCBITI-UHFFFAOYSA-M pent-4-enoate Chemical compound [O-]C(=O)CCC=C HVAMZGADVCBITI-UHFFFAOYSA-M 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- 230000003711 photoprotective Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 229960000851 pirprofen Drugs 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-M pivalate Chemical compound CC(C)(C)C([O-])=O IUGYQRQAERSCNH-UHFFFAOYSA-M 0.000 description 1
- 229920001485 poly(butyl acrylate) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 239000002952 polymeric resin Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000013966 potassium salts of fatty acid Nutrition 0.000 description 1
- JEMLSRUODAIULV-UHFFFAOYSA-M potassium;2-[dodecanoyl(methyl)amino]acetate Chemical compound [K+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O JEMLSRUODAIULV-UHFFFAOYSA-M 0.000 description 1
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 1
- 229960001896 pramocaine Drugs 0.000 description 1
- 229960003101 pranoprofen Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002335 preservative Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- HJWLCRVIBGQPNF-UHFFFAOYSA-N prop-2-enylbenzene Chemical compound C=CCC1=CC=CC=C1 HJWLCRVIBGQPNF-UHFFFAOYSA-N 0.000 description 1
- LYBIZMNPXTXVMV-UHFFFAOYSA-N propan-2-yl prop-2-enoate Chemical compound CC(C)OC(=O)C=C LYBIZMNPXTXVMV-UHFFFAOYSA-N 0.000 description 1
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 229940097319 quaternium-22 Drugs 0.000 description 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2(1H)-one Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N rac-1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 150000005619 secondary aliphatic amines Chemical class 0.000 description 1
- 229910000338 selenium disulfide Inorganic materials 0.000 description 1
- 229960005265 selenium sulfide Drugs 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 231100000197 serious side effect Toxicity 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 231100000121 skin sensitizing Toxicity 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 235000013875 sodium salts of fatty acid Nutrition 0.000 description 1
- MAKUBRYLFHZREJ-JWBQXVCJSA-M sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate Chemical compound [Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O MAKUBRYLFHZREJ-JWBQXVCJSA-M 0.000 description 1
- HYHAWELIVMOSBT-UHFFFAOYSA-M sodium;2-aminopentadecanoate Chemical compound [Na+].CCCCCCCCCCCCCC(N)C([O-])=O HYHAWELIVMOSBT-UHFFFAOYSA-M 0.000 description 1
- IWMMSZLFZZPTJY-UHFFFAOYSA-M sodium;3-(dodecylamino)propane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCNCCCS([O-])(=O)=O IWMMSZLFZZPTJY-UHFFFAOYSA-M 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-M stearate Chemical compound CCCCCCCCCCCCCCCCCC([O-])=O QIQXTHQIDYTFRH-UHFFFAOYSA-M 0.000 description 1
- 229940114926 stearate Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003440 styrenes Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium Chemical compound [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 description 1
- 229960005349 sulfur Drugs 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 150000003510 tertiary aliphatic amines Chemical class 0.000 description 1
- 229960004989 tetracycline hydrochloride Drugs 0.000 description 1
- FAGUFWYHJQFNRV-UHFFFAOYSA-N tetraethylenepentamine Chemical compound NCCNCCNCCNCCN FAGUFWYHJQFNRV-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960001312 tiaprofenic acid Drugs 0.000 description 1
- 229960004880 tolnaftate Drugs 0.000 description 1
- IAQRGUVFOMOMEM-ONEGZZNKSA-N trans-but-2-ene Chemical compound C\C=C\C IAQRGUVFOMOMEM-ONEGZZNKSA-N 0.000 description 1
- UKLVDIWQOXNDKS-UHFFFAOYSA-N tributyl(octadecyl)azanium;nitrate Chemical compound [O-][N+]([O-])=O.CCCCCCCCCCCCCCCCCC[N+](CCCC)(CCCC)CCCC UKLVDIWQOXNDKS-UHFFFAOYSA-N 0.000 description 1
- 229940029284 trichlorofluoromethane Drugs 0.000 description 1
- IIYFAKIEWZDVMP-UHFFFAOYSA-N tridecane Chemical compound CCCCCCCCCCCCC IIYFAKIEWZDVMP-UHFFFAOYSA-N 0.000 description 1
- FAGMGMRSURYROS-UHFFFAOYSA-M trihexadecyl(methyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(CCCCCCCCCCCCCCCC)CCCCCCCCCCCCCCCC FAGMGMRSURYROS-UHFFFAOYSA-M 0.000 description 1
- PGQNYIRJCLTTOJ-UHFFFAOYSA-N trimethylsilyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)O[Si](C)(C)C PGQNYIRJCLTTOJ-UHFFFAOYSA-N 0.000 description 1
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 230000003612 virological Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 229930003231 vitamins Natural products 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- ZNVKGUVDRSSWHV-UHFFFAOYSA-L zinc;4-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=C(S([O-])(=O)=O)C=C1.OC1=CC=C(S([O-])(=O)=O)C=C1 ZNVKGUVDRSSWHV-UHFFFAOYSA-L 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N zirconium Chemical class [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- XYLMUPLGERFSHI-UHFFFAOYSA-N α-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 description 1
Abstract
The present invention relates to personal care compositions comprising a copolymer complex and a volatile, hydrophobic solvent component for solubilizing or dispersing the copolymer complex. The copolymer complex is formed by complexing a fatty amine with a copolymer, wherein the copolymer comprises a hydrophobic monomer, a hydrophilic monomer such that at least 1%, by weight of the total copolymer, comprises hydrophilic monomers bearing acidic functional groups, and optionally a hydrophobic macromonomer.
Description
COMPOSITIONS FOR PERSONAL CARE
TECHNICAL FIELD This is a continuation in part of the United States Patent Application Serial No. 08 / 708,334, filed September 4, 1996. The present invention relates to personal care compositions comprising a copolymer complex and a hydrophobic, volatile solvent component to solubilize or disperse the copolymer complex. By complexing a fatty amine with a copolymer, the copolymer complex is formed, wherein the copolymer comprises a hydrophobic monomer, a hydrophilic monomer such that at least 1%, by weight of the total copolymer, comprises hydrophilic monomers having groups functional acid, and optionally a hydrophobic macromonomer. These compositions provide the hair and skin with improved distribution, deposition and retention.
BACKGROUND OF THE INVENTION The rheological, retention and film formation properties of polymers and copolymers have contributed to their utility in a wide variety of personal care compositions. Polymer-containing products include hair sprays, shampoos, hair conditioners, cream and skin lotions, make-up products, antiperspirants and deodorants, shaving creams, topical drug compositions, sun-blocking products and the like. Consumers are constantly looking for products that provide improved performance benefits. In their quest to improve current products and to create new products, scientists and formulators are continually looking for new key ingredients for these products. Because polymers play an important role in the formulation of many personal care products, there is a need for new polymers that have new and useful properties. In the area of hair care, for example, by applying either chemical alteration products, permanent products, or temporary styling products, style retention is generally achieved. A permanent chemical alteration product, which is commonly referred to as a "permanent hair ripple" typically comprises treating the hair with various sulfur-containing compounds in order to break the disulfide bridges in the hair fibers, thus allowing alter the shape and orientation of the hair fibers. However, permanent hair curling products have the disadvantage of being harsh and damaging to the hair, and also of being durable and difficult to reverse. Conversely, temporary styling products do not generally break chemical bonds in hair fibers. To coat the fibers of the hair and join them together, these temporary styling products are typically in the form of gels, lotions, creams or aerosols containing polymeric resins or gums. Many products of temporary styling are inconvenient for use and have the disadvantage of not allowing easy re-styling of the hair after the initial application and after the styling is finished, without the additional application of an additional product. It would be preferable to provide styling and retention benefits using rinse products such as conditioners and shampoos. These types of rinse products, however, require styling agents that are substantive to the hair and are not easily removed during the rinsing process. Polymeric materials are especially useful styling and retention agents for rinse compositions. However, these hydrophobic materials can cause an accumulation of an unpleasantly visible residue on the hair with repeated use. This residue can uniformly surround the hair shaft and can be difficult to remove with the hair.
P771 normal wash with shampoo. Therefore, there is a need for improved compositions to provide temporary styling and retention of human hair without the residue and negative effects frequently associated with these compositions. Similarly, there is a need for skin-forming, film-forming compositions that are easily washed with soap and water. In a surprising way; it has been found that hair care products, comprising a copolymer complex comprising a copolymer having at least one acid functional monomer and at least one acid functional monomer and at least one fatty amine formed in complex with the functional group acid, provide excellent benefits of temporary styling and retention, in addition to improved "wash" characteristics. The copolymer complex of the present invention is soluble or dispersible in the solvent components, hydrophobic, and is easily deposited by these, it is still easily washed by the aqueous solutions of surfactants. These compositions can be made in any number of conventional forms including, but not limited to, shampoos, conditioners, creams, gels, lotions, aerosols and the like. It has been found that the copolymer complex and the hydrophobic, volatile solvent component of the
P771 present invention, in addition to the benefits for hair care, mentioned above, are also useful for incorporation into a variety of cosmetic and pharmaceutical compositions for topical application to the skin. These materials provide topical compositions that spread more easily and uniformly, with good skin feel, and even highly substantive. Additionally, these compositions are useful for the provision of occlusion to improve the penetration of a wide variety of cosmetic and pharmaceutical actives into the skin, or alternatively, through the skin for systemic distribution. The compositions of the present invention comprise a copolymer complex and a hydrophobic, volatile solvent component, suitable for application to hair or skin. The copolymer complex comprises a copolymer having at least one acid functional group and at least one fatty amine formed in complex with the acid functional group. Therefore, it is an object of the present invention to provide copolymer complexes having improved solubility or dispersibility characteristics. It is another object of the present invention to provide copolymer complexes that are soluble or
P771 dispersible in solvent components, hydrophobic, and even easily washed by aqueous solutions of surfactants. It is another object of the present invention to provide personal care compositions in the form of hair care compositions having improved styling and / or retention properties and having improved aesthetics. It is another object of the present invention to provide personal care compositions in the form of cosmetic and pharmaceutical, topical compositions useful for the distribution and retention of a wide variety of cosmetic materials and pharmaceutical active ingredients for and through the skin. It is another object of the present invention to provide rinse compositions useful for hair styling and retention. It is another object of the present invention to provide methods for styling and retaining hair. It is another object of the present invention to provide methods for distributing and retaining cosmetic materials and pharmaceutical actives in the skin. These and other objects will become easily apparent from the detailed description.
SUMMARY OF THE INVENTION The compositions of the present invention relate to personal care compositions, which comprise: A.) a copolymer complex comprising: a.) A copolymer having a structure formed from the copolymerization of units of repeating monomer A and monomer B wherein the structure is optionally grafted to these hydrophobic units of macromonomer C wherein the copolymer is prepared by the polymerization combination of the following percentages by weight, relative of units A, B and C: i) from about 10% to about 99% by weight of the copolymer, of one or more hydrophobic units of monomer A, wherein the monomer units A are copolymerizable with the units of monomer B and macromonomer C; ii) from about 1% to about 40% by weight of the copolymer, of one or more hydrophilic units of monomer B, wherein the monomer units B are copolymerizable with the monomer A and macromonomer C units and wherein at least about 1% by weight of the copolymer, of monomer units B, are selected from monomer units B having at least one acid functional group; and iii) from 0 to about 50% by weight of the copolymer of one or more units of macromonomer C, wherein the C units are hydrophobic macromonomer units, copolymerizable with monomer units A and monomer units B; the macromonomer B units have a number average molecular weight of about 1,500 to about 50,000; and b) A complexing fatty amine wherein the fatty amine forms a complex with the acidic functional group of the monomer B units; wherein the weight ratio of the copolymer to the fatty amine is from about 50: 1 to about 1: 1; and B.) a volatile, hydrophobic solvent component for the copolymer complex having a boiling point at an atmosphere of about 260 ° C or less and a solubility parameter of about 8.5 (cal / cm 3) 1/2 or less; wherein the copolymer complex is soluble or dispersible in the hydrophobic, volatile solvent component. In the further embodiments, the present invention relates to a method for making a personal care composition, which comprises the steps of: a.) Preparing a copolymer having a structure formed from the copolymerization of repeat units of monomer A and monomer B, wherein the structure optionally has grafted thereto hydrophobic units of macromonomer C, wherein the copolymer is prepared by the polymerization combination of the following percentages in relative weights of units A, B and C; i) from about 10% to about 99% by weight of the copolymer of one or more hydrophobic units of the monomer A, wherein the monomer units A are copolymerizable with the units of monomer B and of macromonomer
C; ii) from about 1% to about 40% by weight of the copolymer of one or more hydrophilic units of monomer B, wherein the monomer units B are copolymerizable with the units of monomer B and macromonomer C, and wherein at least about 1% by weight of the copolymer, of the monomer units B, are selected from the units of
P771 monomer B having at least one acid functional group; and iii) from 0 to about 50% by weight of the copolymer of one or more units of macromonomer C, wherein the C units are hydrophobic macromonomer units, copolymerizable with the monomer units A and the monomer units B, the units of Macromonomer C having a number average molecular weight from about 1,500 to about 50,000; and b) complexing the copolymer with a fatty amine wherein the weight ratio of the copolymer to the fatty amine is from about 50: 1 to about 1: 1; and c) dissolving or dispersing the copolymer complex in a volatile, hydrophobic solvent component having a boiling point at an atmosphere of about 260 ° C or less and a solubility parameter of about 8.5 (cal / cm 3) 1 2 or less . In additional embodiments, the present invention relates to a personal care composition which, prior to mixing, comprises: A.) A copolymer complex comprising:
P771 a.) A copolymer having a structure formed from the copolymerization of repeating units of monomer A and monomer B wherein the structure has optionally grafted thereto hydrophobic units of the macromonomer C, wherein the copolymer is prepared by the combination of polymerization of the following percentages in relative weights of units A, B and C: i) from about 10% to about 99% by weight of the copolymer of one or more hydrophobic units of monomer A, wherein the monomer units A are copolymerizable with the units of monomer B and macromonomer C. ii) from about 1% to about 40% by weight of the copolymer of one or more hydrophilic units of the monomer B, wherein the monomer units B are copolymerizable with the units of monomer A and C-macromonomer and wherein at least about 1% by weight of the copolymer, of the monomer units B, are selected from the unit s of monomer B having at least one acid functional group; and i) from 0 to about 50% by weight of the copolymer of one or more units of macromonomer C, wherein the C units are hydrophobic macromonomer units, copolymerizable with monomer units A and monomer units B; the macromonomer C units have a number average molecular weight of about 1,500 to about 50,000; and b) a complexing fatty amine wherein the fatty amine forms a complex with the acidic functional group of the monomer B units; wherein the weight ratio of the copolymer to the fatty amine is from about 50: 1 to about 1: 1; and B.) a volatile, hydrophobic solvent component for the copolymer complex having a boiling point at 1 atmosphere of about 260 ° C or less and a solubility parameter of about 8.5 (cal / cm) or less. wherein the copolymer complex is soluble or dispersible in the hydrophobic, volatile solvent component. Unless indicated otherwise, all percentages and ratios used herein are by weight of the total composition. All percentages by weight, unless stated otherwise, are on a weight basis of assets. All elaborate measurements are at 25 ° C, unless otherwise designated
P771 way. The invention herein may comprise, consist of, or consist essentially of, the essential as well as optional ingredients and components described herein.
DETAILED DESCRIPTION OF THE INVENTION ESSENTIAL COMPONENTS The compositions of the present invention comprise a copolymer complex and a hydrophobic solvent component., volatile suitable for application to hair and skin, wherein the copolymer complex comprises a copolymer formed in complex with a fatty amine. The copolymers of the present invention may include graft copolymers. The term "graft copolymers" is familiar to one of ordinary skill in the art of polymer science and is used herein to describe the copolymers resulting from the addition or "grafting" of a polymeric chemical moiety (ie, "grafts"). ) in another polymer portion commonly referred to as the "structure". The structure typically has a higher molecular weight than the grafts. In this way, the graft copolymers can be described as polymers having side chains, polymeric, pendent, and which are formed from the "graft" or incorporation of the side chains, polymer on a polymer, or in it. The polymer to which the grafts are incorporated may be homopolymers or copolymers. The graft copolymers are derived from a variety of monomer units. The copolymers of the present invention can be prepared from the copolymerization of monomer units and macromonomer units such that they "graft" or incorporate macromonomer units into the resulting copolymer. The term "macromonomer" is a term familiar to one of ordinary skill in the art of polymer science, and is used to describe a polymeric material that contains a polymerizable portion. In other words, a macromonomer is a macromolecular monomer, which is essentially a high molecular weight type of monomer building block unit that can be used in a polymerization reaction to form polymers with itself, with other monomers, or with other macromonomers. The term "hydrophilic" is used herein consistent with its normal meaning of affinity for water, while "hydrophobic" is used herein consistent with its normal meaning of lacking affinity for water. The term "hydrophilic" means substantially soluble in water, as used herein
P771 in relation to monomer units and polymeric materials, including macromonomers, copolymers and solvents for the copolymers. "Substantially soluble in water" will refer to a material that is soluble in distilled water (or equivalent) at 25 ° C, at a concentration of 0.2% by weight, and are preferably soluble at 1.0% by weight. In contrast, "hydrophobic" means substantially insoluble in water. In this regard "Substantially insoluble in water" will refer to a material that is not soluble in distilled water (or equivalent), at 25 ° C, at a concentration of 0.2% by weight, preferably it is not soluble at 0.1% by weight. weight. The term "soluble" or "solubility" as used herein, means the ability of a substance to form a solution, that is, either a true solution or a colloidal solution. A true solution that is a uniformly dispersed mixture at the molecular or ionic level, of one or more substances (the solute) in one or more substances (the solvent). These two parts of a solution are called phases. Frequently, a colloidal dispersion is called a solution. Since colloidal particles are larger than molecules it is incorrect to strictly call these dispersions solutions; however, this term is widely used in the literature. The term "dispersible" or
P771"Dispersibility" as used herein, means the ability of a substance to form a dispersion, ie, a two-phase system, wherein a phase consists of finely divided particles (often in the colloidal size range) distributed in all the volume of the substance, the particles are the dispersed or internal phase and the volume substance the continuous or external phase. The term "rinsing or washing" is used herein to mean that the compositions of the present invention are used in a context whereby the composition is rinsed or finally washed from the hair and / or skin either after or during application. of the product. Non-limiting examples of the rinse products of the present invention include conditioners, shampoos, and hair soaps. The term "substantive" or "substantivity" as used herein means the attachment or retention of a chemical or pharmaceutical active to the surface layer of the cornea of the extract or to the hair. The term "suitable for application to human hair or skin" as used herein, means that the compositions or components thereof described thus are suitable for use in contact with human hair and scalp and skin without toxicity, incompatibility,
P771 instability, allergic response, and the like, undue. The aforementioned definitions will also apply to other materials so described herein, to the extent that any other definition with respect to these materials are consistent with those set forth above. The compositions of the present invention comprise the following essential components.
COPOLYMER COMPLEX The hair and skin care compositions of the present invention comprise from about 0.25% to about 30%; preferably from about 2% to about 15% and more preferably from about 2% to about 10% by weight, based on the weight of the hair and skin care composition, of a copolymer complex. The copolymer complex comprises a copolymer having at least one acidic functional monomer complexed with a fatty amine.
COPOLYMER The copolymer complex of the present invention comprises from about 35% to about 99%, preferably from
P771 about 40% to about 90%, and more preferably from about 50% to about 70% by weight, based on the weight of the copolymer complex, of a copolymer. Based on the weight of the complete composition for hair and skin care, the copolymer comprises from about 0.1% to about 10%, preferably from about 1% to about 5%, and more preferably from about 1.5% to about 3.5%, by weight. The copolymers of the present invention have a weight average molecular weight, in grams / mol, of at least 10,000. There is no upper limit for molecular weight except that the applicability of the invention is limited for practical reasons, such as viscosity, processing, aesthetic characteristics, compatibility of the formulation, etc. The weight average molecular weight is generally less than about 5,000,000, more generally less than about 2,500,000, and typically less than about 1,500,000. Preferably, the weight average molecular weight is from about 10,000 to about 5,000,000, more preferably from about 50,000 to about 2,000,000, still more preferably from about 75,000 to about
P771 1,000,000, and most preferably from about 75,000 to about 500,000. The copolymers of the present invention are formed from the copolymerization of monomer units A and monomer units B, randomly repeating, preferably wherein the monomers A are ethylenically unsaturated, polymerizable monomers selected to meet the requirements of the copolymer. By "polymerizable" as used herein, it is meant monomers that can be polymerized using any conventional synthesis techniques. Monomers that are polymerizable using conventional techniques initiated from free radicals are preferred. The term "ethylenically unsaturated" is used herein to mean monomers containing at least one polymerizable carbon-carbon double bond (which may be mono-, di-, tri-, or tetra-substituted). The monomer units B are hydrophilic monomers which are copolymerizable with A and are selected from polar monomers, preferably having a Tg or a Tm, above about -20 ° C, and wherein at least 1% in The weight of the copolymer, of the hydrophobic monomer B, is selected from hydrophilic monomers B having at least one acid functional group. The monomer A and monomer B units form what is called the
P771 polymer structure and can be selected from a wide variety of structures as long as the copolymer has the required properties and meets the molecular weight and other requirements described herein. The copolymers of the present invention may optionally incorporate C macromonomer units. The C-macromonomer units are selected from at least one hydrophobic macromonomer unit containing a polymer portion and a copolymerizable portion of monomer A and monomer B. The units of macromonomer C form the hydrophobic side chains of the copolymer. The copolymers are prepared by the polymerization combination of monomers A and B and can be characterized by the weight percentage of monomers charged to the reaction vessel in which the polymerization reaction is run. C-macromonomers can optionally be incorporated into the polymerization reaction. As will be clear to one skilled in the art and especially from the Examples, the copolymer can have one or more hydrophobic side chains inserted into the structure. As is known in the art, synthesis synthetic graft copolymerization processes can produce a mixture of polymer molecules that contain none, or more than one of the hydrophobic side chains covalently linked to the structure
Polymeric P771, and pendant thereof. From the knowledge of the number and molecular weight in average number of the hydrophobic side chains in a polymer sample, and the average number molecular weight of the polymer sample, it is possible to calculate the average number of hydrophobic side chains per polymer structure . The copolymer complex of the present invention, when dried to a film having 0.5% or less of the volatile, hydrophobic solvent component, has a Tg or a Tm of at least about -20 ° C, more preferably at least about about 20 ° C, so that the copolymers are not excessively sticky, or "adhesive" to the touch. As used herein, the abbreviation "Tg" refers to the glass transition temperature of the polymer structure, and the abbreviation "Tm" refers to the crystalline melting point of the structure, if this transition exists for a polymer dice. Preferably, both the Tg and the Tm, if any, are above about -20 ° C, more preferably above about 20 ° C. The grafted copolymers must satisfy the following criteria: (1) the portion of the polymer side chain is covalently bonded to the structure portion; and (2) the average molecular weight of the
P771 portion of the polymer side chain is from about 1,500 to about 50,000. The copolymers of the present invention are prepared by the polymerization combination of the monomers A and the monomers B. Optionally, the macromonomers C can be incorporated into the polymerization process. By copolymerizing the free radicals of the monomers and macromonomers, the copolymers can be synthesized. The general principles of free radical polymerization methods are well understood. See, for example, Odian, "Principies of Polymerization", 3rd edition, John Wiley & Sons, 1991, pp. 198-334. The desired monomers and macromonomers are all placed in a reactor, together with a sufficient amount of a mutual solvent, so that when the reaction is finished the viscosity of the reaction is reasonable. Unwanted terminators, especially oxygen, are removed as necessary. This is done by evacuating or purging with an inert gas, such as argon or nitrogen. The initiator is introduced and the reaction is set at the temperature necessary for the initiation to occur, assuming that the thermal initiators are used. Alternatively, a redox or radiation initiation may be used. The polymerization is allowed to continue as long as it is necessary for a high level of conversion to be achieved, typically a few hours a
P771 some days. Usually, and by evaporation or precipitation of the copolymer by the addition of a non-solvent, the solvent is removed. Additionally, as desired, the copolymer can be purified. As an alternative to a batch reaction, the copolymer can be made by a semi-continuous or continuous process. In the semicontinuous process, two or more additions of monomers or macromonomers are made during the polymerization reaction. When the polymer is made of several monomers that react during the polymerization at different speeds, this becomes advantageous. The proportions of the monomers added to the reaction at the separate points of addition can be adjusted by one skilled in the art such that the polymers of the final product have a more uniform structure. In other words, the polymers of the final product will have a more consistent distribution of the monomeric content for each of the monomeric types charged to the reaction. Examples of related copolymers and how they are prepared are described in detail in U.S. Patent No. 4,693,935, Mazurek, issued September 15, 1987; U.S. Patent No. 4,728,571, Clemens et al., Issued March 1, 1988, both of which are incorporated by reference in the
P771 present. Additional, grafted polymers are also disclosed in U.S. Patent Nos. 5,166,276 and 5,480,634, Hayama, et al., Issued November 24, 1992 and January 2, 1996, respectively; U.S. Patent No. 5,061,481, Suzuki et al., Issued October 29, 1991; U.S. Patent No. 5,106,609, Bolich et al., Issued April 21, 1992; U.S. Patent No. 5,100,658, Bolich et al., Issued March 31, 1992; U.S. Patent No. 5,100,657, Ansher-Jackson et al., Issued March 31, 1992; and U.S. Patent No. 5,104,646, Bolich et al., issued April 14, 1992, all of which are incorporated herein by reference in their entirety. The copolymer composition is characterized by the amount of each monomer charged to the polymerization reaction vessel, or alternatively used in a continuous or semi-continuous process. For the selection and appropriate combination of the particular monomer units and the macromonomer units; and by choosing the specific relative ratios of the well-known units within the ability of one of ordinary skill in the art, copolymers can be optimized for various physical properties and for compatibility with other ingredients
P771 commonly used in hair care applications.
MONOMER UNITS A The copolymers of the present invention comprise from about 10% to about 99%, preferably from about 40% to about 80%, and most preferably from about 50% to about 70%, by weight of the copolymer hydrophobe, of monomer units A. The monomer unit A is selected from hydrophobic, copolymerizable monomers or mixtures thereof, preferably ethylenically unsaturated monomers. Either an individual type of monomer A or combinations of two or more monomer units A may be used. The monomers A are selected to meet the requirements of the copolymer. Preferably, the units A are soluble or dispersible in the hydrophobic, volatile solvent component. By "copolymerizable", as used herein, it is meant that monomer A can be reacted with monomers A or C macromonomers, or polymerized therewith, in a polymerization reaction using one or more conventional synthetic techniques , such as the ionic polymerization, by emulsion, by dispersion, of Ziegler-Natta, of
P771 free radicals, group transfer or gradual growth. In the present invention, monomers and macromonomers which are copolymerizable using conventional techniques initiated with free radicals are preferred. The term "ethylenically unsaturated" is used herein to mean a material containing at least one polymerizable carbon-carbon double bond, which may be mono-, di-, tri- or tetra-substituted. The non-limiting classes of the hydrophobic monomers A useful herein include monomers selected from the group consisting of unsaturated carboxylic acid esters of alcohols of 1 to 18 carbon atoms, unsaturated alcohols (preferably having about 12 to about 30 carbon atoms), unsaturated hydrocarbons, aromatic hydrocarbons containing unsaturated alkyl groups, vinyl esters of carboxylic acids, vinyl ethers, allyl esters of carboxylic acids, allyl esters, and mixtures thereof. Representative examples of hydrophobic monomers include esters of acrylic or methacrylic acid, of alcohols of 1 to 18 carbon atoms such as methanol, ethanol, methoxy-ethanol, 1-propanol, 1-butanol, 2-methyl-1-propanol, 1 -pentanol, 1-decanol, 2-ethylhexanol,
P771 cyclohexanol, and the like; dicyclopentenyl acrylate; 4-biphenyl acrylate; pentachlorophenyl acrylate; 3, 5-dimethyladamantyl acrylate; 4-methoxycarbonylphenyl methacrylate, trimethylsilyl methacrylate; show us such as methyl styrene; t-butyl styrene, isopropyl styrene; vinyl esters, such as vinyl acetate, vinyl neononanoate, vinyl pivalate; and vinyl propionate; vinyl chloride, vinyl toluene; vinylalkyl ethers, including vinyl isobutyl ether and vinyl-s-butyl ether; allyl chloride, allyl acetate, 1,2-butadiene; 1,3-butadiene, 1,3-hexadiene, 1,3-cyclohexadiene, bicycloheptadiene; 2,3-dicarboxylmethyl-l, 6-hexadiene; ethylene; propylene; isoprene; 1-butene, 2-butene, isobutylene, indene; norbornylene; β-pinene; -pinene; and mixtures thereof. Preferred hydrophobic monomers suitable for use as monomer units A, include monomers selected from the group consisting of n-butyl methacrylate, isobutyl methacrylate, t-butyl acrylate, t-butyl methacrylate, methacrylate 2 -ethyl-hexyl, methyl methacrylate, t-butyl-styrene and mixtures thereof. The monomer units selected from the group consisting of t-butyl styrene, t-butyl acrylate, t-butyl methacrylate, 2-ethylhexyl methacrylate, and mixtures thereof, are
P771 the most preferred.
MONOMER UNITS B The copolymers of the present invention comprise from about 1% to about 40%, preferably from about 5% to about 30%, and most preferably from about 10% to about 25%, by weight of the copolymer , of the monomer units B. The monomer unit B is selected from copolymerizable, hydrophilic monomers; preferably ethylenically unsaturated monomers, comprising at least one monomer copolymerizable with monomer unit A. Either an individual type of monomer unit B, or combinations of two or more monomer units B may be used. Monomers B are selected for meet the requirements of the copolymer. By "copolymerizable", as used herein, it is meant that monomer B can be reacted with monomers A or macromonomers C, or polymerized therewith, in a polymerization reaction using one or more conventional synthetic techniques, such as ionic polymerization, emulsion, dispersion, Ziegler-Natta, free radical, group transfer or gradual growth. In the present invention, the monomers and macromonomers
P771 which are copolymerizable using conventional techniques initiated by free radicals are preferred. The term "ethylenically unsaturated" is used herein to mean a material containing at least one polymerizable carbon-carbon double bond, which may be mono-, di-, tri- or tetra-substituted. The monomer units B are selected from hydrophilic monomers wherein at least 1%, by weight according to the weight of the copolymer, comprises hydrophilic monomers having at least one acid functional group. Preferably, the hydrophilic monomers are selected such that a polymer of these monomers has a Tg or a Tm above about -20 ° C. Preferred hydrophilic monomers B are copolymerizable with monomers A and C, and are selected from the group consisting of unsaturated mono- and polycarboxylic organic acids, unsaturated (meth) acrylates, unsaturated (meth) acrylamides, (meth) alcohols unsaturated acrylates, unsaturated aminoalkylacrylates, unsaturated organic acid anhydrides, unsaturated esters of organic acid anhydrides, vinyl compounds, hydrophilic unsaturates, hydrophilic unsaturated allyl, unsaturated, unsaturated hydrophilic imides, salts of the above compounds and mixtures thereof.
P771 Representative examples of monomers B include acid functional compounds such as acrylic acid, methacrylic acid, maleic acid, crotonic acid and itaconic acid as well as non-acidic functional compounds such as N, N-dimethylacrylamide, dimethylaminoethyl methacrylate, quaternized dimethylaminoethyl methacrylate. , methacrylamide, Nt-butyl acrylamide, maleic anhydride and its ester media, acrylamide, hydroxyethyl methacrylate, diallyldimethyl-ammonium chloride, vinyl pyrrolidone, vinyl ethers (such as methyl vinyl ether), maleimides, vinyl pyridines, vinyl imidazole, others polar vinyl heterocyclics, styrene sulfonate, allyl alcohol, vinyl alcohol (produced by hydrolysis of vinyl acetate after polymerization) and mixtures thereof. Most preferred are monomers B selected from the group consisting of acrylic acid, methacrylic acid, N, N-dimethylacrylamide, dimethyl aminoethyl methacrylate, vinyl pyrrolidone, and mixtures thereof. However, it remains critical that at least 1% by weight, based on the weight of the copolymer, comprises monomers B having at least one acid functional group.
MACROOMONOMER UNITS C The copolymers of the present invention may
P771 comprise from about 0% to about 50%, preferably from about 5% to about 40%, and more preferably from about 15% to about 30%, by weight of the macromonomer C unit copolymer. Macromonomer C are hydrophobic macromonomers copolymerizable with the monomers A and B, these macromonomers C preferably have an ethylenically unsaturated moiety. Herein, either a single type of macromonomer C unit or combinations of two or more macromonomer C units can be used. The C macromonomers are selected to meet the requirements of the copolymer. By "copolymerizable", as used herein, it is meant that C-macromonomers can be reacted with, or polymerized with, monomers A and B in a polymerization reaction using one or more conventional synthetic techniques, such as described above. The macromonomers C that are useful herein contain a polymeric portion and a copolymerizable portion that is preferably an ethylenically unsaturated moiety. Typically, preferred C-macromonomers are those that are capped or capped at the end with the ethylenically unsaturated portion. By
P771"end capped" as used herein is meant to mean that the ethylenically unsaturated portion is in the terminal position of the macromonomer, or near it. The C-macromonomers can be synthesized using a variety of normal synthetic procedures, familiar to the chemistry of polymers of ordinary skill in the art. In addition, these starting macromonomers of commercially available polymers can be synthesized. The macromonomer C has a number average molecular weight from about 1,500 to about 50,000, preferably from about 5,000 to about 50,000, more preferably from about 5,000 to about 30,000, and more preferably from about 8,000 to about 25,000. Preferably, the macromonomer C units are selected from the group consisting of polysiloxane macromonomers, polyalkylene macromonomers, and mixtures thereof. The C polysiloxane macromonomers are exemplified by the following formula:
X (Y) nYes (R) 3_mZm
wherein X is an ethylenically unsaturated group,
P771 copolymerizable with monomers A, such as a vinyl group; And it's a divalent link group; R is hydrogen, hydroxyl, lower alkyl (e.g., 1 to 4 carbon atoms), phenyl, aryl substituted with alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, or alkyl or dialkylamino of 1 to 4 carbon atoms; Z is a polymeric monovalent siloxane portion having an average number average molecular weight of at least about 1500, is essentially unreactive under polymerization conditions, and is pendant from the vinyl polymer structure described above; n is 0 or 1; and m is an integer from 1 to 3. Preferably, macromonomer C has a formula selected from the following formulas:
X- CH2- (CHjJs-SUR1 h-m-Zoi O 0 I X-C-0- (CH2) - (01p-S¡ {R l) 3.mZm
P771 In these structures, s is an integer from 0 to 6, preferably 0, 1 or 2, more preferably 0 or 1; m is an integer from 1 to 3, preferably 1; p is 0 or 1; q is an integer from 2 to 6; R is selected from the group consisting of alkyl of 1 to 10 carbon atoms or aryl substituted with alkyl of 1 to 4 carbon atoms, preferably alkyl of 1 to 6 carbon atoms or aryl substituted with alkyl of 1 to 4 carbon atoms; more preferably alkyl of 1 to 2 carbon atoms; n is an integer selected from 0 to 4, preferably 0 or 1, more preferably 0; R is hydrogen, hydroxyl, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, alkyl-amino or dialkylamino of 1 to 4 carbon atoms, phenyl, aryl substituted with alkyl of 1 to 4 carbon atoms , R is preferably alkyl of 1 to 4 carbon atoms; X is:
CH = C- I I R3 R4
R 3 is hydrogen or -COOH, preferably R 3 is hydrogen, R is hydrogen, methyl or -CH 2 COOH, preferably R is methyl; Z is
P771?
I R7
R, R and R independently are alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, alkyl or dialkylamino of 1 to 4 carbon atoms, phenyl, aryl substituted with alkyl of 1 to 4 carbon atoms, hydrogen or hydroxyl; preferably R, R and R are alkyl of 1 to 4 carbon atoms; and r is an integer from about 20 to about 900, preferably from about 20 to about 675; more preferably r is from about 100 to about 325. More preferably, R, R and R are methyl, p = 0, and q = 3. The polyalkylene macromonomers are exemplified by the general formula:
[I] n- [W] m-E
wherein I is an optionally present initiator (i.e., n = 0 or 1), W is a hydrophobic monomer unit, E is a crown group at the end, and m is an integer from about 10 to about 2000.
P771 I is a portion of chemical initiator, optionally present. Without being limited by theory, I can be derived from a chemical initiator or solvent used in the synthesis of macromonomer C. Non-limiting examples of these initiators from which I can be derived include hydrogen ion, hydrogen, hydride ion, hydroxide ion, hydroxyl radical, peroxide radical, peroxide anion, carbocations of 1 to 20 carbon atoms, carboanions of 1 to 20 carbon atoms, carbon radicals of 1 to 20 carbon atoms , aliphatic anions of 1 to 20 carbon atoms and aromatic alkoxy, ammonium ion and substituted ammonium ions (for example, substituted with alkyl of 1 to 20 carbon atoms and alkoxy of 1 to 20 carbon atoms), and mixtures of the same. I can be derived from any useful solvent, non-limiting examples of which include water, methanol, ethanol, propanol, isopropanol, acetone, hexane, dichloromethane, chloroform, benzene, toluene, and mixtures thereof. W is selected from one or more monomeric, hydrophobic units. The non-limiting classes of this monomer include acrylate esters of 1 to 18 carbon atoms, esters (alk) acrylate of 1 to 18 carbon atoms, straight and branched chain alkenes of 2 to 30 carbon atoms, styrenes, vinyl ethers from 1 to 30 atoms
P771 carbon, straight and branched chain dienes of 4 to 30 carbon atoms, and mixtures thereof. Non-limiting examples of W groups include those selected from the group consisting of n-butyl acrylate, dodecyl acrylate, ethyl acrylate, 2-ethylbutyl acrylate, n-heptyl acrylate, n-hexyl acrylate, acrylate. of iso-butyl, iso-decyl acrylate, iso-propyl acrylate, 3-methylbutyl acrylate, 2-methylpentyl acrylate, nonyl acrylate, octyl acrylate, 1-propyl acrylate, 2-ethylhexyl methacrylate, methacrylate octyl, n-dodecyl methacrylate, n-octadecyl methacrylate, n-decyl methacrylate, n-pentyl methacrylate, isobutylene, isoprene, 1,2-butadiene, 1,3-butadiene, 5-methyl-1-hexene , 6-methyl-1-heptene, 4, 4-dimethyl-1-pentene, vinyl isobutyl ether, styrene, 2-methylstyrene, 3-methylstyrene, 4-methylstyrene, 2-t-butyl-styrene, 3-t-butyl- styrene, 4-t-butyl styrene, and mixtures thereof. E is a copolymerizable portion or a group of
"crowned at the end". Preferably, E is an ethylenically unsaturated moiety. Most preferred is when E is selected from the group consisting of vinyl, allyl, acryloyl, methacryloyl, ethacryloyl, 2-vinylbenzyl, 3-vinylbenzyl, 4-vinylbenzyl, 2-
P771 vinylbenzoyl, 3-vinylbenzoyl, 4-vinylbenzoyl, 1-butenyl, 1-propenyl, isobutenyl, cyclohexenyl, cyclopentenyl, and mixtures thereof. Even more preferred is when E is selected from the group consisting of vinyl, allyl, acryloyl, methacryloyl, ethacryloyl, 3-vinylbenzyl, 4-vinylbenzyl, 3-vinylbenzoyl, 4-vinylbenzoyl, 1-butenyl, 1-pro-enyl , isobutenyl, and mixtures thereof. More preferred is when E is selected from the group consisting of vinyl, allyl, acryloyl, methacryloyl, ethacryloyl, 3-vinylbenzyl, 4-vinylbenzyl, and mixtures thereof. Non-limiting examples of polysiloxane and polyalkylene macromonomer C units useful herein include those selected from the group consisting of acryloyl, methacryloyl, or 3-, or 4-vinylbenzyl, capped polymers of polydimethylsiloxane, polydiethyl siloxane , polyphenylethylsiloxane, polyphenylethylsiloxane, poly (n-butyl acrylate), poly (dodecyl acrylate), poly (2-ethylhexyl acrylate), poly (2-ethylbutyl acrylate), poly (ethyl acrylate), poly (acrylate), n-heptyl), poly (n-hexyl acrylate), poly (isobutyl acrylate, poly (isodecyl acrylate), poly (isopropyl acrylate), poly (3-methylbutyl acrylate), poly (2-methylpentyl acrylate) ), poly (nonyl acrylate), poly (acrylate)
Octyl P771), poly (propyl acrylate), poly (2-ethylhexyl methacrylate), poly (tridecyl methacrylate), poly (hexyl methacrylate), poly (decyl methacrylate), poly (octyl methacrylate), poly (octadecyl methacrylate), poly (dodecyl methacrylate), poly (n-pentyl methacrylate), poly (isobutylene), poly (isoprene), poly (1, 2-butadiene) hydrogenated, poly (1,4-butadiene) hydrogenated, hydrogenated poly (isoprene), poly (1,2-butadiene), poly (1-butene), poly (5-methyl-1-hexene), poly (6-methyl-1-heptene), poly (4, 4-dimethyl-l-pentene), poly (vinyl isobutyl ether), poly [4-t-butyl-vinyl-benzene-co-2-ethylhexyl acrylate], poly [2-ethylhexyl-co-octyl-acrylamide acrylate] ], poly [2-ethyl-vinyl-benzene-co-octyl methacrylate]], and mixtures thereof. C-type "copolymer" macromonomers containing two or more different randomly repeating monomer units are useful herein. Non-limiting examples of this type of "copolymer" of macromonomers include poly [co (4-t-butyl-vinyl-benzene) (2,4-dimethyl-vinyl-benzene)], end-capped with acryloyl, poly [ co (4-t-butyl-vinyl-benzene) (2-ethylhexyl acrylate)], poly [co (2,4-dimethyl-vinyl-benzene) (2-ethylhexyl acrylate)], poly [co (2- (2-ethylhexyl)] ethyl vinylbenzene) (octylmethacrylate)], and the like.
P771 NON IMITATING EXAMPLES OF POLYMER OF RESENT INVENTION Non-limiting examples of polymers useful in making the complexes of the present invention include those selected from the group consisting of poly [(t-butylacrylate-co-acrylic acid) -graft- poly (dimethylsiloxane)], poly [(4-t-butylstyrene-co-acrylic acid) graft-poly (dimethylsiloxane)], poly [t-butylacrylate-co-acrylic acid) -graft-poly (isobutylene)], poly [ (4-t-butylstyrene-co-acrylic acid) -graft-poly (isobutylene)], poly [(t-butylstyrene-co-acrylic acid) -graft-poly (2-ethylhexylmethacrylate)], poly [(4 -t-butylacrylate-co-styrene-co-acrylic acid) -grafting-poly (isobutylene)], poly [(t-butylacrylate-co-methacrylic acid) -graft-poly (dimethylsiloxane)], poly [(4-t -butylstyrene-co-methacrylic acid) -graft-poly (dimethylsiloxane)], poly [t-butylacrylate-co-methacrylic acid) -graft-poly (isobutylene)], poly [(4-t-butyl styrene-co-methacrylic acid) -graft-poly (isobutylene)], poly [(t-butylstyrene-co-methacrylic acid) -graft-poly (2-ethylhexylmethacrylate)], poly [(4-t-butylacrylate- co-styrene-co-methacrylic acid) -graft-poly (isobutylene)], and mixtures thereof. The following, non-limiting, more specific examples of polymers useful for making complexes
P771 of the compositions of the present invention include the following. The percentages by weight refer to the amount of reactive monomer and macromonomer added in the polymerization reaction, not necessarily to the amount in the finished polymer): (I) a copolymer prepared from the polymerization reaction of 10 percent by weight weight of acrylic acid, 70 weight percent of isobutylmethacrylate, and 20 weight percent of polydimethylsiloxane macromonomer having a weight average molecular weight of about 20,000.
(II) a copolymer prepared from the polymerization reaction of 20 weight percent acrylic acid, 62 weight percent t-butyl methacrylate, and 18 weight percent polydimethylsiloxane macromonomer having a molecular weight average weight of approximately 15,000. (III) a copolymer prepared from the polymerization reaction of 50 weight percent t-butyl acrylate, 10 weight percent t-butyl methacrylate, 10 weight percent N, N-dimethylamine propyl methacrylate, 10 percent by weight. weight percent ethylhexyl methacrylate, and 20 weight percent polydimethylsiloxane macromonomer having a weight average molecular weight of 10,000.
P771 (IV) a copolymer prepared from the polymerization reaction of 60 weight percent t-butylacrylate, 15 weight percent acrylic acid, 10 weight percent ethylhexyl methacrylate and 15 weight percent polydimethylsiloxane macromonomer having a weight average molecular weight of about 10,000. (V) a copolymer prepared from the polymerization reaction of 70 weight percent t-butylacrylate, 10 weight percent methacrylic acid, and 20 weight percent polyisobutylene macromonomer having an average molecular weight in weight of approximately 10,000. (VI) a copolymer prepared from the polymerization reaction of 75 weight percent of t-butylacrylate, 5 weight percent of acrylic acid, and 20 weight percent of polydimethylsilyxane macromonomer having an average molecular weight in weight of approximately 10,000. (VII) a copolymer prepared from the polymerization reaction of 70 weight percent t-butylacrylate, 10 weight percent acrylic acid, and 20 ethylhexyl methacrylate polymer.
(VIII) poly [(t-butyl-co-acrylic acid acrylate) -graft-polyoxyldimethylsiloxane)] having a weight average molecular weight of about 700,000, comprising approximately 67% t-butyl acrylate, about 3% of acrylic acid, and about 30% dimethylsiloxane macromonomer with a weight average molecular weight of about 11,000.
AMINO GREASE The copolymer component of the present invention comprises from about 1% to about 65%, preferably from about 30% to about 50%, and more preferably from about 15% to about 30%, based on the weight of the copolymer complex, a fatty amine complex formation and derivatives and salts thereof. The fatty amines useful in the compositions of the present invention include primary, secondary and tertiary amines, quaternary ammonium salts, heterocyclic amines, substituted with alkyl and polyamines such as diamines and triamines. Also useful herein are the salts of these amines and quaternized derivatives of these amines. It is critical for the present invention that the copolymer complex formed by the functional monomer
P771 acid and the complex forming fat amine are soluble in the hydrophobic, volatile solvent component, subsequently analyzed. Without being limited by theory, it is believed that fatty amines are associated with the acidic functional groups of the copolymeric structure to protect the hydrophilic acid functional groups from the hydrophobic solvent component, improving the stability of the solubilized and dispersed copolymer complex. Primary amines or salts thereof having the formula R-NH2, wherein R is a straight or branched chain aliphatic group of 1 to 22 carbon atoms, hydroxyalkyl, amidoalkyl, carboxyalkyl, cyclic, alkoxy, polyalkoxy, or hydroxypolialkoxy , works as useful fatty amines. The secondary amines or salts thereof having the formula R 1 R 2 -NH 2, wherein R 1 and R 2 are independently a straight or branched chain aliphatic group of 1 to 22 carbon atoms, hydroxyalkyl, amidoalkyl, carboxyalkyl, cyclic, alkoxy , polyalkoxy, or hydroxypolyalkoxy, also function as useful fatty amines. Additionally, tertiary amines or salts thereof having the formula R R R N, wherein R 1, R 2 and
3 R are independently a straight or branched chain aliphatic group of 1 to 22 carbon atoms,
P771 hydroxyalkyl, amidoalkyl, carboxyalkyl, cyclic, alkoxy, polyalkoxy, or hydroxypolyalkoxy, function well as fatty amines. Other preferred amines of complex formation are the quaternary ammonium compounds having the formula R1R2R3RN + [X "] wherein R1, R2, R3 and R4 are independently a straight or branched chain aliphatic group of 1 to 22 carbon atoms, hydroxyalkyl , amidoalkyl, carboxyalkyl, cyclic, alkoxy, polyalkoxy, or hydroxypolialkoxy, and X is an anion Examples of the formation of quaternary ammonium amines include alkyl dimethyl ammonium chloride of 12 to 18 carbon atoms. cetyldimethylammonium, n-dodecyltrimethylammonium hydroxide, bait-trimonium chloride, and n-octadecyl tri-n-butylammonium nitrate The polyamines or salts thereof are also suitable for use in the present invention. have the formula RR -N ((CH3) xN) nR R wherein R and R are independently a hydrogen atom or a straight or branched chain aliphatic group of 1 to 22 carbon atoms carbon, hydroxyalkyl, amidoalkyl, carboxyalkyl, cyclic, alkoxy, polyalkoxy or hydroxypolialkoxy, x is an integer from 1 to 3, and n is an integer from 1 to 5. Representative polyamines
P771 are ethylenediamine, and ethylenetrimine, diethylenetetramine, tetraethylenepentamine, pentaethylenehexamine, bait-propylenedimine, 1,2-propanediamine, 1,3,5-pentatriamine, and ethylenediaminetetraacetic acid (EDTA). Heterocyclic amines or salts thereof having imidazolines substituted with straight or branched chain alkyl of 1 to 22 carbon atoms, morpholines or piperazines, are also useful in the present invention. Typical heterocyclic amines include aminoethyl-hexadecylimidazoline, N-ethyl-morpholine and N-ethyl-piperidine. Mixtures of the above fatty amines can also be used. Preferred for use in forming the copolymer complexes of the present invention are tertiary amines or salts thereof. The copolymers of the present invention can be rendered complex with the fatty amines either during the polymerization process or after the polymerization process as part of the final step of complex formation, preferably a weight ratio of copolymer to fatty amine from about 50: 1 to about 1: 1, preferably from about 3: 1 to about 10: 7, more preferably from about 15: 7 to about 10 : 7
P771 COMPONENT OF VOLATILE HYDROPHOBIC SOLVENT The compositions of the present invention further comprise from about 1% to about 99.75%, preferably from about 4% to about 50%, and most preferably from about 4% to about 20%, based on the weight of the composition, of a hydrophobic, volatile solvent for the copolymer complex. The term "solvent" as used herein, means a liquid suitable for solubilizing or dispersing one or more of a variety of substances. The term "solvent component" as used herein means a liquid comprised of a single solvent or a mixture of solvents. The term "volatile", as used herein, means that the solvent exhibits a significant vapor pressure at ambient conditions (e.g., an atmosphere at 25 ° C), as understood by those skilled in the scientific arts. Especially, the solvent component has a boiling point at an atmosphere of about 260 ° C or less, preferably about 230 ° C or less, more preferably about 215 ° C or less, and most preferably about 210 ° C. ° C or less, and a 1 /? Solubility parameter of about 8.5 (cal / cm)
P771 or less. In addition, the boiling point of the solvent will generally be at least about 50%, preferably at least about 90%. The solvent component should also be acceptable for topical application to hair and skin. The copolymers composed of monomer and / or macromonomer units of the present invention must be soluble or dispersible in the hydrophobic, volatile solvent component, once complexed with the complex forming fatty amine agent of the present invention. The hydrophobic solvents for use in the hydrophobic, volatile solvent component are selected from the group consisting of branched chain hydrocarbons, silicones, and mixtures thereof. The preferred hydrophobic branched chain hydrocarbons useful as the solvent component herein contain from about 7 to about 14, more preferably from about 10 to about 13, more preferably from about 11 to about 12 carbon atoms. . Saturated hydrocarbons are preferred, although it is not proposed to exclude unsaturated hydrocarbons. Examples of these preferred branched chain hydrocarbons include isoparaffins of the above chain sizes. Isoparaffins are
P771 commercially available from Exxon Chemical Co .; examples include Isopar E (isoparaffins of 8 to 9 carbon atoms), Isopar MR H and K (isoparaffins of 11 to 12 carbon atoms), and Isopar MR L (isoparaffins of 11 to 13 carbon atoms) or mixtures of the same. Other suitable branched chain hydrocarbons are isododecane and isoundecane. Isododecane is preferred and commercially available from Presperse, Inc. South Plainfield, NJ. USA) as Permethyl ™ 99A. Preferred silicones useful as the hydrophobic, volatile solvent component include volatile siloxanes such as phenyl-pentamethyl-disiloxane, phenylethylpentamethyl-disiloxane, hexamethyldisiloxane, methoxy-propylheptamethyl-cyclotetrasiloxane, chloropropyl-pentamethyl-disiloxane, hydroxypropyl-pentamethyl-disiloxane, octamethyl-cyclotetrasiloxane. , decamethyl-cyclopentasiloxane, and mixtures thereof. More preferred among silicones are cyclomethicones, examples of which include hexamethyl-disiloxane, octamethyl-cyclo-tetrasiloxane and decamethyl-cyclopentasiloxane, which are commonly referred to cyclomethicone D4 and D5, respectively. Also small amounts of hydrophilic solvents such as water, alcohols of 1 to 6 carbon atoms, or mixtures of the
P771 themselves, whereas the solubility parameter of the hydrophobic solvent component, volatile is about 8.5 (cal / cm 3) 1/2 or less. The copolymer complexes of the present invention are soluble or dispersible in the hydrophobic, volatile solvent component, at a concentration by weight of about 0.2%, preferably about 0.5%, and most preferably about 1%. In the case of improved hair styling modalities, the copolymer complex and the volatile hydrophobic solvent are preferably mixed in such a way that the mixture of the copolymer / solvent complex has a viscosity above about 5,000 cps, preferably from about 7,000 cps to about 250,000 cps and more preferably from about 7,000 cps to about 15,000 cps. All viscosities are measured at 25 ° C and at a cutting speed of 10 sec "using a Bohlin cone and plate viscometer, Model VOR (cone diameter: 30 mm, cone angle: 2.5 °) and are expressed in centipoise. Without being limited by theory, it is believed that these higher viscosity modalities improve the deposition efficiency of the polymer and / or improve the attached morphology of the polymer droplets leading to stylization and retention
P771 improved hair.
CARRIERS
TOPICAL COMPOSITIONS FOR CARE OF SKIN AND HAIR CARE The copolymers of the present invention can be formulated in a wide variety of product types, including foams, gels, lotions, creams, ointments, tonics, sprays, aerosols, shampoos, conditioners, rinses, bar soaps, hand and body lotions, facial moisturizers, solid gel bars, sunblocks, anti-acne preparations, topical analgesics, masks, anti-perspirants, deodorants and the like. The carriers optionally used to formulate these types of products must be immiscible with the hydrophobic, volatile solvent component. The term "immiscible" as used herein means the hydrophobic, volatile solvent component, which has a solubility in the carrier of less than 2% by weight, preferably less than 1%, more preferably less than 0.1 % such that at least two liquid phases are formed by combining the hydrophobic, volatile solvent component with the carrier. Optional carriers and additional components vary with the type of product and can be routinely chosen
P771 by a person skilled in the art. The following is a description of some of these carriers and additional components.
COMPOSITIONS FOR HAIR CARE The hair care compositions of the present invention may comprise a carrier, or a mixture of these carriers, which are suitable for application to hair. The carriers are preferably present from about 0.5% to about 99.5%, preferably from about 5.0% to about 99.5%, most preferably from about 10.0% to about 98.0%, of the composition. As used herein, the phrase "suitable for application to hair" means that the wearer does not damage or negatively affect the aesthetics of the hair or cause irritation to the underlying skin. Suitable carriers for use with the hair care compositions of the present invention include, for example, those used in the formulation of hair sprays, foams, tonics, gels, shampoos, conditioners, and rinses. The choice of the appropriate carrier will also depend on the particular copolymer to be used, and if the formulated product is
P771 proposes to be left on the surface to which it is applied (eg, spray, foam, tonic or hair gel) or rinsed after use (eg, shampoo, conditioner, rinse). The carriers used herein may include a wide range of components conventionally used in hair care compositions. The carriers may contain a solvent to dissolve or disperse the additional copolymers that are used, with water, the alcohols of 1 to 6 carbon atoms, and mixtures thereof which are preferred; and water, methanol, ethanol, isopropanol, and mixtures thereof which are more preferred. Carriers may also contain a wide variety of additional materials including, but not limited to, acetone, hydrocarbons (such as isobutane, hexane, decene), halogenated hydrocarbons (such as Freons), linalool, ethers (such as ethyl acetate, dibutyl phthalate), and volatile silicon derivatives (especially siloxanes such as phenyl-pentamethyl-disiloxane, methoxypropyl-heptamethyl-cyclotetrasiloxane, chloropropyl-pentamethyl-disiloxane, hydroxypropyl-pentamethyl-disiloxane, octa ethyl-cyclotetrasiloxane, decamethyl-cyclopentasiloxane, cyclomethicone, and dimethicone having, for example, a viscosity at 25 ° C from about 2.5 centipoise or
P771 minus), and mixtures thereof. When the hair care composition is an aerosol, tonic, gel or foam for the hair, the preferred solvents include water, ethanol, silicone derivatives, volatiles, and mixtures thereof. The solvents used in these mixtures can be miscible or immiscible with each other. Foams and aerosol sprays for hair can also use any of the conventional propellants to distribute the material as a foam (in the case of a foam) or a uniform spray, fine (in the case of an aerosol spray for hair). Examples of suitable propellants include materials such as trichlorofluoromethane, dichlorodifluoromethane, difluoroethane, dimethyl ether, propane, n-butane or isobutane. You can also use an emulsifying agent, a hair spray product or tonic that has a low viscosity. Examples of emulsifying agents include nonionic, cationic, anionic surfactants, or mixtures thereof. Surfactant fluoroagents are especially preferred, particularly if the product is a hair spray composition and more especially if it is an aerosol composition having relatively low levels of volatile organic solvents, such as alcohols, and relatively high levels. of water (for example, in excess of about 10%, by weight of
P771 water). If this emulsifying agent is used, it is preferably present at levels from about 0.01% to about 7.5% of the composition. The level of the propellant can be adjusted as desired, but is generally from about 3% to about 30% of the foam compositions and from about 15% to about 70% of the spray compositions for the hair. Suitable aerosol containers are well known in the art and include conventional, non-pressurized pump aerosols, i.e. "atomizers," aerosol containers or cans having propellant, as described above, and also aerosol containers of pump that use compressed air as the propellant. Pump aerosol containers are described, for example, in U.S. Patent Nos. 4,077,441, March 7, 1978, Olofsson and No, 4,850,577, July 25, 1989, TerStege, both incorporated herein by reference. , and also in U.S. Patent No. 07 / 839,648, Gosselin, Lund, Sojka, and Lefebvre, filed on February 21, 1992, "Consumer Product Package Incorporating A Spray Device Utilizing Large Diameter Bubbles". Aerosol spray for hair, pump using compressed air are also commonly sold by The Procter & Gamble Company
P771 under its trade name hair sprays VIDAL SASSOON AIRSPRAYR. Where the hair care compositions are conditioners and rinses, the carrier may include a wide variety of conditioning materials. Where the hair care compositions are shampoos, the carrier may include surfactants, dispersing agents, surfactants, suspending agents, thickeners, etc. Several additional components useful in hair care compositions are described in U.S. Patent No. 5,106,609 to Bolich Jr. et al, issued April 21, 1992; and U.S. Patent No. 4,387,090, to Bolich, Jr. , granted on June 7, 1983; which are incorporated as a reference in the present. Some of these additional components are described later.
TOPICAL COMPOSITIONS FOR CARE OF THE SKIN The cosmetic and pharmaceutical topical compositions of the present invention may comprise a carrier. The carrier must be "cosmetically and / or pharmaceutically acceptable", which means that the carrier is suitable for topical application to the skin, has good aesthetic properties, is compatible with the copolymers of the present invention and any other
P771 components, and does not cause any safety concerns or adverse toxicity. The carrier can be in a wide variety of ways. For example, emulsion carriers, which include, but are not limited to, oil-in-water, water-in-oil, water-in-oil-in-water, and water-in-silicone emulsions, are useful herein. These emulsions can cover a wide range of viscosities, for example, from about 100 cps to about 200,000 cps. These emulsions can also be distributed in the form of aerosols using either mechanical pump containers or pressurized aerosol containers using conventional propellants. These carriers can also be distributed in the form of a foam. Suitable topical carriers include anhydrous liquid solvents such as oils, alcohols, and silicones (e.g., mineral oil, ethanol, isopropanol, dimethicone, cyclomethicone, and the like); liquid solvents of individual phase, water based (for example, hydroalcoholic solvent systems); and thickened versions of these individual phase, water based and anhydrous solvents (for example, where the viscosity of the solvent has been increased to form a solid or semi-solid by the addition of gums, resins, waxes, polymers, salts, appropriate and similar).
P771 The examples of the topical carrier systems useful in the present invention are described in the following four references all of which are incorporated herein by reference in their entirety. "Sun Products Formulary" Cosmetics & Toiletries, vol. 105, pp. 122-139 (December 1990); "Sun Products Formulary", Cosmetics & Toiletries, Vol. 102, pp. 117-136 (March 1987); U.S. Patent No. 4,960,764 to Figueroa et al., Issued October 2, 1990; and U.S. Patent No. 4,454,105 to Fukuda et al., issued March 3, 1981. The carriers of the skin care compositions preferably comprise from about 50% to about 99% by weight of the compositions of the present invention, more preferably from about 75% to about 99%, and more preferably from about 85% to about 95%. Preferred cosmetically and / or pharmaceutically acceptable topical carriers include hydroalcoholic systems and oil-in-water emulsions. When the carrier is a hydroalcoholic system, the carrier can comprise from about 1% to about 50% ethanol, isopropanol, or mixtures thereof, and from about 40% to about 99% water. Most preferred is a carrier comprising from
P771 about 5% to about 60% ethanol, isopropanol, or mixtures thereof and from about 40% to about 95% water. Especially preferred is a carrier comprising from about 20% to about 50% ethanol, isopropanol, or mixtures thereof, and from about 50% to about 80% water. When the carrier is an oil-in-water emulsion, the carrier can include any of the excipient ingredients, common for preparing these emulsions. The additional components useful in the formulation of these topical compositions are described further below.
ADDITIONAL COMPONENTS A wide variety of additional components can be employed in the hair care compositions and topical compositions for the skin, herein. Non-limiting examples include the following:
PHARMACEUTICAL ACTIVE The compositions of the present invention, especially the topical skin care compositions, can comprise a safe and effective amount
P771 of a pharmaceutical asset. The phrase "safe and effective amount", as used herein, means a quantity of an asset highly sufficient to significantly or positively modify the condition to be treated, but low enough to avoid serious side effects (a a reasonable benefit and risk ratio), within the scope of sound medical judgment. A safe and effective amount of the pharmaceutical active will vary with the specific asset, the ability of the composition to penetrate the active through the skin, the amount of the composition to be applied, the particular condition being treated, the age and condition the patient's physical condition, the severity of the condition, the duration of the treatment, the nature of the concurrent therapy, and similar factors. The pharmaceutical actives that can be used in the compositions of the present invention preferably comprise from about 0.1% to about 20% by weight of the compositions, more preferably from about 0.1% to about 10%, and in the most preferred form. preferred from about 0.1% to about 5%. Mixtures of pharmaceutical actives can also be used. Non-limiting examples of pharmaceutical actives may include the following:
P771 Pharmaceutical active ingredients useful in the compositions of the present invention include anti-acne actives. Preferred anti-acne actives for use in the present invention include keratolytics such as salicylic acid, sulfur, lactic acid, glycolic acid, pyruvic acid, urea, resorcinol, and N-acetylcysteine; retinoids such as retinoic acid and its derivatives (e.g., cis and trans); antibiotics and antimicrobials such as benzoyl peroxide, octopirox, erythromycin, zinc, tetracycline, triclosan, azelaic acid and its derivatives, phenoxy-ethanol and phenoxy-propanol, ethyl acetate, clindamycin and meclocycline; sebostats such as flavinoids; alpha and beta hydroxy acids; and viral salts such as escimnol sulfate and its derivatives, deoxycholate and cholate. Preferred for use herein is salicylic acid. The pharmaceutical actives useful in the compositions of the present invention include analgesic actives. Analgesic actives suitable for use in the present compositions include salicylic acid derivatives such as methyl salicylate, species and derivatives of the capsicum genus such as capsaicin and non-steroidal anti-inflammatory drugs (NSAIDS). The NSAIDS can be selected from the following categories. Derivatives of propionic acid; derivatives of
P771 acetic acid; phenamic acid derivatives; biphenylcarboxylic acid derivatives; and oxicams. All of these NSAIDS are fully described in U.S. Patent No. 4,985,459 to Sunshine et al., Issued January 15, 1991, incorporated herein by reference. More preferred are propionic NSAIDS which include but are not limited to aspirin, acetaminophen, ibuprofen, naproxen, benoxaprofen, flurbiprofen, fenoprofen, fenbufen, ketoprofen, indoprofen, pirprofen, carprofen, oxaprozin, pranoprofen, miroprofen, thioxaprofen, suprofen, alminoprofen, Tiaprofenic acid, fluprofen and bucilloxic acid. Also useful are anti-inflammatory steroid drugs that include hydrocortisone and the like. The pharmaceutical actives useful in the compositions of the present invention include antipruritic drugs. Preferred antipruritic actives for inclusion in the compositions of the present invention include pharmaceutically acceptable salts of metdilizine and trimeprazine. The pharmaceutical actives useful in the compositions of the present invention include anesthetic actives. Preferred anesthetic actives for inclusion in the compositions of the present invention include pharmaceutically acceptable salts of lidocaine, bupivacaine, chlorprocaine, dibucaine, etidocaine,
P771 mepivacaine, tetracaine dyclonine, hexylcaine, procaine, cocaine, ketamine, pramoxin and phenol. Pharmaceutical actives useful in the compositions of the present invention include antimicrobial actives (antibacterial, antifungal, antiprotozoal and antiviral drugs). Preferred antimicrobial actives for inclusion in the compositions of the present invention include pharmaceutically acceptable salts of b-lactam drugs, quinolone drugs, ciprofloxacin, norfloxacin, tetracycline, erythromycin, amikacin, triclosan, doxycycline, capreomycin, chlorhexidine, chlortetracycline, oxytetracycline , clindamycin, ethambutol, metronidazole, pentamidine, gentamicin, kanamycin, lineomycin, methacycline, methenamine, minocycline, neomycin, netilmicin, paromomycin, streptomycin, tobramycin, miconazole and amanfadine. Preferred antimicrobial drugs for inclusion in the compositions of the present invention include tetracycline hydrochloride, erythromycin estolate, erythromycin stearate (salt), amikacin sulfate, doxycycline hydrochloride, capreomycin sulfate, chlorhexidine gluconate, chlorhexidine hydrochloride, Chlortetracycline hydrochloride, oxytetracycline hydrochloride, clindamycin hydrochloride, ethambutol hydrochloride, metronidazole hydrochloride, pentamidine hydrochloride,
P771 gentamicin sulfate, kanamycin sulfate, lineomycin hydrochloride, methacycline hydrochloride, methenamine hippurate, methenamine mandelate, minocycline hydrochloride, neomycin sulfate, netilmicin sulfate, paromomycin sulfate, streptomycin sulfate, tobramycin sulfate, hydrochloride of miconazole, amanfadine hydrochloride, amanfadine sulfate, triclosan, octopirox, parachlorometha-xylenol, nystatin, tolnaftate and clotrimazole. Also useful in the present are sun blocking agents. A wide variety of sun-blocking actives are described in U.S. Patent No. 5,087,445, Haffey et al., Issued February 11, 1992; U.S. Patent No. 5,073,372, Turner et al., Issued December 17, 1991; U.S. Patent No. 5,073,371, Turner et al., Issued December 17, 1991; and Segarin, et al., In Chapter VIII, pages 189 et seq., Of Cosmetics Science and Technology, all the which are incorporated herein by reference in their entirety. Preferred among these sunscreens which are useful in the compositions of the present invention are those selected from the group consisting of 2-ethylhexyl p-methoxycinnamate, 2-ethylhexyl N, N-dimethyl-p-aminobenzoate, p-aminobenzoic acid. , 2-phenylbenzimidazole-5-sulfonic acid, octocrylene, oxybenzone,
P771 homomenthyl salicylate, octyl salicylate, 4,4'-methoxy-t-butyldibenzoylmethane, 4-isopropyl-dibenzoylmethane, 3-benzylidene-camphor, 3- (4-methylbenzylidene) camphor, titanium dioxide, zinc oxide, silica , iron oxide, and mixtures thereof. Still other useful sun blockers are those described in U.S. Patent No. 4,937,370, to Sabatelli, issued June 26, 1990; and U.S. Patent No. 4,999,186 to Sabatelli et al., issued March 12, 1991; These two references are incorporated herein by reference in their entirety. The sun blocking actives described herein have, in a single molecule, two distinct chromophoric portions that exhibit different absorption spectra to ultraviolet radiation. One of the chromophore portions absorbs predominantly in the UVB radiation range and the other absorbs strongly in the UVA radiation range. These active sun blockers provide superior efficiency, wider UV absorption, less skin penetration and more lasting efficacy compared to conventional blockers. Preferred examples especially of these sun blockers include those selected from the group consisting of 4-N, N- (2-ethylhexyl) methyl-aminobenzoic acid ester of 2,4-dihydroxybenzophenone,
P771 4-N, N- (2-ethylhexyl) methylaminobenzoic acid ester with 4-hydroxydibenzoylmethane, 4-N, N- (2-ethylhexyl) methylaminobenzoic acid ester of 2-hydroxy-4- (2-hydroxyethoxy) benzophenone, 4-N, N- (2-ethylhexyl) methylaminobenzoic acid ester of 4-hydroxyethoxy) dibenzoylmethane, and mixtures thereof. In general, sun blockers can comprise from about 0.5% to about 20% of the compositions useful herein. The exact amounts will vary depending on the chosen sunblock and the Sun Protection Factor, desired
(SPF) SPF is a commonly used photoprotection measure of a sunscreen against erythema.
See Federal Register, Vol. 43, No. 166, pp. 38206.38269, August 25, 1978, which is incorporated herein by reference in its entirety. Also useful in the present invention are sunless tanning actives including dihydroxyacetone, glyceraldehyde, indoles and their derivatives, and the like. These sunless tanning assets can also be used in combination with sun blocking agents. Other useful actives include skin lightening (or enlightening) actives including, but not limited to, hydroquinone, ascorbic acid, kojic acid, and sodium metabisulfite.
P771 Other suitable actives which are especially useful for hair care compositions include anti-dandruff actives such as zinc pyrithione, octopirox, selenium disulfide, sulfur, coal tar and the like. Other useful assets include antiperspirant actives. Suitable for use herein are those that comprise any compound, composition or mixtures thereof that have anti-perspirant activity. The astringent metal salts are preferred antiperspirant materials for use herein, particularly the inorganic and organic salts of aluminum, zirconium and zinc, as well as mixtures thereof. Particularly preferred are the aluminum and zirconia salts, such as aluminum halides, aluminum hydroxide halides, zirconyl oxide halides, zirconyl hydroxy halides, and mixtures thereof. Additionally, deodorant actives in the form of bacteriostats can be incorporated into the present compositions. Suitable deodorant bacteriostats include 2, 2'-methylenebis (3,4,6-trichlorophenol), 2,4,4'-trichloro-2'-hydroxy (diphenylether, zinc phenolsulfonate, 2,2'-thiobis ( 4,6-dichlorophenol), p-chloro-m-xylenol, dichloro-m-xylenol and the like The most preferred is 2,, '-trichloro 2' -hydroxy (diphenyl ether), which is known
P771 generically as triclosan and is available from Ciba-Geigy Corporation under the trademark, Irgasan DP-300 Registered MR. When triclosan is used it will be present in a range of from about 0.05 to about 0.9%, preferably from about 0.1 to about 0.5% by weight of the composition. Other types of bacteriostats include sodium n-lauroyl-sarcosine, sodium N-palmitoyl-sarcosine, lauroyl sarcosin, N-myristoyl-glycine, potassium N-lauroyl-sarcosine, and aluminum chlorohydroxy lactate (sold by Reheis Chemical Company under the Chloracel's trademark).
CONDITIONERS Conditioning agents useful herein, and especially useful for hair care compositions, include hydrocarbons, silicone fluids, and cationic materials. The hydrocarbons can be either straight or branched chain and can contain from about 10 to about 16, preferably from about 12 to about 16, carbon atoms. Examples of suitable hydrocarbons are decane, dodecane, tetradecane, tridecane, and mixtures thereof.
P771 The silicone conditioning agents useful herein may include cyclic or linear polydimethylsiloxanes, phenyl and alkyl phenyl silicones, and silicone copolyols. Volatile and linear silicones in general have viscosities of less than about 5 centistokes at 25 ° C, while cyclic materials have viscosities of less than about 10 centistokes. The cationic conditioning agents useful herein include quaternary ammonium salts or the fatty amine salts. These additional cationic agents are used herein for the purpose of providing conditioning and are separated from the complexing agents of the present invention. Preferred quaternary ammonium salts are dialkyl dimethyl ammonium chlorides, wherein the alkyl groups have from 2 to 22 carbon atoms and are derived from long chain fatty acids. Representative examples of the quaternary ammonium salts include ditallow dimethyl ammonium chloride, ditallow dimethyl ammonium methyl sulfate, hexadecyl dimethyl ammonium chloride, and di (hydrogenated tallow) ammonium chloride. Other quaternary ammonium salts useful herein are di-cathionic such as tallow-propane-diammonium dichloride. The quaternary imidazolinium salts are also useful herein.
P771 Examples of these materials are those imidazolinium salts containing alkyl groups of 12 to 22 carbon atoms such as 1-methyl-1- [(stearoylamide) ethyl] -2-heptadecyl-4,5-dihydroimidazolinium chloride, chloride of 1-methyl-l- [(palmitoylamide) ethyl] -2-octadecyl-4,5-dihydroimidazolinium, and 1-methyl-l- [(seboamide) -ethyl] -2-tallow-imidazolinium methyl sulfate. Also useful herein are the salts of fatty amines. Examples of these compounds include stearylamine hydrochloride, soyamine hydrochloride, and stearylamine formate. Useful conditioning agents are described in U.S. Patent No. 4,387,090, Bolich, issued June 7, 1983, which is incorporated herein by reference.
MOISTURIZING AND HYDRATING The compositions of the present invention may contain one or more moisturizing or moisturizing materials. A variety of these materials may be employed and each may be present at a level from about 0.1% to about 20%, more preferably from about 1% to about 10%, and more preferably from about 2% to about 5%. These materials include urea;
guanidine; glycolic acid and glycolate salts (for example, ammonium and quaternary alkylammonium); salts of lactic acid and lactate (for example, ammonium and quaternary alkylammonium); aloe vera in any of its variety of forms (for example, aloe vera gel); polyhydroxy alcohols such as sorbitol, glycerol, hexanetriol, propylene glycol, butylene glycol, hexylene glycol, and the like; polyethylene glycols, sugars and starches; sugar and starch derivatives (eg, alkoxylated glucose); hyaluronic acid; lactate monoethanolamine; acetamide monoethanolamine; and mixtures thereof. The preferred humectants and moisturizers are glycerol, butylene glycol, hexylene glycol, and mixtures thereof.
TENSIOACTIVE AGENTS The compositions of the present invention, especially the shampoo and conditioner compositions, may contain one or more surfactants. These surfactants are useful adjuvants for the carriers of the present compositions, and are not required to solubilize, disperse or complex the copolymers of the present invention. For a shampoo, the level is preferably from about 10% to about 30%, more preferably from 12% to about 25% of the composition. For
P771 conditioners, the preferred level of the surfactant is from about 0.2% to about 3%. The surfactants useful in the compositions of the present invention include anionic, nonionic, cationic, zwitterionic and amphoteric surfactants. A wide variety of surfactants useful in U.S. Patent No. 5,151,209, Mc Cali et al., Issued September 29, 1992; U.S. Patent No. 5,151,210, to Steuri et al., issued September 29, 1992; and U.S. Patent No. 5,120,532, to Wells et al., issued June 9, 1992, all of which are incorporated herein by reference. Non-limiting examples of these surfactants include anionic surfactants such as alkyl sulfates and alkyl ether. These materials respectively have the respective formulas ROS03M and RO (C2H40) x SO3M, wherein R is an alkyl or alkenyl of about 10 to about 20 carbon atoms, x is 1 to 10, and M is a water-soluble cation such as ammonium, sodium, potassium and triethanolamine. Another suitable class of anionic surfactants are water soluble salts of the organic reaction products of sulfuric acid of the formula:
wherein Rx is selected from the group consisting of a straight or branched chain saturated, aliphatic hydrocarbon radical having from about 8 to about 24, preferably from about 12 to about 18 carbon atoms, and M is a cation. Further examples of synthetic, anionic surfactants, which come within the terms of the present invention are the reaction products of fatty acids esterified with isethionic acid and neutralized with sodium hydroxide, where, for example, the fatty acids are derived from from coconut oil; sodium or potassium salts of fatty acid amides of methyl tauride in which the fatty acids, for example, are derived from coconut oil. Still other synthetic anionic surfactants include the class designated as succinamates, olefin sulfonates having from about 12 to about 24 carbon atoms, and the b-alkyl-oxy-alkane sulfonates. Many additional anionic, synthetic, soap-free surfactants are described in McCutcheon's, Detergents and Emulsifiers, 1984 Annual, published by Allured Publishing Corporation, which is incorporated herein by reference. Also, the Patent of the
P771 United States No. 3,929,678, Laughiin et al., Issued December 30, 1975, discloses many other anionic types as well as other surfactants and is incorporated herein by reference. The nonionic surfactants useful herein are preferably used in combination with an anionic, amphoteric, zwitterionic surfactant. These nonionic surfactants can be broadly defined as compounds produced by the condensation of alkylene oxide groups (hydrophilic in nature) with a hydrophobic, organic compound, which may be aliphatic in nature, or aromatic in alkyl. The cationic surfactants useful in the compositions of the present invention are described in the following documents, all of which are incorporated herein by reference: M.C. Publishing Co. , Mc
Cutcheon's, Detergents & Emulsifiers, (edition
North American 1979); Schwartz, et al., Surface Active Agents, their Chemistry and Technology, New York; Interscience Publishiers, 1949; U.S. Patent No. 3,155,591, Hilfer, issued November 3, 1964; U.S. Patent No. 3,929,678, Laughiin et al., Issued December 30, 1975; U.S. Patent No. 3,959,461, Bailey, et al., Issued May 25, 1976; and Patent of the United States No.
P771 4,387,090, Bolich, Jr., issued June 7, 1983. The cationic surfactant, if included in the compositions of the present invention, is present from about 0.05% to about 5%. Zwitterionic surfactants are exemplified by those which can be broadly described as derivatives of ammonium, phosphonium and sulfonium, quaternary, aliphatic compounds, in which the aliphatic radicals can be straight or branched chain, and wherein one of the aliphatic substituents contains from about 8 to about 18 carbon atoms, and the other contains a water, anionic, solubilization group, for example, carboxy, sulfonate, sulfate, phosphate, or phosphonate. Other zwitterionics, such as betaines are also useful in the present invention. Examples of betaines include higher alkyl betaines, such as dimethyl-carboxymethyl-betaine, lauryl-dimethyl-carboxymethyl-betaine, lauryl-dimethyl-alpha-carboxyethyl-betaine, cetyl-dimethyl-carboxymethyl-betaine, lauryl-bis- (2-hydroxyethyl). ) -carboxymethyl-betaine, steryl-bnis- (2-hydroxypropyl) carboxymethyl-betaine, oleyl-dimethyl-gamma-carboxypropyl-betaine, lauryl-bis (2-hydroxypropyl) alpha-carboxyethyl-betaine, coco-dimethyl-sulfopropyl-betaine , stearyl-dimethyl-sulfopropyl-betaine, stearyl-dimethyl,
P771 isopropyl-betaine, lauryl-dimethyl-sulfoethyl-betaine, lauryl-bis- (2-ethoxyethyl) -sulfopropyl-betaine, and amidobetaines and amidosulfobetaines (where the radical RCONH (CH2) 3 binds to the nitrogen atom of betaine ). Examples of amphoteric surfactants that can be used in the compositions of the present invention are those which are broadly described as derivatives of the secondary and tertiary aliphatic amines, in which the aliphatic radical can be straight or branched chain, and wherein one of the aliphatic substituents contains from about 8 to about 18 carbon atoms, and one contains a water, anionic solubilizing group, for example, carboxy, sulfonate, sulfate, phosphate, phosphonate. Examples of compounds that fall within this definition are sodium 3-dodecyl-aminopropionate, sodium 3-dodecylaminopropane sulfonate, N-alkyl taurines such as that prepared by reacting dodecylamine with sodium isethionate in accordance with the teaching of the US Patent. No. 2,658,072, N-higher alkyl aspartic acids such as those known in the teaching of U.S. Patent No. 2,438,091, and the products sold under the trademark "Miranol" and described in U.S. Pat. 2,528,378.
CARBQXILICQ ACID COPQLIMERQ THICKNESSES Another useful component in the compositions herein is a carboxylic copolymer thickener. These crosslinked polymers contain one or more monomers derived from acrylic acid, substituted acrylic acids, and salts and esters of these acrylic acids and substituted acrylic acids, wherein the crosslinking agent contains two or more carbon-carbon double bonds and is drift from a polymeric alcohol. These polymers are included in addition to the fatty acid component of the present invention to provide a thickening action and are not required to solubilize, disperse or complex the copolymers of the present invention. Preferred polymers for use herein are of two general types. The first type of polymer is a crosslinked homopolymer of an acrylic acid monomer or derivative thereof (e.g., wherein the acrylic acid has substituents at the two and three carbon positions, independently selected from the group consisting of alkyl of 1 to 4 carbon atoms, -CN, -COOH, and mixtures thereof). The second type of polymer is a crosslinked copolymer having a first monomer selected from the group consisting of an acrylic acid monomer or derivative thereof (as
P771 describes in the previous statement), a short chain alcohol acrylate monomer (ie, from 1 to 4 carbon atoms, or derivatives thereof) For example, the acrylic acid portion of the ester has substituents in the positions carbon two and three independently selected from the group consisting of 1 to 4 carbon atoms, -CN, -COOH, and mixtures thereof); and a second monomer which is a long-chain alcohol acrylate ester monomer (ie, from 8 to 40 carbon atoms) or derivative thereof (eg, wherein the acrylic acid portion of the ester has substituents on the carbon positions two and three, independently selected from the group consisting of alkyl of 1 to 4 carbon atoms, -CN, -COOH, and mixtures thereof). Also, combinations of these two types of polymers are useful herein. In the first type of crosslinked homopolymers, preferably, the monomers are selected from acrylic acid, methacrylic acid, methacrylic acid, and mixtures thereof, with the acrylic acid being the most preferred. In the second type of crosslinked copolymers, the acrylic acid monomer or derivative thereof is preferably selected from the group consisting of acrylic acid, methacrylic acid, methacrylic acid, and mixtures thereof, with acrylic acid, methacrylic acid and mixtures thereof which are most preferred. The long chain alcohol acrylate ester monomer, or derivative thereof, is preferably selected from the group consisting of alcohol acrylate esters of 1 to 4 carbon atoms, alcohol methacrylate esters of 1 to 4 carbon atoms, and mixtures thereof, with esters of alcohol acrylate of 1 to 4 carbon atoms, esters of methacrylate of alcohol of 1 to 4 carbon atoms, and mixtures thereof, which are most preferred . The long chain alcohol acrylate ester monomer is selected from acrylate esters of from 8 to 40 carbon atoms, with the alkyl acrylate esters of from 10 to 30 carbon atoms being most preferred. The crosslinking agent in both of these types of polymers is a polyalkenyl polyether of a polyhydric alcohol containing more than one alkenyl ether group per molecule, wherein the alcohol, polyhydric of origin contains at least 3 carbon atoms and at least 3 carbon atoms. hydroxyl groups. Preferred crosslinking agents are those selected from the group consisting of allylic ethers of sucrose and allylic ethers of pentaerythritol, and mixtures thereof. These polymers useful in the present invention are more fully described in U.S. Patent No.
P771 5,087,445, Haffey et al., Issued February 11, 1992; U.S. Patent No. 4,509,949, to Huang et al., Issued April 5, 1985; U.S. Patent No. 2,798,053, to Brown, issued July 2, 1997; which are incorporated as a reference in the present. See also, CTFA International Cosmetic Ingredient Directonary, fourth edition, 1991, pp. 12 and 80; and also incorporated herein by reference. Examples of commercially available homopolymers of the first type useful herein include carbomers that are allylic ether homopolymers crosslinked with allylic ether of sucrose or pentaerythritol. Carbomers are available as the Carbopol® series from B.F. Goodrich. Examples of commercially available copolymers of the second type useful herein include copolymers of alkyl acrylates of 10 to 30 carbon atoms with one or more monomers of acrylic acid, methacrylic acid, or one of their short chain esters (i.e. alcohol of 1 to 4 carbon atoms), wherein the crosslinking agent is an allyl ester of sucrose or pentaerythritol. These copolymers are known as cross polymers of alkyl arylates / acrylates of 10 to 30 carbon atoms, are commercially available as Carbopol® 1342, Pemulen TR-1, and Pemulen TR-2, from B.F. Goodrich. In other words, in the examples of the
P771 carboxylic acid polymer thickeners useful herein are those selected from the group consisting of carbomers, acrylate / alkyl acrylate cross-linked polymers of 10 to 30 carbon atoms, and mixtures thereof. The compositions herein can comprise from about 0.025% to about 1%, more preferably from about 0.05% to about 0.75%, and more preferably from about 0.109% to about 0.50% of the carboxylic acid polymer thickeners .
EMULSIONADQRES The compositions herein may contain various emulsifiers. These emulsifiers are useful for emulsifying the various carrier components of the compositions herein, and are not required to solubilize or disperse the copolymers of the present invention. Suitable emulsifiers can include any of a wide variety of nonionic, cationic, anionic and zwitterionic emulsifiers described in the above patents and other references. See, Mc Cutcheon's, Detergents and Emulsifiers, North American Edition (1986), published by Allured Publishing
P771 Corporation: U.S. Patent No. 5,011,681 to Ciotti et al., Issued April 30, 1991; U.S. Patent No. 4,421,769 and Dixon et al., Issued December 20, 1983; and U.S. Patent No. 3,755,560 to Dickert et al., issued August 28, 1973; These four references are incorporated herein by reference in their entirety. Suitable types of emulsifiers include glycerin esters, propylene glycol esters, propylene glycol fatty acid esters, polypropylene glycol fatty acid esters, sorbitan esters, sorbitan anhydride esters, carboxylic acid copolymers, glucose esters and ethers, ethers ethoxylates, ethoxylated alcohols, alkyl phosphates, polyoxyethylene fatty ether phosphates, fatty acid amides, acyl lactylates, soaps and mixtures thereof. Suitable emulsifiers may include, but are not limited to, polyethylene glycol 20 sorbital monolaurate (Polysorbate 20), polyethylene glycol 5 soybean stearate, Steareth-20, Ceteareth-20, methylgluous ether distearate PPG-2, Ceteth-10 , Polysorbate 80, potassium cetyl phosphate, diethanolamine cetyl phosphate, polysorbate 60, glyceryl stearate, PEG-100 stearate, and mixtures thereof. The emulsifiers can be used individually or as
P771 a mixture of two or more and may comprise from about 0.1% to about 10%, more preferably from about 1% to about 7%, and most preferably from about 1% to about 5% of the compositions of the invention. present invention.
EMOLLIENTS The compositions useful in the methods of the present invention may also optionally comprise at least one emollient. Examples of suitable emollients include, but are not limited to, volatile and non-volatile silicone oils, highly branched hydrocarbons, and non-polar carboxylic acid and alcohol esters, and mixtures thereof. Emollients useful in the present invention are further described in U.S. Patent No. 4,919,934, Deckner et al., Issued April 24, 19890, which is incorporated herein by reference in its entirety. The emollients can typically comprise in total from about 1% to about 50%, preferably from about 1% to about 25%, and most preferably from about 1% to about 10% by weight of the emulsions.
P771 compositions useful in the present invention.
DITIONAL COMPONENTS A variety of additional components can be incorporated into the compositions herein. Non-limiting examples of these additional components include vitamins and derivatives thereof (e.g., ascorbic acid, vitamin E, tocopheryl acetate, retinoic acid, retinol, retinoids, and the like); low pH thickeners (for example, polyacrylamide and isoparaffins of 13 to 14 carbon atoms and laureth-7, available from Sepigel of Seppic Corporation; mineral and polyquaternium oil, available from Saleare SC92, Allied Colloide; quaternized methyl dimethylaminomethacrylate crosslinked, and mineral oil, available as Salare SC95 from Allied Colloids: resins, gums and thickeners such as xanthan gum, carboxymethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, alkyl-modified hydroxyalkylcelluloses (for example, hydroxyethylcelluloses modified with long chain alkyl such as cetyl- hydroxyethylcellulose), and magnesium aluminum silicate, cationic polymers and thickeners, for example, guar gum derivatives, cationic such as guar hydroxypropyltrimonium chloride, and hydroxypropyltrimonium hydroxypropyl chloride.
P771 guar, available as the Jaguar C series from Rhone-Poulenc; polymers to assist the film forming and substantivity properties of the composition (such as a copolymer of icosene and vinyl pyrrolidone, an example of which is available from GAF Chemical Corporation as Ganex V-200); dispersing agents such as ethylene glycol distearates and the like; preservatives to maintain the antimicrobial integrity of the compositions; skin penetration aids or aids such as DMSO, 1-dodecylazacycloheptan-2-one (available as Azone from Upjohn Co.) and the like; antioxidants; chelators and sequestrants; and aesthetic components such as fragrances, colorants, essential oils, skin sensitizing agents, astringents, skin softening agents, skin healing agents and the like, non-limiting examples of these aesthetic components include panthenol and derivatives ( example, ethyl panthenol), pantothenic acid and its derivatives, garlic oil, menthol, camphor, eucalyptus oil, eugenol, menthyl lactate, medicinal ointment distillate, allantoin, bisabalol, dipotassium glycyrrhizinate, and the like.
METHOD OF USING AS COMPOSITIONS TO HAIR AND SKIN CARE The hair care and skin care compositions of the present invention are used in
P771 conventional way to provide the desired benefit, appropriate to the product such styling, retention, cleaning, hair conditioning, and the like, for hair care compositions and benefits such as wetting, sunscreen, anti-acne, anti-wrinkle, anti-tanning, anti-analgesic and other cosmetics and pharmaceuticals, for skin care compositions. These methods of use depend on the type of composition used; but in general they comprise the application of an effective amount of the product to the hair or skin, which can then be rinsed from the hair or skin (as in the case of shampoos of some conditioning products), or allowed to remain on the hair (as in the case of aerosol, foams, or gel products), or allowed to remain on the skin (as in the case of skin care compositions). By "effective amount" is meant an amount sufficient to provide the desired benefit. Preferably, the rinse, foam and gel products of the hair are applied to the wet or wet hair prior to the drying and styling of the hair. After these compositions are applied to hair, the hair is dried and styled in the usual manner of the user. Typically, hair sprays are used on dry hair after it has been dried and styled. The compositions for care
P771 skin, topical, cosmetic and pharmaceutical are applied to the skin or rubbed in it.
EXAMPLES The following examples further illustrate the preferred embodiments within the scope of the present invention. The examples are given only for the purposes of illustration and should not be considered as limitations of the present invention since many variations of the invention are possible without departing from their spirit and scope. The ingredients are identified by their chemical or CTFA name. The following synthetic procedure is exemplary of the methods useful for synthesizing the copolymers of the present invention.
EXAMPLE 1 SYNTHESIS OF POLY [(T-BUTYL ACRYLATE?) - (ACRYLIC ACID) -INJERTQ- POLIDIMETILSILQXANO)] Place 60 parts of t-butyl acrylate, 20 parts of acrylic acid and 20 parts of polydimethylsiloxane macromonomer (MW 13,000 ) (commercially available from 3M, St. Paul, MN) in a flask. Add enough acetone as the reaction solvent to produce a
P771 final monomer concentration of 20%. Purge the vessel with an inert atmosphere, preferably nitrogen or argon. Add the initiator, (2,2'-azobisisobutyronitrile) to a level appropriate for the desired molecular weight. Typically, this is in the range of from about 0.5% to about 1.0% by weight relative to the amount of the monomer. Heat at 60 ° C and maintain this temperature for 6 hours while stirring. Finish the reaction by cooling to room temperature. The polymer is purified by drying the reaction solvent in an oven.
EXAMPLE 2 SYNTHESIS OF POLY [(T-BUTYL ACRYLATE) - (METACRYLIC ACID) -INJERTQ- POLYMIDIMETILSILQXAN)] Place 70 parts of t-butyl acrylate, 10 parts of methacrylic acid and 20 parts of polydimethylsiloxane macromonomer (MW 13,000) (commercially available from 3M, St. Paul, MN) in a flask. Add enough acetone as the reaction solvent to produce a final monomer concentration of 20%. Purge the vessel with an inert atmosphere, preferably nitrogen or argon. Add the initiator, (2,2'-azobisisobutyronitrile) to a level appropriate for the desired molecular weight. Typically, this is in the range
P771 from about 0.5% to about 1.0% by weight relative to the amount of monomer. Heat at 60 ° C and maintain this temperature for 6 hours while stirring. The reaction ends on cooling to room temperature. The polymer is purified by drying the reaction solvent in an oven.
EXAMPLE 3 SYNTHESIS OF POLY [(T-BUTYL ACRYLATE) - (METACRYLIC ACID) - (2-ETHYLXYL METHACRYLATE)] Place 70 parts of t-butyl acrylate, 10 parts of methacrylic acid and 20 parts of dimethylaminoethyl methacrylate and 20 parts of 2 -ethylhexyl methacrylate in a flask. Add enough acetone as the reaction solvent to produce the final monomer concentration of 20%. Purge the vessel with an inert atmosphere, preferably nitrogen or argon. Add the initiator, (2,2'-azobisisobutyronitrile) to a level appropriate for the desired molecular weight. Typically, this is in the range of about 0.5% to about 1.0% by weight relative to the amount of monomer. Heat at 60 ° C and maintain this temperature for 6 hours while stirring. Finish the reaction on cooling to room temperature. The polymer is purified by drying and the solvent
P771 reaction in an oven.
EXAMPLE 4 SYNTHESIS OF POLY [(T-BUTYL ACRYLATE?) - (ACRYLIC ACID) -INJERT- POLYISQBUTILENE)] Place 60 parts of t-butyl acrylate, 20 parts of acrylic acid and 20 parts of polyisobutylene macromonomer in a flask . Add enough acetone as the reaction solvent to produce a final monomer concentration of 20%. Purge the vessel with an inert atmosphere, preferably nitrogen or argon. Add the initiator, (2,2'-azobisisobutyronitrile) to a level appropriate for the desired molecular weight. Typically, this is in the range of from about 0.5% to about 1.0% by weight relative to the amount of monomer. Heat at 60 ° C and maintain this temperature for 6 hours while stirring. The reaction ends on cooling to room temperature. The polymer is purified by drying the reaction solvent in an oven.
EXAMPLE 5 SYNTHESIS OF POLY [(T-BUTYL ACRYLATE) - (METACRYLIC ACID) -INJERTQ- PQLISQBUTILENE)] Place 70 parts of t-butyl acrylate, 10
P771 parts of methacrylic acid and 20 parts of polyisobutylene macromonomer in a flask. Add enough acetone as the reaction solvent to produce a final monomer concentration of 20%. Purge the vessel with an inert atmosphere, preferably nitrogen or argon. Add the initiator, (2,2'-azobisisobutyronitrile) to a level appropriate for the desired molecular weight. Typically, this is in the range of about 0.5% to about 1.0% by weight relative to the amount of monomer. Heat at 60 ° C and maintain this temperature for 6 hours while stirring. The reaction ends on cooling to room temperature. The polymer is purified by drying the reaction solvent in an oven.
EXAMPLE 6 SYNTHESIS OF POLY [(T-BUTYL ACRYLATE) - (METACRYLIC ACID) - (2-ETHYLHYL-METHACRYLATE)] Place 70 parts of t-butyl acrylate, 10 parts of methacrylic acid and 20 parts of 2-ethylhexylmethacrylate in a flask . Add enough acetone as the reaction solvent to produce a final monomer concentration of 20%. Purge the vessel with an inert atmosphere, preferably nitrogen or argon. Add the initiator, (2,2'-
P771 azobisisobutyronitrile) at a level appropriate for the desired molecular weight. Typically, this is in the range of about 0.5% to about 1.0% by weight relative to the amount of monomer. Heat at 60 ° C and maintain this temperature for 6 hours while stirring. The reaction ends on cooling to room temperature. The polymer is purified by drying the reaction solvent in an oven. By varying the monomers and macromonomer used, the general procedures given in Examples 1-6 are used to prepare other copolymers of the present invention.
EXAMPLE 7 The following is a representative hair conditioner composition of the present invention.
Component% by weight
Water . b. ] p. 100%
Hydroxyethylcellulose hydrophobically 0. 25% modification of the stearalconium chloride 0. 87%
Cetyl alcohol 1. 85"5 stearyl alcohol 0.21%
Estearamidopropi1-dimethylamine 0. fifty %
CF1213R [2] 2. 33%
P771 Methylchloroisothiazolinone- 0.03% methylisothiazolinone Perfume 0.33%
Copolymer 3 t3) 2.00%
Dimethylmyristamine (ARMEEN DM14D) M1 0.56%
Cyclomethicone D4 9.63% [Polysurf 67R supplied by Aqualon .2] Dimethicone rubber in D5 cyclomethicone, commercially available from GE [31-poly [(t-butyl acrylate) - (methacrylic acid) - (2-ethylhexylmethacrylate)] [Commercially available from Akzo
This product is prepared by dispersing the copolymer in Cyclomethicone D4 (solvent), then adding the dimethylmiristamine. Heat the solution to 67 C and use an appropriate homogenizer to facilitate the incorporation of the copolymer into the solvent component. The other components (except Kathon and perfume) are mixed in a separate container at a sufficiently high temperature
(80 C) to melt the solids. The mixture of polymer / solvent component and CF121 are added separately to the other components after they have been cooled to 45 ° C. Finally, Kathon and perfume are added, and the product is cooled to room temperature.
This composition is useful for application to hair for
P771 provide conditioning, styling and retention benefits.
EXAMPLE 8 The following is a representative hair conditioner composition of the present invention.
Component% by weight
Water c.b.p. 100%
Hydroxyethylcellulose hydrophobically 0.50% modifiedLIJ Stearalkonium chloride 0.87%
Cetyl alcohol 1.85%
Stearyl alcohol 0.21%
Stearamidopropyl-dimethylamine 0.50%
CF1213R [2] 2. 33%
Methylchloroisothiazolinone- 0.03% methylisothiazolinone Perfume 0.33%
Copolymer 1 [3] 2.00% dimethylillauramine (ARMEENDM12D) [4] 1.18%
Isododecane 4.81% hexamethyl-disiloxane 4.81% [1] Polysurf 67R supplied by Aqualon [21 Dimethicone gum in D5 cyclomethicone, commercially available from GE
P771 Poly [(t-butyl acrylate) - (methacrylic acid) - (2-ethylhexyl methacrylate)] Commercially available from Akzo
This product is prepared by dispersing the copolymer in isododecane and hexamethyldisiloxane (solvent component), then adding the dimethylillamined. Heat the solution to 65 ° C and use an appropriate homogenizer to facilitate the incorporation of the copolymer into the solvent component. The other components (except Kathon and perfume) are mixed in a separate container at a sufficiently high temperature (80 ° C) to melt the solids. The polymer / solvent component mixture and the dimethicone gum are added separately to the other components after they have been cooled to at least 45 ° C. Finally, Kathon and perfume are added, and the product is cooled to room temperature. This composition is useful for application to hair to provide conditioning, styling and retention benefits.
EXAMPLE 9 The following is a hair shampoo composition representative of the present invention.
Component% by weight
P771 Water c.b.p. 100%
Ammonium lauryl sulfate 3.14%
Ammonium Laureth Sulfate 13.56%
Cetyl alcohol 0.45%
Stearyl alcohol 0.19%
Coco-monoethanol-amide 3.00%
Ethylene glycol distearate 2.00%
Tricetyl-methyl-ammonium chloride 0.50%
Methylchloroisothiazolinone- 0.03% methylisothiazolinone Perfume 020%
Copolymer 2 [1] 4.00%
Stearamine (ARMEEN 18) [2] 1.25%
Isododecane 7.40% [11poli [(t-butyl acrylate) - (methacrylic acid) - (2-ethylhexylmethacrylate)] Commercially available from Akzo
This product is prepared by dispersing the copolymer in isododecane (solvent component), then adding stearamine. Heat the solution to 65 ° C and use an appropriate homogenizer to facilitate the incorporation of the copolymer into the solvent. The other components are mixed in a separate vessel at a temperature high enough to melt the solids. The polymer / solvent component mixture is added to
P771 the other components after they have cooled This composition is useful for application to the hair to provide cleaning, styling and retention benefits.
EXAMPLE 10 The following is a hair shampoo composition representative of the present invention.
Component% by weight
Water c.b.p. 100%
Cocoamidopropylbetaine 8.30%
Ammonium lauryl sulfate 2.12%
Ammonium Laureth Sulfate 6.35%
Coco-monoethanol-amide 1.50%
Hydroxypropyl-methocellulose (K15) 0.25%
Ethylene glycol distearate 1.50%
0.50% Tricetyl Ammonium Chloride
Methylchlorothiazolinone- 0.03% methylisothiazolinone Perfume 0.20%
Copolymer 4 [1] 3.00%
Dimethyl stearamine (ARMEEN DM18D) [2] 2.48%
Isododecane 5.00%
Cyclomethicone 5.00% poly [(t-butyl acrylate) - (acid
P771 methacrylic) - (2-ethylhexyl methacrylate)] Commercially available from Akzo
This product is prepared by dispersing the copolymer in isododecane and cyclomethicone (solvent component), then adding dimethylstearamine. Heat the solution to 65 ° C and use an appropriate homogenizer to facilitate the incorporation of the copolymer in a solvent. The other components are mixed in a separate vessel at a temperature high enough to melt the solids. The polymer / solvent component solution is added to the other components after they have cooled.
EXAMPLE 11 The following is a hair styling gel composition representative of the present invention.
Component% by weight
Polymer-Solvent Mix Copolymer 5 [1] 1.25%
Dimetilpalmitamina 0.39%
Isopar HR [2] 3.75% Water Premix 43.%
P771 Hydrogenated Disodium Chloride 1.00% (Quaternium 18) Main Water Mix 48.47%
Carbopol 940R 0.75% Triethanolamine 1.00% Panthenol 0.05% Perfume 0.20% poly [(t-butyl acrylate) - (methacrylic acid) - (2-ethylhexylmethacrylate)] [2] Isoparaffin of 11 to 12 carbon atoms, available from Exxon Chemical Co.
This product is prepared by dispersing the copolymer in Isopar H (solvent component), then adding dimethylpalmitamine. Heat the solution to 65 ° C and use an appropriate homogenizer to facilitate the incorporation of the copolymer into the solvent component. Quaternium 18 is mixed with water at 80 ° C. The polymer-solvent component mixture is then added to the premix containing Quaternium 18 at a high or low temperature. The other components are mixed in a separate vessel at room temperature. The Quaternium 18 premix with the polymer / solvent component mixture is cooled (if necessary) and added to the other components. This composition is
P771 useful for hair application to provide conditioning, styling and retention benefits.
EXAMPLE 12 The following is an aerosol gel hair composition representative of the present invention.
Component% by weight
Water c.b.p. 100%
Seborrimony chloride 0.10%
Hydrogenated Disodbondimony Chloride 0.90% (Quaternium 18) Panthenol 0.05%
Perfume 0.20%
Copolymer 6 [1] 1.00% Myristamine 0.25%
Hexamethyl-disiloxane 3.00% [1] poly [(t-butyl acrylate) - (methacrylic acid) - (2-ethylhexylmethacrylate)]
This product is prepared by dissolving the # 2 copolymer in hexamethyldisiloxane (solvent component) then adding the myristamine. Heat the solution to 65 ° C and use an appropriate homogenizer to facilitate the incorporation of the copolymer into the solvent. The other components are mixed in a separate container
P771 at a sufficiently high temperature (70 ° C) to melt the solids. The polymer / solvent component solution is added to the other components either at a high or low temperature. This composition is useful for application to hair to provide conditioning, styling and retention benefits.
EXAMPLE 13 The following is a hair styling rinse composition representative of the present invention.
Component% by weight
Water Premix 8.14%
Disodbodimony Chloride (Varisoft 470) 1.43%
CF1213R [1] 2.33%
Amodimethicone 0.10% Premix B Water 5.45%
Stearalkonium Chloride 0.30%
Pantenol DL 0.225%
Panfilo ethyl ether 0.025% Main Mix Water 67. 05%
P771 hydrophobic hydrophobic cellulose 1.23% modified1 ^ xanthan gum 0.25%
Citric acid 0-.092%
Sodium citrate 0.09%
Cetyl alcohol 0.12%
Stearyl alcohol 0.08% Polymer-solvent mixture Copolymer 1 [3] 2.00%
Cyclomethicone D4 5.00%
Hexamethyl disiloxane 5.00%
Dimethylmyristamine (ARMEENDM14D) [4] 1.33%
Methylchloroisothiazolinone- 0.03% methylisothiazolinone Perfume 0.33%
Benzyl alcohol 0.50%
Dimethicone rubber in D5 cyclomethicone, commercially available from GE Polysurf 67R supplied by Aqualon I31poli [(t-butyl acrylate) - (methacrylic acid) - (2-ethylhexylmethacrylate)] [4] Commercially available from Akzo
This product is prepared by dispersing the copolymer in cyclomethicone D4 and hexamethyldisiloxane
(solvent component) then adding the dimethylmiristamine. Heat the solution to 65 ° C and use a
P771 suitable homogenizer to facilitate the incorporation of the copolymer in the solvent component. Premixes A and B are prepared by combining the materials at 70 ° C. Premix A goes through a colloid mill and is cooled to 38 ° C. The materials in the "main mix", except benzyl alcohol, are mixed at 65 ° C. Then the polymer solution is added to the "master mix". The main mixture goes through a colloid mill and then cooled to 38 ° C. The premixes and the "main mix" are combined at 38 ° C. Then the benzyl alcohol is added. This composition is useful for application to hair to provide conditioning, styling and retention benefits.
EXAMPLE 14 The following is a hair styling foam composition representative of the present invention.
Component% by weight
Water c.b.p. 100%
Seborrimony chloride 0.10%
Hydrogenated Disodbondimony Chloride 0.90% (Quaternium 18) Lauramine Oxide 0.20%
P781 Panthenol 0.05%
Perfume 0.20%
Copolymer 1 [1] 1.00% lauramine 0.51%
Hexamethyl disiloxane 3.00%
Isobutane 7.00% [1] poly [(t-butyl acrylate) - (methacrylic acid) - (2-ethylhexylmethacrylate)]
This product is prepared by dispersing the copolymer in hexamethyldisiloxane (solvent component) then adding the lauramine. Heat the solution to 65 ° C and use an appropriate homogenizer to facilitate the incorporation of the copolymer into the solvent. The other components (except isobutane) are mixed in a separate vessel at a sufficiently high temperature (70 ° C) to melt the solids. The polymer / solvent component solution is added to the other components after they have cooled. Aluminum aerosol cans can be filled with 93 parts of this batch, equipped with a valve that is crimped in position, and finally filled under pressure with 7 parts of isobutane. This composition is useful for application to hair to provide conditioning, styling and retention benefits.
P771 EXAMPLE 15 The following is a hair styling spray composition representative of the present invention.
Component% by weight
Water c.b.p. 100%
Pantenol 0.05%
Perfume 0.20%
Copolymer 4 [1] 2.00%
Dimethylmyristamine 1.33%
Cyclomethicone D4 7.00%
Isobutane 25.00% [1Italy [(t-butyl acrylate) - (methacrylic acid) - (2-ethylhexylmethacrylate)]
This product is prepared by dispersing the copolymer in Cyclomethicone D4 (solvent component) then adding the dimethylmiristamine. Heat the solution to 65 ° C and use an appropriate homogenizer to facilitate the incorporation of the copolymer into the solvent. The other components (except isobutane) are mixed in a separate container. The polymer solution / solvent component and is added to the other components. Then aluminum aerosol cans are filled with 75 parts of this batch, equipped with a valve that fits in your
P771 position, and finally it is filled under pressure with 25 parts of isobutane. This composition is useful for application to hair to provide conditioning, styling and retention benefits. When the compositions defined in Examples 4-12 are applied to the hair in the conventional manner, they provide effective hair conditioning and styling / retention benefits without leaving a sticky / stiff feel to the hair.
EXAMPLE 16 The following is a hair styling rinse composition representative of the present invention.
Component% by weight
Water Premix 8.14%
Disodbodimony Chloride (Varisoft 470) 1.43%
CF1213R (dimethicone gum) [2] 2.33%
T modimeticone 0.10% Premix B Water 5.45%
Stearalkonium Chloride 0.30%
Pantenol DL 0.225%
P771 Panfilo ethyl ether 0.025% Main water mixture 71.35%
Hydroxyethylcellulose hydrophobically 1.23% modified UJ Xanthan gum 0.25 5
Citric acid 0.02%
Sodium Citrate 0.09%
Cetyl alcohol 0.12%
Stearyl Alcohol 0.08% Polymer-Solvent Mix Copolymer # 1 2.00%
Cyclomethicone D4 4.67%
Dimethylmylamine (ARMEENDM14D) 1.33%
Methylchloroisothiazolinone- 0.03% methylisothiazolinone Perfume 0.33%
Benzyl alcohol 0.50%
Polysurf 67R supplied by Aqualon Commercially available from GE
This product is prepared by dispersing copolymer # 1 in cyclomethicone D4 (solvent), then adding dimethylmiristamine. Heat the solution to 65 ° C and use an appropriate homogenizer to facilitate the incorporation of the copolymer into the solvent. They are getting ready
P771 the premixes A and B when combining the materials at 70 ° C. Premix A goes through a colloid mill and is cooled to 38 ° C. The materials in the "master mix", except benzyl alcohol, are mixed at 65 ° C. The polymer solution is then added to the "master mix". The main mixture goes through a colloid mill and is cooled to 38 ° C. The premixes and the "main mix" are combined at 38 ° C. Then the benzyl alcohol is added. This composition is useful for application to hair to provide conditioning, styling and retention benefits.
EXAMPLE 17 The following is a hair styling rinse composition representative of the present invention.
Component% by weight
Water Premix 8.14%
Disodbodimony Chloride (Varisoft 470) 1.43%
CF1213R (dimethicone gum) [2] 2.33%
Amodimethicone 0.10% Premix B Water 5.45%
P771 Stearalkonium Chloride 0.30%
Pantenol DL 0.225%
Panfilo ethyl ether 0.025% Main Mix Water 70.46%
Hydrophobic hydrophobic cellulose 1.23% modified J xanthan gum 0.25%
Citric acid 0.02%
Sodium citrate 0.09%
Cetyl alcohol 0.12%
Stearyl alcohol 0.08% Polymer-solvent mixture Copolymer # 1 2.00%
Cyclomethicone D4 5.56%
Dimethylmylamine (ARMEENDM14D) 1.33%
Methylchloroisothiazolinone- 0.03% methylisothiazolinone Perfume 0.33%
Benzyl alcohol 0.50% r 11 Polysurf 67R supplied by Aqualon 1 Commercially available from GE
This product is prepared by dispersing copolymer # 1 in cyclomethicone D4 (solvent), then adding dimethylmiristamine. Heat the solution to 65 ° C and
P771 use an appropriate homogenizer to facilitate the incorporation of the copolymer into the solvent. Premixes A and B are prepared by combining the materials at 70 ° C. Premix A goes through a colloid mill and is cooled to 78 ° C. The materials in the "main mix", except cetyl alcohol, are mixed at 65 ° C. Then, the polymer solution is added to the "master mix." The main mixture is passed through a colloid mill and cooled to 38 ° C. The premixes and the "master mix" are combined at 38 ° C. Add benzyl alcohol This composition is useful for hair application to provide conditioning, styling and retention benefits.
EXAMPLE 18 The following is a hair styling rinse composition representative of the present invention.
Component% by weight
Water Premix 8.14%
Disodbodimony Chloride (Varisoft 470) 1.43%
CF1213R (dimethicone gum) [2] 2.33%
Amodimethicone 0.10%
P771 Premix B Water 5.45%
Stearalkonium Chloride 0.30%
Pantenol DL 0.225%
Panfilo ethyl ether 0.025% Main Mix Water 72.08%
Hydroxyethylcellulose hydrophobically 1.23% modified UJ 0.25% xanthan gum
Citric acid 0.02%
Sodium citrate 0.09%
Cetyl alcohol 0.12%
Stearyl Alcohol 0.08% Polymer-Solvent Mix Copolymer # 1 2.00%
Isododecano 4.97%
Dimethylmyristamine (ARMEENDM12D) 1.18%
Methylchloroisothiazolinone- 0.03% methylisothiazolinone Perfume 0.33%
Benzyl Alcohol 0.50% í 11 Polysurf 67R supplied by Aqualon [21 Commercially available from GE
This product is prepared by dispersing the
P771 copolymer # 1 in the cyclomethicone D4 (solvent) then adding the dimethylmiristamine. Heat the solution to 65 ° C and use an appropriate homogenizer to facilitate the incorporation of the solvent copolymer. Premixes A and B are prepared by combining the materials at 70 ° C. Premix A is passed through a colloid mill and cooled to 38 ° C. The "main mix" materials, except benzyl alcohol, are mixed at 65 ° C. Then, the polymer solution is added to the "master mix". The main mixture is passed through a colloid mill and cooled to 38 ° C. The premixes and the "main mix" are combined at 38 ° C. Then the benzyl alcohol is added. This composition is useful for application to hair to provide conditioning, styling and retention benefits.
EXAMPLE 19 The following is a sunblock composition representative of the present invention. An oil-in-water emulsion is prepared by combining the following components using conventional mixing techniques.
Ingredients% by weight
Phase A
P771 Water CS 100
Carbomer 95 0.24
Carbomer 1342 [2] 0.16
Disodium EDTA 0.05 Phase B Isoaraquidyl Neopentanoate 2.00
PVCP-eicosene copolymer [4] 2.00
Octyl methoxycinnamate 7.50
Octocrylene 4.00
Oxybenzone 1-00
Titanium dioxide 2.00
Cetyl Palmitate 0.75 Stearoxitrimethylsilane (y) Stearyl Alcohol [0.50
Glyceryl tribehenate 0.75
Dimeticone 1.00
0.10 tocopheryl acetate
DEA-cetyl Phosphate 0.20 Phase C Water 2.00
Triethanolamine 99% 0.60 Phase D Water 2.00
Butylene glycol 2.00 DMDM Hydantoin (y)
P771 iodopropynyl butyl carbamate 0.25 Panthenol dL 1.00 Phase E Cyclomethicone D4 4.00 Copolymer 6 [7] 1.00 Stearamine 1.25 [1] Available as Carbopol 954 from B.F. Goodrich [2] Available as Carbopol 1342 from B.F. Goodrich [3] Available as Ganez V-220 from GAF Corporation [4] Available as DC 580 Wax from Dow Corning [5] Available as Synchrowax HRC from Croda [6] Available as Lonza Glydant Plus. [7] poly [(t-butyl acrylate) - (methacrylic acid) - (2-ethylhexyl methacrylate)]
In a suitable container, the ingredients of phase A are dispersed in the water and heated to 75-85 ° C. In a separate container, the ingredients of Phase B (except DEA-cetyl phosphate) are combined and heated to 85-90 ° C until melted. Then, the DEA-cetyl phosphate is added to the liquid phase B and stirred until dissolved. This mixture is then added to phase A to form the emulsion. The ingredients of phase C are combined until dissolved and then added to the emulsion. The emulsion is then cooled to 40-45 ° C with
P771 mixed continuously. In another container, the ingredients of phase D are heated with mixing at 40-45 ° C until a clear solution is formed and this solution is then added to the emulsion. Finally, the emulsion is cooled to 35 ° C and the ingredients of the E phase are combined at 65 ° C, a suitable homogenizer is used to facilitate the incorporation of the copolymer into the solvent component. Phase E is cooled to 35 ° C, added and mixed. This emulsion is useful for topical application to the skin to provide protection from the dangerous effects of ultraviolet radiation.
EXAMPLE 20 The following is a facial wetting composition representative of the present invention. A leave-on facial emulsion composition containing a hydrophobic, cationic surfactant is prepared by combining the following components using conventional mixing techniques.
Ingredient% by weight
Phase A Water CS 100
Glycerin 3.00 Cetyl Palmitate 3.00
P771 Cetyl alcohol 1.26 Quaternium 22 1.00 Glyceryl-monohydroxy stearate 0.74 Dimethicone 0.60 Stearic acid 0.55 Octyldodecyl myristate 0.30 Potassium hydroxide 0.20 Carbomer 1342 0.125
Tetrasodium EDTA 0.10 DMDM Hydantoin and carbamate 0.10 iodopropynyl butyl Carbomer 951 0.075
Phase B Isododecane 4.00 Copolymer 2 tl] 1.00 Stearamine 0.31] poly [(t-butyl acrylate) - (methacrylic acid) - (2-ethylhexyl methacrylate)]
In a suitable container, the ingredients of phase A combine to form an emulsion. Phase B is prepared by dispersing the copolymer in Isododecane
(solvent component) then added the stearamine. Heat the solution to 65 ° C and use an appropriate homogenizer to facilitate the incorporation of the copolymer into the solvent component. Cool phase B and mix in
P771 phase A using conventional mixing techniques. This emulsion is useful for application to the skin as a humectant.
EXAMPLE 21 The following is a representative antiperspirant composition of the present invention.
Component% by weight
Myristyl Propionate PPG 2 34.00%
C18-C36 glyceryl wax acid ester 0.40%
Cyclomethicone 32.75%
Copolymer 1 [1] 1.00%
Dimethylmyristamine 0.67%
Aluminum hydrochloride 19.00%
Ceteth 20 PPG 5 7.50%
Water 1.50% [11poli [(t-butyl acrylate) - (methacrylic acid) - (2-ethylhexylmethacrylate)]
Mix the myristyl propionate PPG 2 and the glyceryl C18-C36 wax acid ester, heat to 75 ° C. Disperse the hydrochloride. Disperse the copolymer in cyclomethicone (solvent component) then add dimethylmiristamine. Heat the solution to 65 ° C and use an appropriate homogenizer to facilitate the incorporation of the
P771 copolymer in the solvent component. Add the cyclomethicone mixture to the hydrochloride dispersion. Mix Ceteth PPG 5 and water, then add oils, perfume and cool.
EXAMPLE 22 The following is an anti-acne composition representative of the present invention.
Component% by weight
Copolymer-Solvent Copolymer 5 mixture [1] 1.00%
Dimetilpalmitamina 0.31%
Isopar HR i 2] 3.75% Main Mix Water c.b. 100%
Ethanol (SDA 40) 40.00%
Carbopol 940R 0.75%
Triethanolamine 1.00%
Salicylic Acid 2.00% [11poli [(t-butyl acrylate - - (methacrylic acid) - (2-ethylhexylmethacrylate)] Isoparaffin Cn-C12, available from Exxon Chemical Co.
This product is prepared by dispersing the
P771 copolymer in Isopar H (solvent component) then adding dimethylpalmitamine. Heat the solution to 65 ° and use an appropriate homogenizer to facilitate the incorporation of the copolymer in the solvent. The other components are mixed in a separate vessel at room temperature. The copolymer-solvent component pre-mix is cooled (if necessary) and added to the other components. This composition is useful for application to the skin to provide improved resistance to water and is useful in the treatment of acne.
EXAMPLE 23 The following is a representative anti-acne composition of the present invention.
Component% by weight
Copolymer-Solvent Copolymer 1 mixture [11 1.00% dimethylpalmitamine 0.74%
Isopar HR [1] 3.75% Main Mix Water c.b. 100%
Ethanol (SDA 40) 20.00%
Carbopol 940R 0.75%
P771 Triethanolamine 1.00%
Ibuprofen 2.00% [1] poly [(t-butyl acrylate) - (methacrylic acid) - (2-ethylhexylmethacrylate)] [] C-12 isoparaffin, available from Exoon Chemical Co.
This product is prepared by dispersing the copolymer in Isopar H (solvent component), then adding dimethylpalmitamine. Heat the solution to 65 ° C and use an appropriate homogenizer to facilitate the incorporation of the copolymer into the solvent component. The other components are mixed in a separate vessel at room temperature. The copolymer-solvent component pre-mix is cooled (if necessary) and added to the other components. This composition is useful for application to the skin to provide improved resistance to water and is useful for analgesic effects.
P771
Claims (66)
- CLAIMS: 1. A composition for personal care, comprising: A.) a copolymer complex comprising: a.) A copolymer having a structure formed from the copolymerization of repeating units of monomer A and monomer B in wherein the structure is optionally grafted to these hydrophobic units of the macromonomer C wherein the copolymer is prepared by the polymerization combination of the following percentages by weight, relative of units A, B and C: i) from about 10% to about 99 % by weight of the copolymer, of one or more hydrophobic units of monomer A, wherein the monomer units A are copolymerizable with the units of monomer B and macromonomer C; ii) from about 1% to about 40% by weight of the copolymer, of one or more hydrophilic units of monomer B, wherein the monomer units B are copolymerizable with the monomer A and macromonomer C units and wherein at least about 1% by weight of the copolymer, of monomer units B, are selected from units of monomer B P771 having at least one acid functional group; and iii) from 0 to about 50% by weight of the copolymer of one or more units of macromonomer C, wherein the C units are hydrophobic macromonomer units, copolymerizable with monomer units A and monomer units B; the macromonomer C units have a number average molecular weight of about 1,500 to about 50,000; and b.) a complexing fatty amine wherein the fatty amine forms a complex with the acidic functional group of the B monomer units; wherein the weight ratio of the copolymer to the fatty amine is from about 50: 1 to about 1: 1; and B.) a volatile, hydrophobic solvent component for the copolymer complex having a boiling point at an atmosphere of about 260 ° C or less and an i / solubility parameter of about 8.5 (cal / cm) or less; wherein the copolymer complex is soluble or dispersible in the hydrophobic, volatile solvent component.
- 2. A personal care composition according to claim 1, wherein the units of P771 macromonomer C are present at a concentration of from about 5% to about 40% by weight of the copolymer.
- 3. A personal care composition according to claim 2, wherein the monomer A and monomer B units are ethylenically unsaturated and wherein the macromonomer C units have a polymeric portion and an ethylenically unsaturated moiety.
- 4. A personal care composition according to claim 3, wherein the macromonomer C units is a polyethylene macromonomer.
- 5. A personal care composition according to claim 4, wherein the polyethylene macromonomers correspond to the formula: [I] n- [W] mE wherein I is an initiating portion, n is an integer of 0 or 1 , W is a monomer unit, hydrophobic, E is a crowned group at the end, and m is an integer from about 10 to about 2000.
- 6. A personal care composition according to claim 5, wherein the hydrophobic unit A it is selected from the group consisting of esters of acrylic acid, esters of methacrylic acid, vinyl compounds, vinylidene compounds, unsaturated hydrocarbons, esters of alcohols of 1 to 18 carbon atoms. P771 carbon of organic acids and anhydrides of organic acids, and mixtures thereof. A personal care composition according to claim 6, wherein the A, hydrophobic unit is selected from the group consisting of t-butyl acrylate, t-butyl methacrylate, t-butyl styrene, 2-ethylhexyl methacrylate , and mixtures thereof. 8. A personal care composition according to claim 7, wherein the hydrophilic unit B is selected from the group consisting of mono- and polycarboxylic acids, organic, unsaturated, unsaturated acrylates and methacrylates, unsaturated acrylamides and methacrylamides, unsaturated acrylate alcohols, and methacrylate alcohols, unsaturated amino alkylacrylates, unsaturated organic acid anhydrides, unsaturated esters of organic acids, hydrophilic unsaturated vinyl compounds, hydrophilic unsaturated allyl compounds , unsaturated, hydrophilic imides, and mixtures thereof. 9. A personal care composition according to claim 8, wherein the hydrophilic unit B is selected from the group consisting of acrylic acid, methacrylic acid, N, N-dimethylacrylamide, t-butyl acrylamide, vinyl pyrrolidone, and mixtures thereof. P771 10. A personal composition according to claim 9, wherein I is selected from the group consisting of initiators derived from hydrogen ion, hydrogen radical, hydride ion, hydroxide ion, hydroxyl radical, peroxide radical, anion of peroxide, carbocations of 1 to 20 carbon atoms, carboanions of 1 to 20 carbon atoms, carbon radicals of 1 to 20 carbon atoms, aliphatic alkoxy anions of 1 to 20 carbon atoms, anions of aromatic alkoxy acids of 1 to 20 carbon atoms, ammonium ion, alkyl substituted ammonium ions of 1 to 20 carbon atoms, alkoxy substituted ammonium anions of 1 to 20 carbon atoms, and mixtures thereof; W is selected from the group consisting of n-butyl acrylate, dodecyl acrylate, ethyl acrylate, 2-ethylbutyl acrylate, n-heptyl acrylate, n-hexyl acrylate, isobutyl acrylate, isodecyl acrylate, acrylate. of isopropyl, 3-methylbutyl acrylate, 2-methylpentyl acrylate, nonyl acrylate, octyl acrylate, 1-propyl acrylate, 2-ethylhexyl methacrylate, octyl methacrylate, n-dodecyl methacrylate, n-octadecyl methacrylate , n-decyl methacrylate, n-pentyl methacrylate, isobutylene, isoprene, 1,2-butadiene, 1,3-butadiene, 5-methyl-1-haxane, 6-methyl-1-heptane, 4, 4-dimethyl -l-pentane, isobutyl vinyl ether, P771 styrene, 2-methylstyrene, 3-methylstyrene, 4-methylstyrene, 2-t-butylstyrene, and mixtures thereof; and E is selected from the group consisting of vinyl, allyl, acryloyl, methacryloyl, ethacryloyl, 3-vinylbenzyl, 4-vinylbenzyl, 3-vinylbenzyl, 4-vinylbenzoyl, 1-butenyl, 1-propenyl, isobutenyl, and mixtures thereof. the same. 11. A composition according to claim 10, wherein the macromonomer C units are selected from the group consisting of polymers end capped with acryloyl, methacryloyl, or 2-, 3-, or 4-vinylbenzyl poly (acrylate) n-butyl), poly (dodecyl acrylate), poly (2-ethylhexyl acrylate), poly (2-ethylbutyl acrylate), poly (n-heptyl acrylate), poly (n-hexyl acrylate), poly (isobutyl acrylate), poly (isodecyl acrylate), poly (isopropyl acrylate), poly (3-methylbutyl acrylate), poly (2-methylpentyl acrylate), poly (nonyl acrylate), poly (acrylate) octyl), poly (propyl acrylate), poly (2-ethylhexyl methacrylate), poly (tridecyl methacrylate), poly (hexyl methacrylate), poly (decyl methacrylate), poly (octyl methacrylate), poly ( octadecyl methacrylate), poly (dodecyl methacrylate), poly (n-pentyl methacrylate), poly (isobutylene), poly (isoprene), poly (1, 2-butadiene) hydrogenated , poly (1,4- Butadiene P771) hydrogenated, hydrogenated poly (isoprene), poly (1,2-butadiene), poly (1-butene), poly (5-methyl-1-hexane), poly (6-methyl-1-heptene), poly (4,4-dimethyl-l-pentene), poly (isobutyl vinyl ether), poly [4-t-butyl-vinyl-benzene-2-ethylhexyl acrylate], poly [2-ethylhexyl-co-acrylate] octyl acrylamide], poly [2-ethyl-vinyl-benzene-co-octyl methacrylate]], and mixtures thereof. 12. A personal care composition according to claim 11, wherein the complex forming fat amine is selected from the group consisting of primary amines, secondary amines, and tertiary amines, quaternary ammonium salts, heterocyclic amines substituted with alkyl, polyamines, derivatives thereof, salts thereof, and mixtures thereof. 13. A personal care composition according to claim 12, wherein the complex forming fatty amine is a tertiary amine or a salt thereof having the formula R 1 R 2 R 3 N wherein R 1, R 2 and R 3 are independently selected from the group consisting of straight chain aliphatic groups of 1 to 22 carbon atoms, hydroxyalkyl of 2 to 22 carbon atoms, amidoalkyl of 2 to 22 carbon atoms, carboxyalkyl of 2 to 22 carbon atoms, cyclic groups of 3 to 22 carbon atoms, alkoxy of 2 to 22 carbon atoms, polyalkoxy P771 of 2 to 22 carbon atoms, and hydroxypolialkoxy of 2 to 22 carbon atoms and branched chain aliphatic groups of 1 to 22 carbon atoms, hydroxyalkyl of 2 to 22 carbon atoms, amidoalkyl of 2 to 22 carbon atoms, carboxyalkyl of 2 to 22 carbon atoms, cyclic groups of 3 to 22 carbon atoms, alkoxy of 2 to 22 carbon atoms, polyalkoxy of 2 to 22 carbon atoms, and hydroxypolyalkoxy of 2 to 22 carbon atoms, and mixtures of the same. 14. A personal care composition according to claim 13, wherein the complexing fatty amine is a tertiary amine or a salt thereof having the formula RRRN wherein R is selected from the group consisting of aliphatic groups straight chain, 10 to 18 carbon atoms, hydroxyalkyl of 10 to 18 carbon atoms, amidoalkyl of 10 to 18 carbon atoms, cycloalkyl of 10 to 18 carbon atoms, cyclic groups of 10 to 18 carbon atoms, alkoxy from 10 to 18 carbon atoms, polyalkoxy of 10 to 18 carbon atoms, and hydroxypolialkoxy of 10 to 18 carbon atoms and branched chain aliphatic groups of 10 to 18 carbon atoms, hydroxyalkyl of 10 to 18 carbon atoms, amidoalkyl from 10 to 18 carbon atoms, carboxyalkyl from 10 to 18 carbon atoms, cyclic groups from 10 to 18 carbon atoms, alkoxy from 10 to 18 carbon atoms, P771 polyalkoxy of 10 to 18 carbon atoms, and hydroxypolialkoxy of 10 to 18 carbon atoms with the proviso that R 2 is a methyl group and R 3 = R 2. 15. A personal care composition according to claim 14, wherein the copolymer of the copolymer complex is prepared by the polymerization combination of the following relative weight percentages of units A, B and C: a. from about 40% to about 80% of the hydrophobic A unit; b. from 5% to about 30% of the hydrophobic unit B; c. from about 5 to about 40% of the hydrophobic C unit wherein unit C has a weight average molecular weight of from about 5,000 to about 50,000. 16. A personal care composition according to claim 15, wherein the component is hydrophobic, volatile solvent is selected from the group consisting of branched hydrocarbons, from 7 to 14 carbon atoms, volatile, hydrophobic, silicones, volatile hydrophobic and mixtures thereof. 17. A personal care composition according to claim 16, wherein the component of P771 hydrophobic, volatile solvent is selected from the group consisting of hexamethyldisiloxane, isododecane, cyclomethicone, and mixtures thereof. 18. A personal care composition according to claim 17, further comprising a carrier selected from the group consisting of foams, gels, lotions, creams, ointments, tonics, sprays, aerosols, shampoos, conditioners, rinses, soaps in bar, body and hand lotions, facial moisturizers, solid gel bars. 19. A personal care composition according to claim 18, wherein the composition further comprises from about 10% to about 30% of the composition of a synthetic surfactant. 20. A personal care composition according to claim 19, wherein the synthetic surfactant is selected from the group consisting of alkyl sulfates, ethoxylated alkyl sulphates, and mixtures thereof. 21. A personal care composition according to claim 20, wherein the composition is a shampoo. 22. A personal care composition according to claim 18, wherein the composition P771 further comprises a pharmaceutical active selected from the group consisting of anti-acne active, analgesic active, anti-pruritic active, anesthetic active, antimicrobial active, sun-blocking active, tanning active without sun., skin lightening assets, anti-dandruff active, antiperspirant active, active deodorants, and mixtures thereof. 23. A personal care composition, comprising: A.) a copolymer complex comprising: a.) A copolymer having a structure formed from the copolymerization of repeating units of monomer A and monomer B wherein the structure is optionally grafted to these hydrophobic units of the macromonomer C wherein the copolymer is prepared by the polymerization combination of the following percentages by weight, relative of units A, B and C: i) from about 10% to about 99% in weight of the copolymer, of one or more hydrophobic units of monomer A, wherein the monomer units A are copolymerizable with the units of monomer B and macromonomer C; ii) from about 1% to about 40% P771 by weight of the copolymer, of one or more hydrophilic units of monomer B, wherein the units of monomer B are copolymerizable with the monomer A and macromonomer C units and wherein at least about 1% by weight of the copolymer, of the units of monomer B, are selected from monomer units B having at least one acid functional group; and iii) from about 0 to about 50% by weight of the copolymer of one or more units of macromonomer C, wherein the C units are hydrophobic macromonomer units, copolymerizable with monomer units A and monomer units B; the macromonomer C units have a number average molecular weight of about 1,500 to about 50,000; and b.) a complexing fatty amine wherein the fatty amine forms a complex with the acidic functional group of the B monomer units; wherein the weight ratio of the copolymer to the fatty amine is from about 50: 1 to about 1: 1; and B. ) a component of hydrophobic solvent, volatile for the P771 copolymer complex having a boiling point at an atmosphere of about 260 ° C or less and a parameter of 3 1/2 solubility of about 8.5 (cal / cm) or less; and C.) a carrier immiscible with the hydrophobic, volatile solvent component, wherein the copolymer complex is soluble or dispersible in the component in the hydrophobic, volatile solvent component. 24. A personal care composition according to claim 23, wherein the macromonomer C units are present in a concentration from about 5% to about 40% by weight of the copolymer. 25. A method for treating the hair, by administering a safe and effective amount of the compositions according to claim 1. 26. A method for treating the skin, by administering a safe and effective amount of the compositions according to the claim 1. A method for making a personal care composition, comprising the steps of: a.) Preparing a copolymer having a structure formed from the copolymerization of monomer units A and monomer B, repeating, in where the structure has optionally grafted the P771 C-macromonomer units, hydrophobic, wherein the copolymer is prepared by the polymerization combination of the following percentages by weight, relative of units A, B, and C: i) from about 10% to about 99% by weight of the copolymer of one or more hydrophobic units of monomer A, wherein the monomer units A are copolymerizable with the units of monomer B and macromonomers C; ii) from about 1% to about 40% by weight of the copolymer of one or more hydrophilic units of monomer B, wherein the monomer units B are copolymerizable with the monomer A and macromonomer C units, and wherein at least about 1% by weight of the copolymer, the monomer units B are selected from units of monomer B having at least one acid functional group; and iii) from about 0 to about 50% by weight of the copolymer of one or more units of macromonomer C, wherein the C units are hydrophobic macromonomer units, copolymerizable with monomer units A and monomer units B, units of macromonomer C have a number average molecular weight from about 1,500 to about 50,000; and b.) forming the copolymer complex with a fatty amine, wherein the weight ratio of the copolymer to the fatty amine is from about 50: 1 to about 1: 1; and c.) dissolving or dispersing the copolymer complex in a hydrophobic, volatile solvent component having a boiling point at an atmosphere of about 260 ° C or less, and a solubility parameter of about 8.5 (cal / cm 3) 12 or less . 28. A personal care composition according to claim 27, wherein the macromonomer C units are present at a concentration of from about 5% to about 40% by weight of the copolymer. 29. A personal care composition, which before mixing, comprises: A.) a copolymer complex, comprising: a.) A copolymer having a structure formed from the copolymerization of repeating units of monomer A and monomer B, wherein the structure optionally has units of macromonomer C, hydrophobic, wherein the P771 copolymer is prepared by the polymerization combination of the following relative weight percentages of units A, B, and C: i) from about 10% to about 99% by weight of the copolymer of one or more hydrophobic units of monomer A, wherein the monomer units A are copolymerizable with the units of monomer B and macromonomers C; ii) from about 1% to about 40% by weight of the copolymer of one or more hydrophilic units of monomer B, wherein the units of monomer B are copolymerizable with the units of monomer A and macromonomer C, and wherein at least about 1% by weight of the copolymer, of the monomer units B, are selected from units of monomer B having at least one acid functional group; and iii) from about 0 to about 50% by weight of the copolymer of one or more units of macromonomer C, wherein the C units are hydrophobic macromonomer units, copolymerizable with the monomer units A and the monomer units B, the units of macromonomer C have an average molecular weight in number from about 1,500 to about 50,000; and b.) a complexing fatty amine wherein the fatty amine forms a complex with the acid functional group of the B monomer units; wherein the weight ratio of the copolymer to the fatty amine is from about 50: 1 to about 1: 1; and B.) a volatile, hydrophobic solvent component for the copolymer complex having a boiling point at an atmosphere of about 260 ° C or less, and a solubility parameter of about 8.5 (cal / cm 3) 1/2 or less where the copolymer complex soluble or dispersible in the hydrophobic, volatile solvent component. 30. A personal care composition according to claim 29, wherein the macromonomer C units are present at a concentration of from about 5% to about 40% 40% by weight of the copolymer. 31. A styling and hair conditioning composition, comprising: A.) a copolymer complex comprising: a.) A copolymer having a structure formed from the copolymerization of units of P771 repeating monomer A and monomer B wherein the structure has optionally grafted to these hydrophobic units of macromonomer C wherein the copolymer is prepared by the polymerization combination of the following percentages by weight, relative of units A, B and C: i) from about 10% to about 99% by weight of the copolymer, of one or more hydrophobic units of monomer A, wherein the monomer units A are copolymerizable with the units of monomer B and macromonomer C; ii) from about 1% to about 40% by weight of the copolymer, of one or more hydrophilic units of monomer B, wherein the monomer units B are copolymerizable with the monomer A and macromonomer C units and wherein at least about 1% by weight of the copolymer, of monomer units B, are selected from monomer units B having at least one nitrogen-containing functional group; and iii) from 0 to about 50% by weight of the copolymer of one or more units of macromonomer C, wherein the C units are hydrophobic macromonomer units, copolymerizable with monomer units A and monomer units B; the macromonomer C units have a number average molecular weight of about 1,500 to about 50,000; and b.) a complexing fatty amine wherein the fatty amine forms a complex with the acidic functional group of the B monomer units; wherein the weight ratio of the copolymer to the fatty amine is from about 50: 1 to about 1: 1; and B.) a volatile, hydrophobic solvent component for the copolymer complex having a boiling point at an atmosphere of about 260 ° C or less and a solubility parameter of about 8.5 (cal / cm 3) 1/2 or less where the copolymer complex is soluble or dispersible in the hydrophobic solvent component, volatile and wherein the copolymer complex and the volatile, hydrophobic solvent component mixture have a viscosity above about 5,000 cps. 32. A hair care composition, comprising: I.) A hair styling and conditioning component, comprising: A.) a copolymer complex, comprising: P771 a.) A copolymer having a structure formed from the copolymerization of repeating units of monomer A and monomer B, wherein the structure optionally has grafted units of macromonomer C, based on siloxane, wherein the copolymer is prepared by the polymerization combination of the following relative weight percentages of units A, B, and C: i) from about 10% to about 99% by weight of the copolymer of one or more hydrophobic units of monomer A, wherein the units of monomer A are copolymerizable with monomer units B and macromonomers C; ii) from about 1% to about 40% by weight of the copolymer of one or more hydrophilic units of monomer B, wherein the units of monomer B are copolymerizable with the units of monomer A and macromonomer C, and wherein at least about 1% by weight of the copolymer, of the monomer units B, are selected from units of monomer B having at least one acid functional group; and iii) from about 0 to about 50% by weight of the copolymer of one or more units of macromonomer C, wherein the C units are hydrophobic macromonomer units, copolymerizable with the monomer units A and the units of monomer B, the units of macromonomer C have a molecular weight in average number from about 1,500 to about 50,000; and b.) a complexing fatty amine wherein the fatty amine forms a complex with the acid functional group of the B monomer units; wherein the weight ratio of the copolymer to the fatty amine is from about 50: 1 to about 1: 1; and B.) a volatile, hydrophobic solvent component for the copolymer complex having a boiling point at an atmosphere of about 260 ° C or less, and a solubility parameter of about 8.5 (cal / cm 3) 1 2 or less in wherein the mixture of the copolymer complex and the hydrophobic, volatile solvent component has a viscosity of above about 5,000 cps; and II.) a carrier immiscible with the solvent component, hydrophobic, volatile. 33. A composition for personal care, which includes: P771 A.) a copolymer complex, comprising: a.) A copolymer having a structure formed from the copolymerization of repeating units of monomer A and monomer B, wherein the structure optionally grafted units of macromonomer C, based on siloxane, wherein the copolymer is prepared by the polymerization combination of the following relative weight percentages of units A, B, and C: i) from about 10% to about 99% by weight of the one or more copolymer hydrophobic units of monomer A, wherein the monomer units A are copolymerizable with the units of monomer B and macromonomers C; ii) from about 1% to about 40% by weight of the copolymer of one or more hydrophilic units of monomer B, wherein the units of monomer B are copolymerizable with the units of monomer A and macromonomer C, and wherein at least about 1% by weight of the copolymer, of the monomer units B, are selected from units of monomer B having at least one acid functional group; and i) from about 0 to about 50% by weight of the copolymer of one or more P771 units of macromonomer C, wherein the C units are hydrophobic macromonomer units, copolymerizable with the monomer units A and the monomer units B, the macromonomer units C have a number average molecular weight from about 1,500 to about 50,000; and b.) a complexing fatty amine wherein the fatty amine forms a complex with the acid functional group of the B monomer units; wherein the weight ratio of the copolymer to the fatty amine is from about 50: 1 to about 1: 1; and B.) a volatile hydrophobic solvent component for the copolymer complex having a boiling point at an atmosphere of about 260 ° C or less, and a solubility parameter of about 8.5 (cal / cm 3) 12 or less where The copolymer is soluble or dispersible in the hydrophobic, volatile solvent component. 34. A personal care composition according to claim 33, wherein the macromonomer C units are present at a concentration of from about 5% to about 40% by weight of the P771 copolymer. 35. A personal care composition according to claim 34, wherein the units of monomer A and monomer B are ethylenically unsaturated, and wherein the unit of macromonomer C has the general formula: X (Y) nSi (R) 3_m ( z) m wherein: X is a vinyl group copolymerizable with the monomers A and the monomers B; And it's a divalent link group; R is a hydrogen, alkyl of 1 to 4 carbon atoms, aryl substituted with alkyl of 1 to 4 carbon atoms, or alkoxy of 1 to 4 carbon atoms; Z is a monovalent siloxane polymer portion having a number average molecular weight of at least about 1500, is essentially non-reactive under copolymerization conditions, and is pendant from the vinyl polymer structure after polymerization; n is 0 or 1; and m is an integer from 1 to 3. 36. A personal care composition according to claim 35, wherein the hydrophobic unit A is selected from the group consisting of esters of P771 acrylic acid, esters of methacrylic acid, vinyl compounds, vinylidene compounds, unsaturated hydrocarbons, esters of alcohols of 1 to 18 carbon atoms, of organic acids, and anhydrides of organic acids, and mixtures thereof. 37. A personal care composition according to claim 36, wherein the A, hydrophobic unit is selected from the group consisting of t-butyl acrylate, t-butyl methacrylate, t-butyl styrene, 2-ethylexyl methacrylate , and mixtures thereof. 38. A personal care composition according to claim 37, wherein the hydrophilic unit B is selected from a group consisting of unsaturated organic mono- and polycarboxylic acids, unsaturated acrylates and methacrylates, unsaturated acrylamides and methacrylamides, alcohols of acrylate and unsaturated methacrylate alcohols, unsaturated aminoalkyl acrylates, unsaturated organic acid anhydrides, unsaturated esters of organic acid anhydrides, hydrophilic unsaturated vinyl compounds, hydrophilic unsaturated allylic compounds, hydrophilic unsaturated imides and mixtures thereof. 39. A personal care composition according to claim 38, wherein the hydrophilic unit B is selected from the group consisting of acid P771 acrylic, methacrylic acid, N, N-dimethylacrylamide, t-butyl acrylamide, vinyl pyrrolidone, and mixtures thereof. 40. A personal care composition according to claim 39, wherein the C unit containing polysiloxane has a formula selected from the following group consisting of: X- CH2- (CHjJs-SilR1 -m-Z, O 0 X-C-0- (CH2)? - (OJp-S¡ (R ') 3.mZm where s is 0, 1, 2, 3, 4, 5, 6; m is 1, 2, or 3; p is 0; q is 2, 3, 4, 5 or 6; R is hydrogen, hydroxyl, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, alkylamino of 1 to 4 carbon atoms, phenyl, or aryl substituted with alkyl of 1 to 4 carbon atoms; R2 is alkyl of 1 to 6 carbon atoms or aryl substituted with alkyl of 7 to 10 carbon atoms; n is 0, 1, 2, 3 or 4; X is P771 CH = C- I I R3 R4 wherein R is hydrogen or -COOH; R is hydrogen, methyl or -CH2COOH; Z is I R7 R, R, and R independently are alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, alkylamino of 1 to 4 carbon atoms, phenyl, aryl substituted with alkyl of 1 to 4 carbon atoms, hydrogen or hydroxyl; and r is an integer from about 20 to about 675. 41. A personal care composition according to claim 40, wherein the C unit containing polysiloxane has the formula: where m is 1; p is 0; q is 3; R is methyl; X is P771 CN = C- I I R4 wherein R 3 is hydrogen; R4 is methyl, and Z is ? R5 - (- S? -O-V fi 7 R, R, and R are all methyl; and r is an integer from about 100 to about 325. 42. A personal care composition according to claim 41, wherein the complexing fat amine is selected from the group consisting of primary amines, secondary amines, and tertiary amines, quaternary ammonium salts, heterocyclic amines substituted with alkyl, polyamines, derivatives thereof, salts thereof, and mixtures thereof. 43. A personal care composition according to claim 42, wherein the complexing fatty amine is a tertiary amine or a salt thereof having the formula RRRN wherein R, R2 and R3 are independently selected from the group that P771 consists of straight chain aliphatic groups of 1 to 22 carbon atoms, hydroxyalkyl of 2 to 22 carbon atoms, amidoalkyl of 2 to 22 carbon atoms, carboxyalkyl of 2 to 22 carbon atoms, cyclic groups of 3 to 22 atoms of carbon, alkoxy of 2 to 22 carbon atoms, polyalkoxy of 2 to 22 carbon atoms, and hydroxypolialkoxy of 2 to 22 carbon atoms and branched chain aliphatic groups of 1 to 22 carbon atoms, hydroxyalkyl of 2 to 22 atoms of carbon, amidoalkyl of 2 to 22 carbon atoms, carboxyalkyl of 2 to 22 carbon atoms, cyclic groups of 3 to 22 carbon atoms, alkoxy of 2 to 22 carbon atoms, polyalkoxy of 2 to 22 carbon atoms, and hydroxypolialkoxy of 2 to 22 carbon atoms, and mixtures thereof. 44. A personal care composition according to claim 43, wherein the complex forming fatty amine is a tertiary amine or salt thereof having the formula RRRN wherein R is selected from the group consisting of aliphatic groups straight chain, 10 to 18 carbon atoms, hydroxyalkyl of 10 to 18 carbon atoms, amidoalkyl of 10 to 18 carbon atoms, cycloalkyl of 10 to 18 carbon atoms, cyclic groups of 10 to 18 carbon atoms, alkoxy of 10 to 18 carbon atoms, polyalkoxy of 10 to 18 carbon atoms, and hydroxypolialkoxy of 10 to 18 carbon atoms P771 carbon and branched chain aliphatic groups of 10 to 18 carbon atoms, hydroxyalkyl of 10 to 18 carbon atoms, amidoalkyl of 10 to 18 carbon atoms, carboxyalkyl of 10 to 18 carbon atoms, cyclic groups of 10 to 18 atoms carbon, alkoxy of 10 to 18 carbon atoms, polyalkoxy of 10 to 18 carbon atoms, and hydroxypolialkoxy of 10 to 18 carbon atoms with the proviso that R is a methyl group and R = R. 45. A personal care composition according to claim 44, wherein the copolymer of the copolymer complex is prepared by the polymerization combination of the following relative weight percentages of the units A, B, and C: a. from about 40% to about 80% of the hydrophobic A unit; b. from 5% to about 30% of the hydrophobic unit B; and c. from about 5% to about 40% of the C unit containing polysiloxane, wherein unit C has a weight average molecular weight of from about 5,000 to about 30,000. 46. A personal care composition according to claim 45, wherein the hydrophobic, volatile solvent component is selected from the P771 group consisting of branched hydrocarbons, from 7 to 14 carbon atoms, volatile, hydrophobic, silicones, hydrophobic, volatile and mixtures thereof. 47. A personal care composition according to claim 46, wherein the hydrophobic, volatile solvent component is selected from the group consisting of hexamethyldisiloxane, isododecane, cyclomethicone, and mixtures thereof. 48. A personal care composition according to claim 47, further comprising a carrier selected from the group consisting of foams, gels, lotions, creams, ointments, tonics, sprays, aerosols, shampoos, conditioners, rinses, bar soaps, body and hand lotions, facial moisturizers, solid gel bars. 49. A personal care composition according to claim 48, wherein the composition further comprises from about 10% to about 30% of a synthetic surfactant. 50. A personal care composition according to claim 49, wherein the synthetic surfactant is selected from the group consisting of alkyl sulfates, ethoxylated alkyl sulphates, and mixtures thereof. 51. A personal care composition according to the P771 claim 50, wherein the composition is a shampoo. 52. A personal care composition according to claim 48, wherein the composition further comprises a conditioning agent, comprising: A. from about 0.1% to about 10% of a lipid carrier material; and B. from about 0.05% to about 5% of a cationic surfactant. 53. A personal care composition according to claim 52, wherein the composition is a conditioner. 54. A personal care composition according to claim 48, wherein the composition further comprises a pharmaceutical active selected from the group consisting of anti-acne active, analgesic active, antipruritic active, anesthetic active, antimicrobial active, blocking active. of sunrays, sunless tanning assets, skin lightening assets, anti-dandruff active, antiperspirant active, active deodorants, and mixtures thereof. 55. A composition for personal care, P771 comprising: A.) a copolymer complex, comprising: a.) A copolymer having a structure formed from the copolymerization of repeating units of monomer A and monomer B, wherein the structure optionally has units of C-macromonomer, based on siloxane, wherein the copolymer is prepared by the polymerization combination of the following rela weight percentages of units A, B, and C: i) from about 10% to about 99% by weight of the copolymer of one or more hydrophobic units of monomer A, wherein the monomer units A are copolymerizable with the units of monomer B and macromonomers C; ii) from about 1% to about 40% by weight of the copolymer of one or more hydrophilic units of monomer B, wherein the units of monomer B are copolymerizable with the units of monomer A and macromonomer C, and wherein at least about 1% by weight of the copolymer, of the monomer units B, are selected from units of monomer B having at least one acid functional group; and iii) from about 0 to about P771 50% by weight of the copolymer of one or more units of macromonomer C, wherein the C units are hydrophobic units of macromonomer, copolymerizable with the units of monomer A and the units of monomer B, the units of macromonomer C have a molecular weight in average number from approximately 1,500 to approximately 50,000; and b.) from about 1% to about 65 % by weight of a complex amine complex fatty amine complex, wherein the fatty amine forms a complex with the acid functional group of the B monomer units; wherein the weight ratio of the copolymer to the fatty amine is from about 50: 1 to about 1: 1; and B.) a volatile, hydrophobic solvent component for the copolymer complex having a boiling point at an atmosphere of about 260 ° C or less, and a solubility parameter of about 8.5 (cal / cm 3) 1/2 or less, and C.) a carrier immiscible with the hydrophobic, volatile solvent component wherein the copolymer complex is soluble or dispersible P771 in the hydrophobic, volatile solvent component. 56. A personal care composition according to claim 55, wherein the macromonomer C units are present at a concentration of from about 5% to about 40% by weight of the copolymer. 57. A method for treating the hair, by administering a safe and effec amount of the compositions according to claim 48. 58. A method for cleaning the hair, by administering a safe and effec amount of the compositions according to claim 51. 59. A method for styling and retaining the hair, by administering a safe and effec amount of the compositions according to claim 53. 60. A method for treating the skin, by administering a safe and effec amount of the compositions according to claim 54. 61. A method for making a personal care composition, comprising the steps of: a.) Preparing a copolymer having a structure formed from the copolymerization of repeating monomer A and monomer B units, wherein the structure has optionally grafted C-macromonomer units, based on siloxane, P771 wherein the copolymer is prepared by the polymerization combination of the following rela weight percentages of units A, B, and C: i) from about 10% to about 99% by weight of the copolymer of one or more hydrophobic units of monomer A, wherein the monomer units A are copolymerizable with the units of monomer B and macromonomers C; ii) from about 1% to about 40% by weight of the copolymer of one or more hydrophilic units of monomer B, wherein the monomer units B are copolymerizable with the monomer A and macromonomer C units, and wherein at least about 1% by weight of the copolymer, the monomer units B, are selected from units of monomer B having at least one acid functional group; and iii) from about 0 to about 50% by weight of the copolymer of one or more units of macromonomer C, wherein the C units are hydrophobic macromonomer units, copolymerizable with monomer units A and monomer units B, units of macromonomer C have a number average molecular weight from about 1,500 to about 50,000; b.) forming the copolymer complex with a fatty amine, wherein the weight ratio of the copolymer to the fatty amine is from about 50: 1 to about 1: 1; and c.) dissolving or dispersing the copolymer complex in a hydrophobic, volatile solvent component having a boiling point at an atmosphere of about 260 ° C or less, and a solubility parameter of about 8.5 (cal / cm 3) 1 2 or less . 62. A personal care composition according to claim 61, wherein the macromonomer C units are present at a concentration of from about 5% to about 40% by weight of the copolymer. 63. A personal care composition which before mixing, comprises: A.) a copolymer complex, comprising: a.) A copolymer having a structure formed from the copolymerization of repeating units of monomer A and monomer B, where the structure has optionally grafted units P771 of macromonomer C, based on siloxane, wherein the copolymer is prepared by the polymerization combination of the following relative weight percentages of units A, B, and C: i) from about 10% to about 99% by weight of the copolymer of one or more hydrophobic units of monomer A, wherein the monomer units A are copolymerizable with the units of monomer B and macromonomers C; ii) from about 1% to about 40% by weight of the copolymer of one or more hydrophilic units of monomer B, wherein the monomer units B are copolymerizable with the monomer A and macromonomer C units, and wherein at least about 1% by weight of the copolymer, the monomer units B are selected from units of monomer B having at least one acid functional group; and iii) from about 0 to about 50% by weight of the copolymer of one or more units of macromonomer C, wherein the C units are hydrophobic macromonomer units, copolymerizable with monomer units A and monomer units B, units of macromonomer C have a number average molecular weight from about 1,500 to about 50,000; and b.) from about 1% to about 65% by weight of the complex complex fatty amine complex, wherein the fatty amine forms a complex with the acid functional group of the monomer units B; wherein the weight ratio of the copolymer to the fatty amine is from about 50: 1 to about 1: 1; and B.) a volatile, hydrophobic solvent component for the copolymer complex having a boiling point at an atmosphere of about 260 ° C or less, and a solubility parameter of about 8.5 (cal / cm 3) 1/2 or less where the copolymer complex is soluble or dispersible in the hydrophobic, volatile solvent component 64. A personal care composition according to claim 63, wherein the macromonomer C units are present at a concentration of from about 5% to about 40% by weight of the copolymer. 65. A styling and conditioning composition for hair, comprising: P771 A.) a copolymer complex, comprising: a.) A copolymer having a structure formed from the copolymerization of repeating units of monomer A and monomer B, wherein the structure optionally grafted units of macromonomer C, based on siloxane, wherein the copolymer is prepared by the polymerization combination of the following relative weight percentages of units A, B, and C: i) from about 10% to about 99% by weight of the one or more copolymer hydrophobic units of monomer A, wherein the monomer units A are copolymerizable with the units of monomer B and macromonomers C; ii) from about 1% to about 40% by weight of the copolymer of one or more hydrophilic units of monomer B, wherein the units of monomer B are copolymerizable with the units of monomer A and macromonomer C, and wherein at least about 1% by weight of the copolymer, of the monomer units B, are selected from units of monomer B having at least one acid functional group; and iii) from about 0 to about 50% by weight of the one or more copolymer P771 units of macromonomer C, wherein the C units are hydrophobic macromonomer units, copolymerizable with the monomer units A and the monomer units B, the macromonomer units C have a number average molecular weight from about 1,500 to about 50,000; and b.) from about 1% to about 65% by weight of the complex complex fatty amine complex, wherein the fatty amine forms a complex with the acid functional group of the monomer units B; wherein the weight ratio of the copolymer to the fatty amine is from about 50: 1 to about 1: 1; and B.) a volatile, hydrophobic solvent component for the copolymer complex having a boiling point at an atmosphere of about 260 ° C or less, and a solubility parameter of about 8.5 (cal / cm3) 1/2 or less wherein the copolymer complex soluble or dispersible in the hydrophobic, volatile solvent component, and wherein the mixture of copolymer complex and the hydrophobic, volatile solvent component has a P771 viscosity above about 5,000 cps. 66. A hair care composition, comprising: I.) a styling and conditioning component of the hair, comprising: A.) a copolymer complex, comprising: a.) A copolymer having a structure formed at Starting from the copolymerization of repeating units of monomer A and monomer B, wherein the structure has optionally grafted units of macromonomer C, based on siloxane, wherein the copolymer is prepared by the polymerization combination of the following relative weight percentages of units A, B, and C: i) from approximately 10% to approximately 99% by weight of the copolymer of one or more hydrophobic units of monomer A, wherein the monomer units A are copolymerizable with the units of monomer B and macromonomers C; ii) from about 1% to about 40% by weight of the copolymer of one or more hydrophilic units of monomer B, wherein the monomer units B are copolymerizable with the units of monomer A and macromonomer C, and wherein at least about 1% by weight of the P771 copolymer, of monomer units B, are selected from monomer units B having at least one acid functional group; and iii) from about 0 to about 50% by weight of the copolymer of one or more units of macromonomer C, wherein the C units are hydrophobic macromonomer units, copolymerizable with monomer units A and monomer units B, units of macromonomer C have a number average molecular weight from about 1,500 to about 50,000; and b.) from about 1% to about 65% by weight of the complex amine complex fatty amine complex, wherein the fatty amine forms a complex with the acidic functional group of the monomer units Well where the weight ratio of the copolymer to the fatty amine is from about 50: 1 to about 1: 1; and B.) a volatile, hydrophobic solvent component for the copolymer complex having a boiling point at an atmosphere of about 260 ° C or less, and a solubility parameter of about 8.5 (cal / cm 3) 172 P771 or less and wherein the copolymer complex is soluble or dispersible in the hydrophobic, volatile solvent component wherein the mixture of the copolymer complex and the hydrophobic, volatile solvent component has a viscosity of above 5,000 cps. II.) A carrier immiscible with the hydrophobic, volatile solvent component. P771
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70755496A | 1996-09-04 | 1996-09-04 | |
US70833496A | 1996-09-04 | 1996-09-04 | |
US707554 | 1996-09-04 | ||
US08707554 | 1996-09-04 | ||
US708334 | 1996-09-04 | ||
US08/708334 | 1996-09-04 | ||
US08/833,819 US5916548A (en) | 1996-09-04 | 1997-04-09 | Personal care compositions |
US08833819 | 1997-04-09 | ||
US08/833,820 US5863527A (en) | 1996-09-04 | 1997-04-09 | Personal care compositions |
US08833820 | 1997-04-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9902153A MX9902153A (en) | 1999-07-01 |
MXPA99002153A true MXPA99002153A (en) | 1999-09-20 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3174060B2 (en) | Thermoplastic elastomeric copolymer and hair and skin care composition containing it | |
KR100295938B1 (en) | Silicone grafted thermoplastic elastomers and hair and skin protective compositions containing them | |
KR100294138B1 (en) | Silicone-grafted thermoplastic success polymer and hair and skin protection compositions containing same | |
US6696067B2 (en) | Cosmetic compositions containing dispersion polymers | |
CA2097265C (en) | Cosmetic composition | |
US5916548A (en) | Personal care compositions | |
JPH08512084A (en) | Thermoplastic elastomeric copolymer and hair and skin care compositions containing it | |
AU712379B2 (en) | Topical personal care composition containing alkenyl or styrene end-capped silicone grafted copolymer | |
US5804173A (en) | Personal care compositions | |
US5830447A (en) | Personal care compositions | |
EP0927022A2 (en) | Personal care compositions | |
US5863527A (en) | Personal care compositions | |
AU4249397A (en) | Personal care compositions | |
MXPA99002153A (en) | Personal care compositions | |
MXPA99002154A (en) | Personal care compositions | |
JP2002509522A (en) | Body care composition | |
CA2319800A1 (en) | Thermoplastic elastomeric copolymers and hair and skin care compositions containing the same | |
MXPA97008097A (en) | Topical composition of personal care containing copolymer grafted with silicone and blocked at the end with his styrene or alken | |
JP2002193730A (en) | Cosmetic and preparation for external use |